NETWORK IMAGING CORP
S-1/A, 1997-12-09
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: RACOTEK INC, DEFR14A, 1997-12-09
Next: PROVIDIAN LIFE & HEALTH INSURANCE CO SEPARATE ACCOUNT V, 497, 1997-12-09








                                December 8, 1997


Securities and Exchange Commission
450 Fifth Street N.W.
Washington, D.C. 20549

         RE:      Network Imaging Corporation
                  Registration Statement of Form S-1
                  (Registration No. 333-36385)

Gentlemen:

         Network  Imaging  Corporation  hereby  requests   acceleration  of  the
effective date of the above captioned Registration Statement on Form S-1 to 5:00
p.m.,  Eastern  time,  on Tuesday,  December 9, 1997,  or as soon  thereafter as
practicable.

                                           Very truly yours,



                                           NETWORK IMAGING CORPORATION

                                           By:  /s/ James J. Leto
                                              ----------------------
                                              James J. Leto






<PAGE>


   
    As filed with the Securities and Exchange Commission on December 8, 1997
                                                      Registration No. 333-36385
    
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                         
                               AMENDMENT NO. 1 TO
                                    FORM S-1
                                          
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933

                           NETWORK IMAGING CORPORATION
             (Exact name of Registrant as specified in its charter)

     Delaware                        7373                      54-1590649
(State or other           (Primary Standard Industrial      (I.R.S. Employer
   
jurisdiction of              Classification Code        Identification Number)
incorporation or
organization)
    



                             500 Huntmar Park Drive
                             Herndon, Virginia 20170
                                 (703) 478-2260
               (Address, including zip code, and telephone number,
        including area code, of Registrant's principal executive offices)


                              Julia A. Bowen, Esq.
                       Vice President and General Counsel
                           Network Imaging Corporation
                             500 Huntmar Park Drive
                             Herndon, Virginia 20170
                                 (703) 478-2260
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)


                                    Copy to:
                               Cary J. Meer, Esq.
                           Kirkpatrick & Lockhart LLP
                         1800 Massachusetts Avenue, N.W.
                             Washington, D.C. 20036
                                 (202) 778-9000

Approximate  date of  commencement  of proposed  sale to the public:  As soon as
practicable after the effective date of this Registration Statement.
If any of the  securities  being  registered in this Form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, check the following box. [X]
   
<TABLE>
<CAPTION>
                                           CALCULATION OF REGISTRATION FEE

- ------------------------------- -------------- ------------------ ------------------- ------------------
                                               Proposed Maximum    Proposed Maximum
    Title of Each Class of      Amount To Be    Offering Price        Aggregate           Amount of
 Securities To Be Registered     Registered      Per Share(1)     Offering Price(1)     Registration
                                                                                           Fee(1)
- ------------------------------- -------------- ------------------ ------------------- ------------------
<S>                             <C>            <C>                <C>                 <C>
- ------------------------------- -------------- ------------------ ------------------- ------------------
Common Stock                      2,150,000    $1.55              $3,332,500          $1,010(3)
(par value $.0001 per
share)(2)
- ------------------------------- -------------- ------------------ ------------------- ------------------
</TABLE>
    
(1)  Estimated  pursuant  to  Rule  457  for  the  purpose  of  calculating  the
registration  fee only;  based upon the average of the high and low sales prices
for the Common  Stock on  September  18, 1997.  Registration  fee is  calculated
pursuant to Rule 457.

(2) Includes shares of Common Stock issuable on conversion of and as interest on
the Company's Convertible Notes.

   
(3) Previously paid.
    







================================================================================

The registrant hereby amends this  registration  statement on such date or dates
as may be necessary to delay its effective date until the registrant  shall file
a further amendment which specifically  states that this registration  statement
shall  thereafter  become  effective  in  accordance  with  Section  8(a) of the
Securities  Act of  1933  or  until  the  registration  statement  shall  become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.


<PAGE>


PROSPECTUS

                    SUBJECT TO COMPLETION, ___________, 1997

                                2,150,000 SHARES

                           NETWORK IMAGING CORPORATION

                                  COMMON STOCK

   
         All of the 2,150,000  shares  ("Shares" or "Offered  Shares") of Common
Stock,  $.0001  par value per  share  ("Common  Stock"),  that  Network  Imaging
Corporation  ("Network Imaging" or the "Company") is seeking to register and can
be offered  hereby will be sold by Wood Gundy in trust for RRSP 550 98866 19 and
Gundyco in trust for RRSP 550 99119 12 (collectively referred to as the "Selling
Stockholders").  The Shares are issuable  upon  conversion of and as interest on
certain 8% convertible notes ("Convertible  Notes") that are due on July 8, 2002
and August 20,  2002.  This  Prospectus  relates to the resale of such shares of
Common  Stock by such  Selling  Stockholders.  See  "Plan of  Distribution"  and
"Selling  Stockholders."  The  Company's  Common Stock is quoted on the National
Association of Securities  Dealers,  Inc. Automated  Quotation System ("Nasdaq")
National  Market.  On December  5, 1997,  the last  reported  sale price for the
Common Stock on the Nasdaq National Market was $1 1/4 per share.

         None of the proceeds from the sale of the Offered Shares by the Selling
Stockholders will be received by the Company. The Company will pay substantially
all of the  expenses  with  respect to the  offering and the sale of the Offered
Shares to the  public,  including  the costs  associated  with  registering  the
Offered Shares under the Securities Act of 1933, as amended  ("Securities  Act")
and preparing and printing this Prospectus.  Normal underwriting commissions and
broker fees,  however,  as well as any applicable  transfer  taxes,  are payable
individually by the Selling Stockholders.
    

         See "Risk  Factors"  beginning  on page 4 for a  discussion  of certain
factors that should be considered in connection  with the purchase of securities
hereunder.

                     ---------------------------------------
  THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
  EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES
        AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED
   UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE
                         CONTRARY IS A CRIMINAL OFFENSE.
                     ---------------------------------------
  INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGIS-
     TRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE
  SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY
     OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT
   BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR
    THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE
     SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD
     BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES
                             LAWS OF ANY SUCH STATE.
                     ---------------------------------------


   
                  , 1997
    


<PAGE>

                               PROSPECTUS SUMMARY

   
         The following summary is qualified in its entirety by the more detailed
information  and financial  statements,  including the notes thereto,  appearing
elsewhere in this  Prospectus.  The Common Stock offered hereby  involves a high
degree of risk. See "Risk Factors." Unless otherwise indicated,  all information
in this  Prospectus  regarding stock ownership and voting power of the Company's
Common Stock is as of November 13, 1997.
    


                                   THE COMPANY

         Network  Imaging  Corporation  ("Network  Imaging"  or  the  "Company")
provides  software  products  supporting  storage,  management and distribution.
These products provide businesses and government organizations with an automated
method of  electronically  storing,  managing and distributing  large volumes of
structured data (text) and unstructured data (diagrams, documents, photos, voice
and full-motion video).

         The  Company  is a leader in content  and  storage  management  for all
unstructured  information.  Its flagship product,  the 1View suite,  manages the
storage,  access and distribution of any multimedia (or unstructured) data, such
as diagrams,  documents,  photographs,  voice, and full-motion video. 1View is a
unique solution for use in distributed,  high  transaction,  high volume mission
critical applications across legacy,  client/server and Internet/intranet  based
environments.  The Company is also a software  developer  for  mainframe  and PC
based  Computer  Output to Laser  Disk  ("COLD")  systems  and a  developer  and
marketer  of  storage  management  software  systems.   1View,   InfoAccess(TM),
Treev+(TM) and the Company logo are trademarks of Network  Imaging  Corporation.
All other product and brand names are  trademarks  or  registered  trademarks of
their respective companies.

         The Company's  executive offices are located at 500 Huntmar Park Drive,
Herndon, Virginia 20170. The Company's telephone number is (703) 478-2260.

                             SUMMARY FINANCIAL DATA
                      (in thousands, except per share data)

STATEMENT OF OPERATIONS DATA                      Quarter Ended
                                   ---------------------------------------------
                                    Dec. 31,    Sept. 30,   June 30,    Mar. 31,
                                      1995        1995        1995        1995

Net revenue                        $ 12,791    $ 16,042    $ 20,270    $ 20,048
Costs and expenses:
Costs of revenue                      8,103       7,995      12,811      13,555
Product development                   1,536       1,448       1,972       2,176
Selling, general and
 administration                       7,048       7,473      10,777      10,247
Settlement with stockholders           --          --           892         750
Gain (loss) on closure and sale of
 subsidiaries, net                     --          (147)      9,906        (492)
Restructuring costs                    (396)       (946)       (286)        195


<PAGE>



   
STATEMENT OF OPERATIONS DATA                       Quarter Ended
    

                                    --------------------------------------------
                                    Dec. 31,    Sept. 30,    June 30,   Mar. 31,
                                      1995        1995        1995        1995

(Loss) before interest
income and income taxes              (3,500)        219     (15,802)     (6,383)
Interest income (expense), net           17         318        (167)         55
(Loss) before income taxes           (3,483)        537     (15,969)     (6,328)
Income tax (benefit) expense           (256)        157          72        (253)
Net income (loss)                    (3,227)        380     (16,041)     (6,075)

Preferred stock preferences          (6,874)     (1,020)     (1,020)     (1,020)
                                   ========    ========    ========    ========
Net loss applicable to
common shares                      $(10,101)   $   (640)   $(17,061)   $ (7,095)
                                   ========    ========    ========    ========

Net loss per common
 share                             $  (0.60)   $  (0.05)   $  (1.25)   $  (0.52)
                                   ========    ========    ========    ========

Weighted average shares
 outstanding                         16,945      13,780      13,628      13,628




STATEMENT OF OPERATIONS DATA                       Quarter Ended
                                   ---------------------------------------------
                                    Dec. 31,    Sept. 30,   June 30,    Mar. 31,
                                      1996        1996        1996        1996

Net revenue                        $ 10,428    $  9,379    $  9,129    $ 10,542
Costs and expenses:
Costs of revenue                      5,594       5,536       6,838       7,244
Product development                   1,401       1,410       1,327       1,734
Selling, general and
 administration                       5,520       5,379       7,453       6,394
Exchange fee and gain
 on sale of asset, net                 --          --          --           619
Loss on closure and sale of
 subsidiaries, net                     --           921        --          --
Restructuring costs                    --          --           (19)       (156)

                                   --------    --------    --------    --------
(Loss) before interest income
and income taxes                     (2,087)     (3,867)     (6,470)     (5,293)
Interest income (expense), net          121          41          87          59
                                   --------    --------    --------    --------
(Loss) before income taxes           (1,996)     (3,826)     (6,383)     (5,234)
Income tax (benefit) expense             21         (77)       (114)        102
                                   --------    --------    --------    --------
Net (loss)                           (1,987)     (3,749)     (6,269)     (5,336)

Preferred stock preferences            (981)       (865)       (865)     (1,020)
                                   ========    ========    ========    ========
Net loss applicable to common
 shares                            $ (2,968)   $ (4,614)   $ (7,134)   $ (6,356)
                                   ========    ========    ========    ========

Net loss per common share          $  (0.13)   $  (0.22)   $  (0.35)   $  (0.34)
                                   ========    ========    ========    ========

Weighted average shares
 outstanding                         22,470      21,113      20,209      18,911










   
STATEMENT OF OPERATIONS DATA                        Quarter Ended,
                                       ----------------------------------------
                                        September 30,    June 30,      Mar. 31,
                                            1997           1997           1997

Net revenue                              $  9,944       $  9,334       $  9,119
Costs and expenses:
Costs of revenue                            6,450          6,132          5,840
Product development                         1,142          1,266          1,042
Selling, general and
 administration                             5,298          5,329          5,223
Gain from extinguishment
 of debt                                     --             --             (267)
                                         --------       --------       --------

Loss before interest
 income and income taxes                   (2,946         (3,393)        (2,719)
Interest income (expense),
 net                                         (130)           (64)            31
                                         --------       --------       --------
Loss before income taxes                   (3,076)        (3,457)        (2,688)
Income tax (benefit)
 expense                                     (142)            61             (6)
                                         --------       --------       --------
Net loss                                   (2,934)        (3,518)        (2,682)

Preferred stock preferences                (1,704)          (930)          (976)
                                         ========       ========       ========
Net loss applicable to
 common shares                           $ (4,638)      $ (4,448)      $ (3,658)
                                         ========       ========       ========

Net loss per common share                $  (0.18)      $  (0.18)      $  (0.15)
                                         ========       ========       ========
Weighted average shares
 outstanding                               25,437         24,964         24,464
    



                       CERTAIN FORWARD-LOOKING STATEMENTS

         This  Prospectus  contains  or  may  contain  certain   forward-looking
statements  and  information  as well as estimates and  assumptions  made by the
Company's management. When used in this Prospectus,  words such as "anticipate,"
"believe,"   "estimate,"   "expect,"  "future,"  "intend,"  "plan"  and  similar
expressions, as they relate to the Company or the Company's management, identify
forward-looking  statements.  Such  statements  reflect the current views of the
Company  with  respect  to future  events  and are  subject  to  certain  risks,
uncertainties and assumptions  relating to the Company's  operations and results
of operations, shifts in market demand, the timing of product releases, economic
conditions  in foreign  countries,  competitive  products  and pricing and other
risks and uncertainties including, in addition to any uncertainties specifically
identified in the text surrounding such statements,  uncertainties  with respect
to changes or  developments in social,  economic,  business,  industry,  market,
legal and regulatory  circumstances  and conditions and actions taken or omitted
to be taken by third parties,  including the Company's stockholders,  customers,
suppliers, business partners, competitors, and legislative, regulatory, judicial
and other  governmental  authorities and officials.  Should one or more of these
risks or  uncertainties  materialize,  or should  the  underlying  estimates  or
assumptions prove incorrect,  actual results or outcomes may vary  significantly
from those anticipated, believed, estimated, expected, intended or planned.


                                  RISK FACTORS

         An  investment in the  Company's  securities  involves a high degree of
risk. In evaluating the Company and its business,  prospective purchasers of the
Shares  offered  hereby  should  carefully  consider  the risk factors set forth
below, as well as the other  information  included in this Prospectus,  prior to
making an investment.


Lack of Profitability

   
         The Company has had net losses in each period of its operations, except
for one quarter,  and it had an  accumulated  deficit at  September  30, 1997 of
$122.2 million.  Net losses  applicable to common shares were $June12.7  million
for the nine months ended  September 30, 1997,  $21.1 million for the year ended
December 31, 1996,  and $34.9 million for the year ended  December 31, 1995. The
losses have resulted primarily from non-recurring  charges (including in 1994, a
non-recurring  charge of $8.8  million for  purchased  in-process  research  and
development and a write-off of $8.7 million in capitalized software that related
to products that were abandoned in favor of 1View,  and, in 1995,  non-recurring
net charges of $9.3 million in  connection  with the  bankruptcy  of IBZ Digital
Production  AG ("IBZ"),  a company  that had been  purchased by the Company as a
wholly owned subsidiary,  and business divestitures) as well as the delay in the
commercial release of the Company's 1View product,  the lead time to close sales
and  recognize  revenues,  increasing  sales  and  marketing  efforts  and costs
associated with product research and development. See "Business."


Continued Adverse Results of Operations Through 1997

         The adverse  results of operations  that the Company has experienced is
expected to continue at least for the  remainder of 1997until  the first part of
1998.  The Company  believes that its existing  cash,  together with the current
proceeds from the  convertible  notes,  a debt offering the Company  effected in
July 1997 (the "Convertible  Notes"),  current and future proceeds from the sale
of Series K Stock and warrants and the anticipated  cash flows from  operations,
should  provide  sufficient  resources to fund its  activities  through the next
twelve  months.  and to maintain net tangible  assets of at least $6.0  million,
which is required for  continued  inclusion of the  Company's  securities on the
Nasdaq National Market. However, there can be no assurance that the Company will
be able to satisfy the  conditions  precedent to The Company  believes  that the
combination of existing cash,  potential  future  proceeds from such  additional
offerings of equity  securities  as may be required,  and the  anticipated  cash
flows  from  operations,   should  provide  sufficient  resources  to  fund  its
activities  through the next twelve months and to achieve net tangible assets of
at least $6 million as of December  31, 1997,  which is required  for  continued
inclusion of the Company's securities on the Nasdaq National Market. The Company
is  also  proposing  some  changes  to the  terms  of its  Series  A  Cumulative
Conevertible Preferred Stock ("Series A Stock"). See "--Amendment to Certificate
of  Designations  of Series A  Stock."  The  Company  has had  discussions  with
prospective  investors with respect to selling additional equity of the Company.
While no formal or  contractual  commitments  have been  received  to date,  the
Company believes that, if required,  it could sell such equity for cash prior to
January 1, 1998, and thereby raise sufficient  additional equity to achieve such
tangible  net asset  measure at  December  31,  1997;  however,  there can be no
assurance  that such efforts  would be successful  should they become  required.
Anticipated cash flows from operations are largely  dependent upon the Company's
ability to achieve its sales and gross profit objectives for its 1View and other
products.  If the Company is unable to meet these  objectives,  it will consider
alternative  sources  of  liquidity,  such as  additional  offerings  of  equity
securities. Although the Company believes that it can successfully implement its
operating  plan and, if necessary,  raise  additional  capital,  there can be no
assurance that  implementation of the plan will be successful or that financing,
if sought, will be available.

    

Continued Listing on the Nasdaq National Market

   
         At June 30, and September 30, 1997,  the Company had not maintained net
tangible  assets  of at  least  $4  million,  which  is one of the  quantitative
maintenance  criteria for  inclusion of the  Company's  securities on the Nasdaq
National  Market.  To remedy the short-fall and offset any adverse  impact,  the
Company issued, during July 1997, 3,300 shares of Series K Convertible Preferred
Stock  ("Series K Stock") and warrants and received net proceeds of $2.9 million
and, on December 8, 1997, issued 3,250 shares of Series L Convertible  Preferred
Stock ("Series L Stock") and received net proceeds of $2.99 million.


         On August 21,  1997,  the  Company  received  a letter  from the Nasdaq
National Market  indicating  that the Company may not have sufficient  assets to
continue its listing on the Nasdaq National Market. The Company has responded to
that inquiry and after further  correspondence  with Nasdaq  requested a hearing
before the Nasdaq National  Market's Hearing  Department to explain its plan for
achievement  and  maintenance  of the minimum net tangible  assets  requirement.
Following  a hearing  held on  Thursday,  October  30,  1997,  a Nasdaq  Listing
Qualifications  Panel determined to granted the Company's  request for continued
inclusion in the Nasdaq  National  Market pursuant to an exception to the Nasdaq
National Market's minimum net tangible asset requirement. 1997.

         The Panel found that the Company had  presented a  reasonable  plan for
compliance.  Based upon the plan  detailed by the Company,  the Panel  concluded
that the Company could achieve compliance with the continued listed requirements
for the long-term.

         On December 2, 1997, the Nasdaq Listing Qualifications Panel granted an
extension to the exception.

         In order to fully  comply  with both the  exception  and the  extension
granted by the Panel,  the  Company  must  complete  its plan of  compliance  in
accordance with a timetable set forth by the Panel. The Company must demonstrate
full compliance with the Nasdaq National Market continued  listing  requirements
by December 31, 1997. The Panel also required that the Company have a minimum of
$6.0 million in net tangible  assets to ensure long term compliance with the net
tangible  assets  requirement.  Although  the  Company  would not be required to
maintain this minimum each quarter going  forward,  the Company would be subject
to the new net tangible assets requirements (requiring a minimum of $5.0 million
in net  tangible  assets) for the  continued  inclusion  on the Nasdaq  National
Market that becomes  effective in February  1998. In the event the Company fails
to comply with any of the terms of this exception, the Panel has stated that the
Company's  securities  will be  immediately  delisted  from the Nasdaq  National
Market.

         Although the Company believes that it can maintain achieve the required
net tangible assets of at least $6 million through certain  proposed  changes to
the terms of its Series A Stock (See "--Amendment to Certificate of Designations
of Series A Stock") and other additional  offerings of equity securities,  there
can be no assurance  that the Company will complete  such  offerings or that, if
completed,  they  will be on terms  favorable  to the  Company  or in an  amount
sufficient to permit the Company to continue to achieve and maintain the minimum
tangible net assets of at least $6  millionasset  requirements  as stipulated by
Nasdaq. If the Company  ultimately is unable to achieve the minimum tangible net
asset  requirements,  the  Company's  Common  Stock,  Series A Stock and  Public
Warrants would be delisted from the Nasdaq  National  Market.  While the Company
believes that trading of its Common Stock could continue, any inability to trade
on a national  exchange could adversely impact the value of the Company's stock.
Under  the  terms of the  Series A Stock,  the  Company's  Series F  Convertible
Preferred  Stock  ("Series  F  Stock),  its  existing  line  of  credit  and the
Convertible  Notes,  a delisting of the  Company's  stock would not affect those
transactionse  Company's  ability  to meet the terms and  requirements  of those
agreements.
    


Inadequate Dividend Coverage

   
         The annual  dividend  requirements  on the Company's  Series A Stock is
$3.2  million  payable  quarterly.  All  quarterly  dividends  on the  Series  A
Preferred Stock have been paid through April 1997. The Company suspended payment
on the  quarterly  dividends  on the Series A Stock due in July and  October 31,
1997 in the  amounts of $0.50 per share or $803,000  in the  aggregate  for each
period,  respectively.  Failure to pay any quarterly  dividend has resulted in a
reduction in the  conversion  price and failure to pay a total of four quarterly
dividends  will entitle the holders of the Series A Stock to elect one director.
(Because the sole holder of all of the outstanding  shares of Series F Stock has
agreed to sell all of such shares to the  Company  for a set price,  the Company
accrues  dividends  on the  outstanding  shares  of  Series F Stock,  but is not
obligated to make any payments  until January 31, 1998 or upon the occurrence of
certain conditions under the control of the Company).  However,  the Company may
not redeem the Series F Stock when there are accrued and unpaid dividends on the
Series A By law,  dividends  may be paid from  surplus  or net  profits  for the
fiscal year in which the dividend is declared and/or the preceding  fiscal year.
The Company may not declare  any  dividends  payable to holders of Common  Stock
until all accrued and unpaid cash  dividends  are paid in full to the holders of
the Series A and F Stocks.  There can be no  assurance  that  future  surplus or
earnings,  if any, will be adequate to pay dividends on the preferred stock. See
"Description of Capital Stock."
    


European Operations

   
         The Company's  European  operations are conducted through the Company's
subsidiary  Dorotech,  S.A.  ("Dorotech") and accounted for approximately 46% of
its revenue in 19961997.  and approximately 40% of the Company's revenue and 10%
of its net loss during the first nine months of 1997. The Company's  business in
European  markets is subject to the risks  customarily  associated with overseas
operations,  including  fluctuations  in  foreign  currency  exchange  rates and
controls,  tariffs,  expropriation,  nationalization and other economic, tax and
regulatory  policies of foreign  governments.  Since Dorotech conducts virtually
all of its business in currencies other than the U.S.  dollar,  foreign currency
fluctuations  may affect the  Company's  asset  valuations  and net income.  The
Company  has not used  financial  instruments  with  off-balance  sheet  risk in
managing foreign currency  fluctuation risks. The Company's results will also be
affected by any laws  affecting its ability to repatriate  foreign  profits,  if
any,  and by changes in  foreign  tax laws and tax rates,  as well as changes in
international  tax  treaties.  There can be no assurance  that these and similar
factors will not have a negative impact on the Company's operations.
    
   
                           On  December  31,  1996,  the  Company  entered  into
a purchase agreement with CDR Enterprises  ("CDRE") for the sale and purchase of
all of the Series F Stock.  Pursuant to the  purchase  agreement  with CDRE,  as
amended on May 30,  1997,  and December 1, 1997 the Company is obligated to make
to CDRE an aggregate  cash payment of $6,400,000  plus interest in the amount of
$190,000.  (Because the sole holder of all of the outstanding shares of Series F
Stock has agreed to sell all of such shares to the Company for a set price,  the
Company accrues  dividends on the outstanding  shares of Series F Stock,  but is
not  obligated  to make any  payments  until  January 31,  1998 or upon  certain
conditions  under the control of the  Company.  The  Company has granted  CDRE a
first  ranking  pledge on all of the  outstanding  stock of Dorotech and, if the
Company  fails to make the payments to CDRE when due, CDRE is at liberty to sell
all of the Dorotech shares owned by the Company and may withhold all amounts due
and payable to CDRE before paying back excess money, if any, to the Company. See
"--  Guarantee  of ATG  Lease  Payment"  and  "Description  of  Capital  Stock -
Acquisition   Preferred  Stock."  See  "--  Inadequate  Dividend  Coverage"  and
"Description  of  Capital  Stock -- Series A  Cumulative  Convertible  Preferred
Stock."
    

         The  Company is  endeavoring  to sell all of the  outstanding  stock of
Dorotech to a third party.  There can be no  assurance  that the Company will be
able to do so by January 31, 1998 or at all or on favorable terms.


Guarantee of ATG Lease Payments

   
         Prior to the acquisition of Dorotech by the Company,  Dorotech's parent
(which was merged into Dorotech prior to the acquisition)  signed a guarantee of
lease payments by an affiliated company,  ATG Gigadisc SA ("ATG"),  under a sale
and leaseback of land and buildings by ATG. At December 31, 1995,  the remaining
lease payments due by ATG totaled approximately $6.1million,  including interest
of  approximately  $1.8  million.  On May 31,  1996,  ATG filed  for  bankruptcy
protection  with the Court of Commerce in Toulouse,  France,  and officials were
appointed by the Court to supervise  the  operations  of ATG. In July 1996,  the
lessor  notified  Dorotech  that ATG was in  default  with  respect to one lease
payment,  that, as a result, it was filing a claim with one of the officials for
accelerated payment of all remaining amounts due under the lease and that it was
requesting from Dorotech the amount due under the guarantee.  The Company is not
itself a party to the guarantee;  however,  if Dorotech were to become obligated
to  fulfill  the  guarantee,  there  could be a material  adverse  effect on the
Company's results of operations and financial  condition.  On December 31, 1996,
the  Company  entered  into a  purchase  agreement  with  CDRE  for the sale and
purchase of the Series F Stock.  See "--European  Operations." As a condition to
entering into that purchase agreement, CDRE agreed it would endeavor to obtain a
release of the lease  guarantee.  To date,  neither the Company nor Dorotech has
received a release of the lease  guarantee.  If claims  were to be made  against
Dorotech.
    

         Dorotech believes it has meritorious defenses to, and intends to defend
vigorously  against,  any  action  that may be  brought  against it based on the
guarantee.  There can be no assurance,  however,  that Dorotech would prevail if
such action were brought.

   
         In the event that Dorotech is sold by January 31, 1998, CDRE has agreed
to be responsible  for any claims or damages  brought by any party in connection
with the ATG lease.
    


Competition; Rapid Technological Change

         The computer industry,  including the information  access,  imaging and
optical disk storage segments,  is highly  competitive,  and is characterized by
rapid and  continuous  technological  change,  short  product  cycles,  frequent
product innovations and new product introductions,  evolving industry standards,
and changes in customer  requirements  and  preferences.  The  Company's  future
profitability  will depend,  among other things, on wide-scale market acceptance
of the Company's  products,  the Company's  ability to demonstrate the potential
advantages  of its  products  over other  types of similar  products  and on the
Company's  ability to  develop  in a timely  fashion  enhancements  to  existing
products or new products that are  responsive to the demands of the  marketplace
for information access,  imaging and optical disk storage systems.  There can be
no assurance  that the Company will be able to market  successfully  its current
products,  develop and market enhancements to existing products or introduce new
products.  In addition,  the Company faces existing  competitors that are larger
and more established and have substantially  greater resources than the Company.
Because of the rapid  expansion of the information  access,  imaging and optical
disk storage market,  the Company will also face  competition from new entrants,
possibly   including   the   Company's   customers,   suppliers  or   resellers.
Technological  advances by any of the  Company's  current or future  competitors
could render  obsolete or less  competitive  the products  being  offered by the
Company.  The Company believes that the principal  competitive factors affecting
the market for  information  access,  imaging and optical disk storage  products
include effectiveness,  scope of product offerings,  technical features, ease of
use, reliability,  customer service and support, name recognition,  distribution
resources and price. Current and potential competitors have established,  or may
establish  in the  future,  strategic  alliances  to increase  their  ability to
compete for the Company's  prospective  customers.  Accordingly,  it is possible
that new  competitors  or alliances may emerge and rapidly  acquire  significant
market  share.  Such  competition  could have a material  adverse  effect on the
Company's business, financial condition and results of operations.


Risks of Defects and Development Delays

   
         The Company's  development of enhancements to existing  products and of
new products is subject to the kinds of problems  and delays that are  routinely
encountered  in the  development  of  software.  For  example,  the  Company may
experience schedule overruns in software  development  triggered by factors such
as insufficient staffing or the unavailability of development-related  software,
hardware  or  technologies.  Further,  during the  development  of new  software
products,  or the enhancement of existing  products,  the Company's  development
schedules  may be  altered  as a  result  of the  discovery  of  software  bugs,
performance  problems  or changes to the  product  specification  in response to
customer requirements, market developments or Company initiated changes. Changes
in product  specifications  may delay completion of documentation,  packaging or
testing,  which may, in turn,  affect the release  schedule of the  product.  In
connection  with complex  software  products,  the  technology  market may shift
during the development cycle,  requiring the Company either to enhance or change
a product's  specifications  to meet a customer's  changing needs.  Any of these
factors  may cause a product  to enter the  market  behind  schedule,  which may
adversely affect market acceptance of the product, or place it at a disadvantage
relative to a  competitor's  product  that has already  gained  market  share or
market acceptance during the delay. The Company does not believe,  however, that
it is  practicable  to  quantify  the impact that such delays have had or in the
future may have on its  operating  results.  There can be no assurance  that the
Company will not experience  difficulties  that will interrupt the marketing and
distribution  of its current  products or that the Company  will not  experience
difficulties in the future that could materially delay or prevent the successful
development of other products.
    

Dependence on Key Personnel

         The Company is  substantially  dependent on the business and  technical
expertise and business relationships of certain key personnel and on its ability
to attract and retain key  management  and  technical  employees  in the future.
Competition for such employees is intense.  The loss of current key employees or
the Company's  inability to attract and retain other  employees  with  necessary
business or technical  skills in the future would have a material adverse effect
on the Company's business.


Dependence on Suppliers

         The Company relies  exclusively  on outside  suppliers for the hardware
components  of its products  such as scanners,  printers,  computers and optical
disk drives and jukeboxes.  Most parts and  components  are currently  available
from  multiple  sources at  competitive  prices.  To date,  the  Company has not
experienced  significant  delays in obtaining parts and components and, although
there can be no assurance, the Company does not expect to experience such delays
in the future.  Lack of availability of certain  components  could require minor
redesign of the Company's products and result in production delays.


Evolving Distribution Channels

         The Company has  developed a  distribution  strategy  that involves the
development   of  strategic   alliances   with   resellers,   integrators,   and
international  distributors  to enable  the  Company  to  achieve  broad  market
penetration. The Company's reseller distribution channel is established, and the
Company intends to expand that channel. There can be no assurance, however, that
the Company will be able to continue to attract  distributors and resellers that
will be able to market the Company's products  effectively and will be qualified
to provide timely and cost-effective  customer support and service.  The Company
ships products to distributors and resellers on a purchase-order  basis, and its
distributors,  integrators and resellers may, in some instances, carry competing
product  lines.  Therefore,  there  can be no  assurance  that any  distributor,
integrator,  or reseller will continue to represent the Company's products.  The
inability to recruit,  or the loss of, important sales personnel,  distributors,
integrators  or  resellers  could  materially  adversely  affect  the  Company's
business, financial condition and results of operations in the future.


Long Sales Cycle; Seasonality

         Sales  of  the  Company's  products  sometimes  involve  a  significant
commitment  of  capital  by  customers,  with the  attendant  delays  frequently
associated  with large capital  expenditures.  Prior to such sales,  the Company
often  permits  customers to evaluate  products  being  considered  for license,
generally involving a small license fee. In addition,  the type of software that
the Company  manufactures  and sells is of the type that requires  businesses to
re-engineer  their processes,  and completion of this may be arduous.  For these
and other reasons,  the sales cycle  associated  with the Company's  products is
likely to be lengthy and subject to a number of significant risks over which the
Company has little or no control and, as a result, the Company believes that its
quarterly  results are likely to vary  significantly in the future.  The Company
may be  required  to  ship  products  shortly  after  it  receives  orders  and,
consequently,  order  backlog,  if  any,  at the  beginning  of any  period  may
represent only a small portion of that period's expected revenues.  As a result,
product revenues in any period will be substantially  dependent on orders booked
and shipped in that  period.  The Company  plans its  production  and  inventory
levels  based  on  internal  forecasts  of  customer  demand,  which  is  highly
unpredictable and can fluctuate  substantially.  If revenues fall  significantly
below  anticipated  levels,  the  Company's  financial  condition and results of
operations could be materially and adversely affected. In addition,  the Company
has  experienced  significant  seasonality  in its  business,  and the Company's
financial  condition and results of operations may be affected by such trends in
the  future.  Such trends may  include  higher  revenues in the third and fourth
quarters of the year and lower  revenues in the first and second  quarters.  The
Company  believes that revenues may tend to be higher in the fourth  quarter due
to year-end budgetary pressures on the Company's commercial customers.


Intellectual Property Rights; Infringement Claims

   
         The Company regards its software as proprietary and relies  principally
on the protection afforded by contractual provisons, trade secret, copyright and
trademark  laws and by routinely  requiring all of its  employees,  consultants,
suppliers and others with access to the  Company's  proprietary  information  to
enter into  non-disclosure  agreements that require such persons to maintain the
confidentiality of such information.  The Company filed two patent  applications
in 1995, one of which was granted in July 1997, and expects to file several more
in the near future  covering key  components of the 1View suite.  Prosecution of
these patent  applications,  and any other patent  applications that the Company
may  subsequently  determine to file, may require the expenditure of substantial
resources.  The  issuance of a patent from a patent  application  may require 24
months or longer.  There can be no assurance that the Company's  technology will
not become  obsolete while the Company's  applications  for patents are pending.
There also can be no  assurance  that any pending or future  patent  application
will be granted, that any future patents will not be challenged,  invalidated or
circumvented  or that the rights  granted  thereunder  will  provide  meaningful
competitive  advantages  to the  Company.  Further,  the Company has not pursued
patent protection outside of the United States for the technology covered by the
Company's existing patent and pending patent applications. The Company currently
intends  to pursue  patent  protection  outside  of the  United  States  for the
technology  covered  by  such  patent  applications,  although  there  can be no
assurance that any such protection will be granted or, if granted,  that it will
adequately protect the technology covered thereby. In addition,  there can be no
assurance that others will not  independently  develop  similar  technologies or
duplicate any technology  developed by the Company or that its  technology  will
not infringe upon  patents,  copyrights or other  intellectual  property  rights
owned by others.
    

         Further,  the Company may be subject to additional  risk as the Company
enters into transactions in countries where  intellectual  property laws are not
well developed or are poorly enforced. Legal protections of the Company's rights
may be  ineffective in foreign  markets and technology  developed by the Company
may not be  protectable in such foreign  jurisdictions  in  circumstances  where
protection is ordinarily available in the United States.

   
         The  Company  believes  that,  due to the rapid  pace of  technological
innovation for the Company's imaging and optical storage products, the Company's
abilityestablished  to  maintain  a position  of  technology  leadership  in the
industry is dependent  more upon the skills of its  development  personnel  than
upon legal protections afforded its existing or future technology.

         As the  number of  information  access,  imaging  and  optical  storage
products in the  industry  increases  and the  functionality  of these  products
further  overlap,   software  developers  may  increasingly  become  subject  to
infringement  claims.  There can be no  assurance  that third  parties  will not
assert  infringement  claims  against the Company in the future with  respect to
current or future products. The Company also may desire or be required to obtain
licenses from others in order to develop, produce and market commercially viable
products  effectively.  Failure to obtain those  licenses  could have a material
adverse effect on the Company's ability to market its software  products.  There
can be no  assurance  that such  licenses  will be  obtainable  on  commercially
reasonable  terms, if at all, that the patents (if any) underlying such licenses
will be valid and enforceable or that the  proprietary  nature of any unpatented
technology underlying such licenses will remain proprietary.
    

         Any claims or litigation,  with or without  merit,  could be costly and
could  result in a  diversion  of  management's  attention,  which  could have a
material  adverse  effect on the  Company's  business,  financial  condition and
results of operations.  Furthermore,  there can be no assurance that the Company
will have adequate  resources to prosecute or defend such claims or  litigation,
or that the Company's  proprietary  rights,  including patents,  if any, will be
upheld.  Adverse  determinations  in such claims or litigation could also have a
material  adverse  effect on the  Company's  business,  financial  condition and
results of operations.

Fluctuations in Financial Performance

         Timing and volume differences in the shipment of the Company's products
and  the  performance  of  services  under  contracts  can  produce  significant
fluctuations  in  quarter-to-quarter  and  year-to-year  financial  performance.
Factors  that could affect such timing  include,  among other  things,  customer
purchasing   patterns,   new   product   transitions,   delays  in  new  product
introductions  and shortages of system  components.  Past financial  performance
should not be considered to be a reliable indicator of future performance in any
particular fiscal period.

Control of the Company

   
         The executive  officers and directors of the Company  beneficially  own
approximately 6% of the Company's  outstanding  Common Stock, other officers and
employees of the Company beneficially own at least another 6% of the outstanding
shares and  officers  and  employees  may,  in the future,  acquire  substantial
additional  amounts of Common Stock upon the exercise of stock options which are
not currently  exercisable.  Although  there are no  arrangements  requiring the
executive officers and other employees of the Company to vote their Common Stock
collectively, those persons may exert considerable influence over the outcome of
matters  requiring  stockholder  votes,  including the election of directors and
proposals to sell, merge or liquidate the Company.
    

Dividend Policy

   
         The  Company  has not paid  dividends  on its  Common  Stock  since its
inception,  and it does not anticipate paying cash dividends on its Common Stock
in the  foreseeable  future.  The Company may not declare  dividends  payable to
holders of Common Stock unless and until all accrued cash dividends  through the
most recent past dividend  payment date have been paid in full to holders of the
Series A Stock and the  Company's  Series F Stock.  The  Company  suspended  its
quarterly dividend on the Series A Stock due in July and October 31, 1997 in the
amounts of $0.50 per share or  $803,000 in the  aggregate  for each  period.  By
their terms, the Series K Stock and Series L Stock purchase  agreements  require
that  the  Company  not use the  proceeds  of that  offering  to make  quarterly
dividend payments to the holders of Series A Stock. See  "--Inadequate  Dividend
Coverage,"  "Dividend and Market Price Information," and "Description of Capital
Stock -- Common Stock."
    


Shares  Eligible  for Future  Sale;  Effect on Market Price of Common Stock and
         the Ability of the Company to Raise Additional Capital

   
         As of November 13, 1997, the Company had outstanding  25,959,101 shares
of Common Stock,  of which  approximately  3.5 million  shares were  "restricted
securities"  as that term is defined under Rule 144 of the Securities Act ("Rule
144"), which were not covered by an effective  registration  statement under the
Securities  Act or eligible for sale  pursuant to Rule 144(k).  Of those shares,
approximately 1.8 million were otherwise eligible for sale under Rule 144.

         As of  November  13,  1997,  the Company  had  outstanding  options and
warrants  that were  exercisable  for  8,947,487  shares of  Common  Stock  with
exercise  prices of the options and  warrants  ranging  from $1.00 to $14.88 per
share  (subject to adjustment  pursuant to the  anti-dilution  provisions of the
respective  instruments  and based  upon the  closing  sale and bid price of the
Company's  Common  Stock on November 13,  1997).  The number of shares of Common
Stock into which the Company's  convertible  securities  convert could  increase
significantly depending upon a number of factors,  including the market price of
the  Company's  Common  Stock at the time of  conversion  or  redemption  of the
convertible  securities,  the issuance of the Series K Stock, the Series L Stock
and the related warrants, and the adoption of certain amendments to the terms of
Series A Stock. See "Risk Factors -- Amendment to Certificate of Designations of
Series A Stock" and  "Description  of Capital  Stock." The options and  warrants
expire at various times through November 11, 2007.

         As of  November  13,  1997,  the  Company  and  had  outstanding  other
convertible  securities  (including the the NConvertible Notes, and the Series A
and K Preferred  Stock) that were  convertible  into 7,187,855  shares of Common
Stock  (subject to adjustment  pursuant to the  anti-dilution  provisions of the
respective  instruments  and based  upon the  closing  sale and bid price of the
Company's  Common Stock on November 13, 1997).  On December 8, 1997, the Company
issued 3,250 shares of Series L Stock. The number of shares of Common Stock into
which the Company's convertible  securities convert could increase significantly
depending upon a number of factors,  including the market price of the Company's
Common   Stock   at   the   time   of    conversion   or   redemption   of   the
instruments).convertible  securities  and the adoption of certain  amendments to
the terms of Series A Stock.  However,  the  Company may not redeem the Series F
Stock when there are accrued  and unpaid  dividends  on the Series A Stock.  See
"Risk Factors - Amendment to Certificate of Designation of Series A Stock." (The
Common Stock  issuable on conversion of the Series F Stock has not been included
as the holder of the Series F Stock is  obligated  to sell the Series F Stock to
the Company at a set price.  See  "Description  of Capital Stock --  Acquisition
Preferred Stock). The conversion prices of the convertible securities range from
$1.01 to $12.61 per share.  The  convertible  securities  may convert at various
times through 2001August 20, 2002.

         Those options, warrants and convertible securities that are not subject
to  registration  rights may, upon exercise or  conversion,  be sold pursuant to
Rule 144 or, if applicable,  Rule 144(k). In addition,  the Company is obligated
to  issue  additional  shares  of  Series L Stock  and  warrants  that  would be
convertible  into or exercisable for 3,385,417 shares of Common Stock in certain
circumstances.  See  "Description  of  Capital  Stock --  Series  L  Convertible
Preferred Stock."


         The Company has  registration  commitments  with  respect to  6,569,176
shares  ("Registrable  Shares")  of  Common  Stock in  connection  with  certain
options,  warrants and convertible securities that the Company has issued. (This
amount does not include  3,385,417 shares of Common Stock issuable on conversion
of Series L Stock and warrants that the Company may be obligated to issue to the
Purchasers  and Zanett in certain  circumstances.  See  "Description  of Capital
Stock  --  Series  L  Convertible  Preferred  Stock.")  The  Company  has  filed
registration  statements  with the  Securities and Exchange  Commission  ("SEC")
covering in the aggregate  14,994,884 of the Registrable  Shares  (including the
2,150,000 shares covered by this Registration  Statement),  which may be offered
from time to time by the stockholders  named in such registration  statements or
that  may be  sold  by the  Company  upon  exercise  or  conversion  of  certain
outstanding  warrants,  options or  convertible  securities.  In  addition,  the
Company  has  filed a  registration  statement  in  connection  with a  proposed
amendment  to the  Certificate  of  Designations  of the  Series  A  Stock.  See
"--Amendment to Certificate of Designations of Series A Stock." In addition, the
Company  has  registered  9,100,000  shares of Common  Stock  that may be issued
pursuant to stock option  plans.  The  Company's  obligations  generally  are to
maintain such  registration  statements  for varying  periods  ranging from nine
months to two years at its  expense,  except  for  commissions  and legal  costs
incurred by selling stockholders.

         The Company  believes  that the  existence of  convertible  securities,
options  and  warrants,  with  conversion  or  exercise  prices  less  than  the
prevailing  market price of the Common Stock, and the possibility of, as well as
actual, sales of shares of Common Stock under Rule 144, pursuant to registration
statements and otherwise in all likelihood  have had and may continue to have an
adverse  effect on the  market  price of the Common  Stock and on the  Company's
ability to raise future equity capital. In addition, if the Selling Stockholders
or the others, individually or in the aggregate, were to offer a large amount of
Common  Stock in the  market,  the  market  price of the  Common  Stock  and the
Company's ability to raise additional capital could be adversely  affected.  See
"Selling Stockholders" and "Plan of Distribution."


Amendment to Certificate of  Designations of Series A Stock

         Prior to the  Company's  issuance  in July  1997 of  shares of Series K
Stock and  warrants  and the  issuance in July and August  1997 the  Convertible
Notes and  warrants  (see  "Management's  Discussion  and  Analysis of Financial
Condition and Results of  Operatoions - Recent  Events" for a description of the
cConvertible  nNotes),  and the  issuance of 3,250  shares of Series L Stock and
warrants  on  December 8, 1997,  the  outstanding  shares of Series A Stock were
convertible into 1.9826 shares of Common Stock in the aggregate.  As a result of
anti-dilution  provisions to which the shares of Series A Stock are subject, and
the issuance of shares of Series K Stock,  the Series L Stock,  the  Convertible
Notes and  warrants,  the  holders of Series A Stock will be entitled to receive
additional  shares of Common Stock. See "Description of Capital Stock - Series A
Cumulative  Convertible  Preferred  Stock." The number of  additional  shares of
Common Stock to which the holders of Series A Stock would be entitled to receive
will depend upon the conversion prices of the Series K Stock, the Series L Stock
and  the  Convertible  Notes  and  the  exercise  prices  of the  warrants.  The
conversion  prices of the Series K Stock, the Series L Stock and the Convertible
Notes are not fixed; they vary based on formulas tied to the market price of the
Common Stock at the time of conversion of the Series K Stock, the Series L Stock
and the  redemption or conversion  of the  Convertible  Notes and on the date of
conversion or redemption.  See "Description of Capital Stock" and  "Management's
Discussions  and Analysis of Financial  Conditionss  and Results of Operations -
Recent  Events."  The  exercise  prices of the  wwarrants  are also  subject  to
antidilution  adjustments.  Accordingly,  because these  conversion and exercise
prices vary, the Company cannot ascertain  definitively the number of additional
shares of Common  Stock  that the  holders  of Series A Stock may  receive  as a
result of the  Series A Stock's  anti-dilution  provisions  until the  shares of
Series A Stock are actually  converted.  The Company is also  obligated to issue
additional shares of Series L Stock in certain  circumstances.  See "Description
of Capital Stock."  Nonetheless,  the holders of Series A Stock will be entitled
to receive a significant number of additional shares Common Stock as a result of
such anti-dilution provisions.

         The number of shares of Common Stock that each holder of Series A Stock
will receive may be limited, however, as a result of a resolution adopted by the
Board of Directors of the Company that  provides for certain  amendments  to the
Certificate of Designations of Series A Cumulative  Convertible Stock ("Series A
Amendment").  If the Series A Amendment is approved,  the rate at which  holders
may  voluntarily  convert shares of Series A Stock into Common Stock would be as
follows:

                                     Shares of Common
                                        Stock per one
                                       Share of Series
           Average Stock Price (1)         A Stock
         ----------------------------- ------------------

          $1.30 or less                     7.68

          $1.31-$1.50                       6.67

          $1.51-$1.75                       5.71

          More than $1.75                   5.00


- --------------

(1)      The Average Stock Price would be equal to the average closing price per
         share of Common  Stock on the  Nasdaq  National  Market  during  the 20
         trading days following the date the Series A Amendment is approved.

         If the  Series A  Amendment  is  approved,  the  Company  may not force
conversion of shares of Series A Stock into Common Stock during 1998.  Beginning
January 1, 1999,  the Company would be able convert each share of Series A Stock
into shares of Common Stock if the closing price per share of Common Stock is at
least  equal to $4.00 per  share  for 20  consecutive  trading  days.  Beginning
January 1, 2000,  the Company would be able convert each share of Series A Stock
into shares of Common Stock if the closing price per share of Common Stock is at
least  equal to $3.00 per  share  for 20  consecutive  trading  days.  Beginning
January 1, 2001,  the Company would be able convert each share of Series A Stock
into shares of Common Stock at any time at the Company's  option.  The number of
shares of Common Stock  received on  conversion of the Series A Stock would also
be determined  based on the Average Stock Price in accordance with the table set
forth  above.  In the  event of a change  of  control  (which  would  include  a
transaction  where an third  party  acquires  more  than 50% of the  outstanding
shares of Common  Stock),  the holders of Series A Stock  would  receive no less
than $25 in value, either in cash, securities or a combination of both.

         If the Series A Amendment is approved,  cash  dividends on the Series A
Stock would cease to accrue at their current rate on April 30, 1997. Starting on
the date the  Series A  Amendment  is  approved  and until the Series A Stock is
converted,  the Series A Stock would accrue an annual dividend of $1.75 1.84 per
share,  payable  quarterly in cash or Common Stock, at the Company's  option. If
the  dividend  is paid in Common  Stock,  the  number of shares of Common  Stock
distributed  as a dividend will be based on the average  closing price per share
of Common  Stock during the 10 day period  following  the  Company's  release of
earnings for the applicable quarter. If the Series A Amendment is approved,  the
liquidation  price per share of Series A Stock  would be reduced  from $25.00 to
$10.0012.00.

         The  Company  currently  plans to hold a  meeting  of  stockholders  to
approve the Series A Amendment on December 31, 1997 or as soon  thereafter as is
reasonably  possible.  (Approval of the Series A Amendment requires the approval
of a majority  of the voting  power of all of the  outstanding  shares of Common
Stock voting  separately as a class and a majority of the voting power of all of
the  outstanding  shares of Series A Stock,  Series F Stock,  Series K Stock and
Series L Stock, each voting separately as a class.) If the Series A Amendment is
approved, the anti-dilution provisions of the Series A Stock currently in effect
would no longer be in effect.  If the Series A Amendment  is not  approved,  the
Company  will be required  to continue  accruing  dividends  on the  outstanding
shares of Series A Stock and will be required to issue a  significant  number of
shares of Common Stock to the holders of Series A Stock in  accordance  with the
currently  applicable  Certificate of Designations.  See "Description of Capital
Stock -- Series A Cumulative Convertible Preferred Stock."

    

Certain Anti-takeover Provisions of Certificate of Incorporation
        and Delaware Law

   
         The  Company's  Board of  Directors  has the  authority  to issue up to
20,000,000  shares  of  preferred  stock and to  determine  the  price,  rights,
preferences,  privileges  and  restrictions,  including  voting  rights of those
shares,  without any further vote or action by the Company's  shareholders.  The
rights of the holders of Common  Stock will be subject to, and may be  adversely
affected by, the rights of the holders of preferred  stock that has already been
issued and that may be issued in the future.  The issuance of  preferred  stock,
while providing desirable  flexibility in connection with possible  acquisitions
and other corporate purposes,  could have the effect of making it more difficult
for a third party to acquire a majority of the voting stock of the  Company.  As
of December 8, 1997, the Company had  outstanding  1,605,025  shares of Series A
Stock,  792,186  shares  of Series F Stock,  3,300  shares of Series K Stock and
3,250  shares of Series L Stock.  The  Company  may issue  additional  shares of
Series L Stock. See "Description of Capital Stock."
    

         The Company is subject to Section 203 of the Delaware General  Corpora-
tion  Law,  which  places  certain  restrictions  on  the  ability  of  Delaware
corporations to engage in business  combinations  with interested  shareholders.
See "Description of Capital Stock."


Impact of Offerings and Acquisitions on Net Operating Loss Carryforwards

         As a result of the  issuance  of the Series A Stock,  the  issuance  of
securities in acquisitions and the sale of shares by certain  stockholders,  the
utilization of the Company's net operating loss  carryforward  of  approximately
$53 million at December 31, 1996 is subject to the  limitations  and  expiration
periods  imposed by Section 382 and other  provisions  of the  Internal  Revenue
Code, thereby increasing the probability that all or a portion may expire before
utilization.



                                 USE OF PROCEEDS

   
         There will be no proceeds to the Company from the sale of the Shares by
the Selling Stockholders.  Any proceeds of sales of Common Stock received by the
Selling Stockholders will be retained by the Selling Stockholders
    


                      DIVIDEND AND MARKET PRICE INFORMATION

         The Company's  Common Stock is quoted on Nasdaq  National  Market under
the symbol IMGX. The following table  indicates,  for each calendar quarter from
January 1, 1995,  the high and low sales prices for the Common Stock as reported
by Nasdaq.

 PERIOD                                     HIGH       LOW
    1995     -First Quarter                    4 3/4      2 5/8
             -Second Quarter                   5 7/16     3 1/8
             -Third Quarter                    7 3/4      4 7/8
             -Fourth Quarter                   5 1/8      2 13/16

    1996     -First Quarter                    5 7/8      3 3/4
             -Second Quarter                   5 5/8      3 7/16
             -Third Quarter                    5 1/16     3 1/16
             -Fourth Quarter                   4 5/32     2 11/16

    1997     -First Quarter                    3 1/2      2 9/16
             -Second Quarter                   2 29/32    1 11/16

   
             -Third Quarter                    2 1/32     1 1/4
             -Fourth Quarter                   1 3/4      1 1/32
    (through December 4, 1997)

             On December 4, 1997, the closing sale price for the Common Stock as
    reported by Nasdaq was 1 1/4. As of that date, the Company had approximately
    385 holders of record of its Common Stock, and based on information supplied
    by certain of such holders of record,  the Company estimates that as of such
    date there were approximately 7,600 beneficial owners of its Common Stock.

             The Company  has not paid any cash  dividends  on its Common  Stock
    since its inception and does not anticipate paying any cash dividends on its
    Common  Stock  in the  foreseeable  future.  The  Company  may  not  declare
    dividends  payable to holders of Common  Stock  unless and until all accrued
    cash dividends  through the most recent past dividend payment date have been
    paid in full to holders  of the  Series A Stock and the Series F Stock.  The
    Company  suspended  payment of the quarterly  dividend on the Series A Stock
    due in July and October 1997 of $0.50 per share or $803,000 in the aggregate
    for each period,  respectively.  The Company's future earnings,  if any, may
    not be adequate for the payment of dividends  on its  outstanding  preferred
    stocks.  In  addition,  the purchase  agreements  for the Series K Stock and
    Series L Stock each  require  that the Company not use the  proceeds of that
    offering  to make its  quarterly  dividend  payments  to the  holders of the
    Series A Stock.

             At June 30 and September 30, 1997,  the Company had not  maintained
    net tangible assets of at least $4 million, which is one of the quantitative
    maintenance  criteria for continued inclusion of the Company's securities on
    the Nasdaq  National  Market.  See "Risk Factors - Continued  Listing on the
    Nasdaq National Market."
    



                                 CAPITALIZATION

   
             The  following  table sets forth,  as of September  30,  1997,  the
    capitalization of the Company (including loan capital).

                                         September 30, 1997 (unaudited)
                                     (in thousands, except share amounts)

Short-Term Debt:

 Bank credit facilities                             $    648
 Other notes payable                                     590
                                                        ----
 Total Short-Term Debt                                 1,238
Long-Term Debt and Obligations
  Under Capital Leases                                 7,318
Mandatorily Redeemable Series F
 Preferred Stock, 792,186
 shares outstanding                                    6,357
Mandatorily Redeemable Series K
 Preferred Stock, 3,300 shares
 outstanding                                           3,700
Stockholders' Equity:
 Preferred stock, par value $.0001
 per share, 20,000,000 shares
 authorized; 1,605,035 shares
 outstanding
 Common stock, par value $.0001
  per share, 50,000,000 shares
  authorized; 25,865,809
  shares outstanding                                       3
 Additional paid in capital                          121,108
 Accumulated deficit                                (122,233)
Translation adjustment                                  (569)
 Stockholders' Deficit                                (1,691)
                                                      ------
Total Capitalization                                 $16,922
                                                      ======
    



                             SELECTED FINANCIAL DATA

   
         The following selected financial data for the five years ended December
31,  1996 are derived  from the audited  consolidated  financial  statements  of
Network  Imaging  Corporation.  The financial data as of and for the nine months
ended 30,September 30, 1996 and 1997 are derived from the unaudited consolidated
financial  statements of Network Imaging  Corporation.  The unaudited  financial
statements  include all adjustments,  consisting of normal  recurring  accruals,
which Network Imaging Corporation considers necessary for a fair presentation of
the  financial  position and results of  operations  for this period.  Operating
results  for the nine  months  ended  September  30,  1997  are not  necessarily
indicative  of the  results  that may be  expected  for the entire  year  ending
December 31, 1997. The data should be read in conjunction  with the consolidated
financial statements, related notes, and other financial information included in
this Prospectus.
    

   
<TABLE>
<CAPTION>
STATEMENT OF OPERATIONS DATA                      Year ended December 31,
- ----------------------------       -----------------------------------------------------
(in thousands, except per
 share amounts)                     1996        1995        1994        1993        1992
<S>                              <C>         <C>         <C>         <C>         <C>

Net revenue                      $ 39,477    $ 69,151    $ 67,028    $ 34,069    $ 27,961
Costs and expenses:
Costs of revenue                   24,374      42,398      48,189      25,094      21,366
Product development                 6,500       7,058       4,666       1,315         310
Selling, general and
 administration                    24,956      35,679      36,765      11,886       6,697
Exchange fee and gain
 on sale of asset, net                619        --          --          --          --
Purchased in-process
 research and development            --          --         8,821      24,550        --
Settlement with stockholders         --         1,642        --          --          --
Loss on closure and sale of
 subsidiaries, net                    921       9,274        --          --          --
Restructuring costs                  (175)     (1,433)      1,654       1,646        --
Capitalized software
 write-off                           --          --         8,743         286

(Loss) before interest income
  and income taxes                (17,718)    (25,467)    (41,810)    (30,708)       (412)
Interest income (expense), net        309         224         579          77        (106)
                                 --------    --------    --------    --------    --------
(Loss) before income taxes        (17,409)    (25,243)    (41,231)    (30,631)       (518)
Income tax (benefit) expense          (68)       (280)     (1,606)        186         (53)
                                 --------    --------    --------    --------    --------
Net (loss)                        (17,341)    (24,963)    (39,625)    (30,817)       (465)

Preferred stock preferences        (3,730)     (9,933)     (4,496)       (604)       --
                                 ========    ========    ========    ========    ========
Net loss applicable to
 common shares                   $(21,071)   $(34,896)   $(44,121)   $(31,421)   $   (465)
                                 ========    ========    ========    ========    ========

Net loss per common share        $ (1.02)    $  (2.41)   $  (3.56)   $  (4.48)  $  (0.13)
                                 ========    ========    ========    ========    ========

Weighted average shares
 outstanding                       20,682      14,502      12,391       7,015       3,486
</TABLE>
    


   
STATEMENT OF OPERATIONS DATA:                    Nine Months Ended September 30,
(in thousands, except per share amounts)        --------------------------------
                                                          1997            1996

Net revenue                                            $ 28,396        $ 29,049
Costs and expenses:
 Costs of revenue                                        18,421          19,951
 Product development                                      3,451           4,190
 Selling, general and administration                     15,850          19,174
 Exchange fee and gain
  on sale of asset, net                                    --               619
 Gain from extinguishment of debt                          (267)           --
 Loss on sale of subsidiary                                --               921
 Restructuring costs                                       --              (175)
 (Loss) before interest
  income and income taxes                                (9,059)        (15,631)
 Investment and interest
  income (expense), net                                    (163)           (188)

                                                       --------        --------
(Loss) before income taxes                               (9,222)        (15,443)
Income tax (benefit) expense                                (87)            (89)
                                                       --------        --------
Net(loss)                                                (9,135)        (15,354)
Preferred stock preferences                              (3,610)         (2,749)
                                                       --------        --------
Net loss applicable
 to common shares                                      $(12,745)       $(18,103)
                                                       ========        ========

Net loss per common share                              $  (0.51)       $  (0.90)
                                                       ========        ========
Weighted average shares
 outstanding                                             24,957          20,081
    

   
<TABLE>
<CAPTION>
BALANCE SHEET DATA         September 30,           Year ended December 31,
- ------------------         -----------------------------------------------------------
(in thousands)                 1997      1996      1995      1994      1993      1992
<S>                          <C>       <C>       <C>       <C>       <C>       <C>
Cash and cash equivalents    $ 3,782   $ 7,601   $ 9,359   $ 3,989   $39,764   $ 3,385
Working capital                6,246     9,893    13,454    17,513    45,859     3,823
Current assets                21,851    24,709    35,718    46,051    59,516    10,230
Intangible assets, net         5,575     7,050     9,098    19,874    12,855     2,546
Total assets                  31,480    36,778    49,964    71,871    75,519    13,738
Current liabilities           15,605    14,816    22,264    28,538    13,657     6,407
Long term liabilities          7,318       388     2,037     3,568     3,442       287
Redeemable preferred stock    10,057     9,857    15,478    14,609    15,626      --
Total stockholders equity    $(1,691)  $11,717   $10,185   $25,156   $42,794   $ 7,044
</TABLE>
    



                MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                       CONDITION AND RESULTS OF OPERATIONS

         This  Prospectus  contains,  in  addition  to  historical  information,
forward-looking  statements  that involve risks and  uncertainty.  The Company's
actual  results  could differ  significantly  from the results  discussed in the
forward-looking  statements.  Factors  that could  cause or  contribute  to such
differences include those discussed in "Risk Factors" as well as those discussed
elsewhere in this Prospectus.

Results of Operations for the Years Ended December 31, 1996, 1995 and 1994

         Revenue.  Product  revenue  includes  sales of  software  licenses  and
computer  equipment.  Product  revenue  is  recognized  upon  delivery  or,  for
contracts with significant  completion services requiring attainment of customer
acceptance,   upon  customer  acceptance.   Service  revenue  includes  software
maintenance  contracts,  installation  and  customization.  Service  revenue  is
recognized over the terms of the related contracts as the services are completed
or under the percentage of completion method where appropriate.

         Total  revenue  was $39  million in 1996,  $69  million in 1995 and $67
million in 1994. The decrease in total revenue in 1996 over 1995 of $30 million,
or 43%, resulted from decreases in product revenues of $29.2 million, or 61%, to
$18.3 million, and in service revenue of $500,000,  or 2%, to $21.1 million. The
increase in total revenue in 1995 over 1994 of $2 million,  or 3%, resulted from
increases in service revenue of $4.5 million, or 26% to $21.6 million, offset by
a decrease in product revenue of $2.4 million, or 5% to $47.5 million.

         During 1994, the Company  committed  itself to a plan of  restructuring
that was designed to improve  operating  results by concentrating  the Company's
resources on the marketing and continued development of its 1View suite and COLD
software  products.  In connection  with its  restructuring  plan,  the Company,
during  1995  and  1996,   disposed  of  a  number  of   operating   units  (the
"Divestitures"),  which  were  not  considered  complimentary  to the  Company's
business. The decrease in product revenue in 1996 of $29.2 million was primarily
attributable  to the  Divestitures,  which  reduced  product  revenue  by  $19.9
million,  and a major installation  project in 1995 for $9.3 million,  which was
not duplicated in 1996.

   
         The decrease in product  revenue in 1995 of $2.4 million was  primarily
attributable  to the  Divestitures,  which  reduced  product  revenue  by  $10.6
million,  offset by an  increase  of $8.2  million  in 1View and  comparableCOLD
product  revenue.  The increase in 1View  product  revenue was  attributable  to
licenses provided for a major installation project,  involving  approximately 40
servers   and   3,000   clients,   in  more  than  50   districts   of  a  major
telecommunications  company. This project accounted for approximately 15 percent
of the Company's revenues in 1995.

         The decrease in service revenue in 1996 of $500,000 was attributable to
the  Divestitures,  which reduced service revenue by $2.9 million,  offset by an
increase of $2.4  million in 1View sales and service  revenue.  The  increase in
1View sales and service  revenue was  attributable  to  increased  staffing  and
management  emphasis on the  professional  services  business.  The  increase in
service  revenue in 1995 of $4.5  million  was  primarily  attributable  both to
Dorotech,  the  Company's  French  subsidiary,  and  to  domestic  COLD  storage
maintenance services.

         Profit Margins.  Profit margins for product sales improved in 1996 over
1995 as the  cost of  products  sold  decreased  from 62% to 54% of  sales.  The
increase in product sales margins was due to the  continued  increased  sales of
the Company's  internally developed products and due to the dispositions in 1995
of the Company's CAD/CAM resellers. Profit margins for product sales improved in
1995 over  1994 as the cost of  products  sold  decreased  from 74% to 62%.  The
significant  increase in product  sales  margins was also due  primarily  to the
increased  sales of the Company's  internally  developed 1View product suite and
the  dispositions  of the  Company's  WildSoft and Hunt Valley  divisions and PE
Systems,  Inc.,  Microsouth,  Inc., Tekgraf,  Inc., IBZ and Network Imaging (UK)
Holders Limited subsidiaries during 1995, which primarily occurred in the second
and third quarters.
    

         Profit  margins for service  sales  decreased  in 1996 over 1995 as the
cost of  products  sold  increased  from 61% to 68% of sales.  The  decrease  in
service sales margins was primarily  attributable  to the increased  staffing in
the professional services business. Profit margins for service sales improved in
1995 as compared to 1994,  as the cost of service  sales  decreased  from 67% to
61%. The increase in service sales  margins was due  primarily to  customization
and  maintenance  service  sales of the  Company's  internally  developed  1View
product  suite,  an  increase  in  COLD  storage  maintenance  margins  and  the
Divestitures.

         Research  and  Development.  The  Company's  expenditures  on  software
research and development  activities ("R&D") in 1996 were $8.5 million, of which
$2.0 million was capitalized and $6.5 million was expensed.  The slight increase
in  capitalization  between  1996  and 1995  was due to the  development  of the
Company's next  generation  mainframe and PC-based COLD products.  The Company's
expenditures on software R&D activities in 1995 were $8.7 million, of which $1.7
million  was   capitalized   and  $7.0  million  was  expensed.   The  Company's
expenditures  on  software  research  and  development  activities  and  for the
acquisition of software licenses and the software in 1994 were $11.6 million, of
which $7.0  million  was  capitalized  and $4.6  million was  expensed.  The 48%
increase  in  product  development  expense  from $4.6  million  in 1994 to $6.8
million  in 1995  was  primarily  attributable  to the  general  release  of the
Company's  1View product suite in early 1995,  whereas in 1994,  the R&D efforts
for the  1View  product  suite  were  still in the  development  stage.  The net
decrease in total R&D expenditures from $11.6 million in 1994 to $8.5 million in
1995, or $3.1 million, was primarily attributable to the Divestitures; a reduced
focus on the Company's network attachable storage products,  which resulted in a
$770,000  reduction  in R&D  expenditures;  an  increased  focus  on  Dorotech's
engineering   services,   which   resulted  in  a  $810,000   reduction  in  R&D
expenditures;  a net $200,000 reduction in software license  acquisitions;  and,
increased domestic  engineering services for installation and maintenance of the
Company's 1View product suite.

         Selling,  General and  Administrative  Expenses.  Selling,  general and
administrative expenses ("SG&A") were $25.0 million, or 63% of revenue, in 1996,
$35.7 million,  or 52% of revenue, in 1995, $36.8 million, or 55% of revenue, in
1994.  The decrease in 1996  compared to 1995 of $10.7  million,  or 30% was the
result of the  Divestitures,  which  accounted  for a $8.7  million  decrease in
addition  to a $2.0  million  decrease  in  SG&A  expenses  from  the  Company's
continuing 1View, COLD and French  operations.  The decrease in 1995 compared to
1994 of $900,000, or 2%, is due to the Divestitures,  which reduced SG&A expense
an aggregate of $5.0 million, offset by increases in sales and marketing efforts
of $4.1 million.

         Exchange Fee and Gain on Sale of Asset,  Net.  During 1996, the Company
paid a fee of $650,000 plus $80,000 of expenses in connection with the extension
of the redemption date of the Company's  Dorotech  Acquisition  Preferred Stock.
See "Descriptions of Capital  Stock--Acquisition  Preferred Stock." During 1996,
the Company realized a $111,000 gain on the disposition of stock  distributed to
the Company by its medical insurance provider.

   
         Purchased  In-Process  R&D. In connection  with the  acquisition of DCR
Technologies,  Inc. ("TREEV"),  now a division of the Company,  during 1994, the
Company  incurred a charge  totaling  $8.8 million  relating to the expensing of
purchased in-process research and development.

         Settlement with Stockholders. Operating expenses in 1995 include a $1.6
million expense related to settlement of obligations with former stockholders of
IBZ and TREEV for $750,000 and $892,000,  respectively. The Company entered into
an agreement with the former principle  stockholder of IBZ whereby,  in exchange
for  an  aggregate  of  $750,000,   the  former  principle  shareholder  of  IBZ
relinquished  rights to a loan  guarantee.  During  1995,  the  Company and four
former  stockholders  of  TREEV,  entered  into  agreements  to settle a dispute
arising from the  acquisition  of DCR in exchange for  extensions  of employment
agreements and an aggregate of 175,000  additional shares of Common Stock of the
Company, valued at that time at approximately $892,000.

         Restructuring Charges and Capitalized Software Write-Offs.  At December
31, 1996, the 1994 restructuring  plan ("1994 Plan"),  whereby excess personnel,
duplicate  facilities  and  products  to be  discontinued  were  identified  was
complete.  Under the 1994 Plan, the Company incurred a net change in estimate of
$175,000 in 1996.

         During 1995,  the Company  incurred  additional  charges under the 1994
Plan for items that exceeded its original  estimates  totaling  $297,000.  These
additional  charges  were  offset  by $1.4  million  reflecting  a  decrease  in
estimated  charges for  impairment  of inventory  and  maintenance  spare parts.
During 1995, $322,000 of the 1993 restructuring plan costs were reversed after a
release was negotiated from the landlord for vacated property.

         The Company incurred a $2.0 million  restructuring  charge in 1994 when
establishing  the 1994 Plan. In conjunction with the 1994 Plan, the Company also
expensed capitalized software of $5.3 million in 1994, which related to products
that were abandoned in favor of the 1View suite.  During 1994, $300,000 of costs
from the 1993 restructuring plan were adjusted due to changes in estimate.
    

         Investment and Interest Income.  Net investment and interest income was
$309,000 in 1996, $224,000 in 1995 and $579,000 in 1994. The $85,000 increase in
net  investment  and  interest  income  between  1996  and  1995  was  primarily
attributable  to the interest earned for the cash received and invested from the
private  placement  offerings  of Common  Stock and Series H, I and J  Preferred
Stock done during the first three quarters of 1996. The $355,000 decrease in net
investment and interest income between 1995 and 1994 was primarily  attributable
to a decrease in cash,  cash  equivalents  and  short-term  investment  balances
during the same period and to increased interest expense from capital leases and
the lines of credit.

         Income  Taxes.  The Company  incurred  income tax  benefits of $68,000,
$280,000  and $1.6  million in 1996,  1995 and 1994,  respectively.  The $68,000
income  tax  benefit  incurred  in 1996 was the result of net  operating  losses
generated  by  Dorotech's  operations  offset by a decrease  in  Dorotech's  net
deferred tax  liabilities.  The $280,000 income tax benefit incurred in 1995 was
primarily  the result of a decrease of net  deferred tax  liabilities  resulting
from the divestiture of IBZ's European  operations and other purchase accounting
adjustments.  The $1.6  million  income tax  benefit in 1994 was  primarily  the
result of income tax credits generated by Dorotech's European operations for R&D
expenditures and net operating losses generated by Dorotech's and IBZ's European
operations.

         Net Loss.  The  Company's  net loss was $17.3  million  in 1996,  $25.0
million in 1995 and $39.6 million in 1994. The $7.6 million decrease in net loss
between 1996 and 1995 was due to the 1995 losses from the  Divestitures  of $9.3
million,  the $1.6 million settlement with  stockholders,  and the $10.7 million
reduction in SG&A expenses in 1996.  These reductions in expenses were offset by
a  $11.7  million  reduction  in  gross  margin  in  1996,  the  loss on sale of
subsidiary  in 1996 of  $921,000,  and the change in estimate of $1.4 million in
restructuring costs in 1995.

   
         The $14.7  million  decrease in net loss  between 1995 and 1994 was due
primarily to significantly improved margins on product and service sales of $7.8
million,  the 1994  expenses  incurred  for  purchased  in-process  research and
development  of  $8.8  million,   restructuring  charges  of  $1.7  million  and
capitalized software write-offs of $8.7 million in 1994, offset by the 1995 loss
on closure and sales of  subsidiaries  of $9.3 million,  settlement  expenses of
$1.6 million, and reversals of restructuring costs of $1.4 million.
    

         Excluding the impact of the write-off of purchased  in-process  R&D and
the write-off of capitalized  software,  the entities  divested in 1995 and 1996
contributed a net loss of  approximately  $1.1 million in 1996,  $4.3 million in
1995 and $14.4 million in 1994.

         Net Loss  Applicable to Common  Shares.  Net loss  applicable to common
shares  includes  adjustments  for dividends,  accretion and redemption  amounts
related to the  Company's  preferred  stock.  The net loss  applicable to common
shares was $21.1 million,  or $1.02 per share, in 1996; $34.9 million,  or $2.41
per share, in 1995; $44.1 million,  or $3.56 per share, in 1994. The decrease in
1995 over 1994 is  attributable  to the decrease in net loss described above and
the  reduction  in  accretion  to  redemption  value of the  Company's  Series B
Convertible  Preferred  Stock of $417,000  offset by the cost of  redemption  of
Series D Preferred Stock of $5.9 million.

   
         Domestic  and  ExporForeignt  Sales.  For  information   regarding  the
Company's domestic and foreign sales, see Note 13 to the Consolidated  Financial
Statements for the years ended December 31, 1994, 1995 and 1996.
    

Liquidity and Capital Resources for the Years Ended December 31, 1996 and 1995

         As of December 31, 1996,  the Company had $7.6 million in cash and cash
equivalents  compared  to $9.4  million  in cash and cash  equivalents  and $3.0
million in restricted  short-term  investments,  or a total of $12.4 million, at
December 31, 1995. Net working capital decreased to $9.9 million at December 31,
1996 from $13.2 million at December 31, 1995;  however,  the  Company's  working
capital ratio improved from 1.6:1 to 1.7:1.

   
         At December 31, 1996, the Company had outstanding debt of $2.2 million,
$2.1 million of which is due within one year.  This  compares  with debt of $6.6
million at December 31, 1995, $5.4 million of which was due within one year. The
decrease in debt of $4.4 million primarily arose from net repayments of maturing
obligations.  See Note 8 to the Consolidated  Financial Statements for the years
ended December 31, 1994, 1995 and 1996.
    

         For  1996,  the $1.8  million  decrease  in cash  and cash  equivalents
resulted  from a $11.9  million  use of cash  from  operating  activities,  $2.6
million used in investing  activities  and the  generation of $12.7 million from
financing  activities.  The $11.9  million use of cash in  operating  activities
arose  primarily  from the $17.3  million  loss from  operations  offset by $5.8
million in  depreciation  and  amortization  charges.  The $2.6  million to fund
investing  activities  arose with respect to  capitalized  software  development
costs and the purchase of fixed  assets.  The $12.7  million in cash provided by
financing  activities  arose  primarily from the $6.0 million  proceeds from the
issuance  of Common  Stock and  $10.9  million  proceeds  from the  issuance  of
Convertible  Preferred  Stock,  Series H, I and J,  offset  by the $3.2  million
payment of Series A Stock  dividends and net payments in debt and capital leases
of $1.2 million.

   
         During the first quarter of 1996,  the Company  repaid its $2.5 million
U.S. line of credit, which had a termination date of March 31, 1996. At December
31, 1995,  $2.5 million of the $3.1 million  restricted  short-term  investments
served as collateral for this line of credit.  The Company negotiated a new line
of credit  during the fourth  quarter  of 1996,  see Note 8 to the  Consolidated
Financial Statements for the years ended December 31, 1994, 1995 and 1996.
    

         For  1995,  the $5.4  million  increase  in cash  and cash  equivalents
resulted from a $9 million use of cash from operating activities, the generation
of $9.6 million from  investing  activities,  and the generation of $4.7 million
from financing  activities.  The $9 million use of cash in operating  activities
arose  primarily  from  the $25  million  net loss  offset  by $6.3  million  in
depreciation  and  amortization  charges and a $9.3  million loss on the sale of
subsidiaries.  The $9.6 million raised from investing activities arose primarily
from  the  sale  of  short-term   investments  offset  by  capitalized  software
development  costs and purchases of fixed assets.  The $4.7 million  raised from
financing  activities  arose primarily from the $28.1 proceeds from the issuance
of Preferred Stocks, Series D, E and G, and the issuance of Common Stock, offset
by the $15.6  million  redemption  cost for the Series D Preferred  Stock,  $3.2
million in dividend payments on the Series A Stock, $2.3 million net payments in
debt and capital  lease  financings,  and $3.1  million  purchase of  restricted
short-term investments.  In 1995, the Company divested seven operating units for
which the Company received $1.2 million in cash.

         As a result  of stock  offerings  in 1996,  the  Company  received  net
proceeds  of  approximately  $16.9  million  which  included  offering  costs of
approximately $500,000. Under the offerings, the Company issued 1,760,285 shares
of Common Stock and 1,100 shares of Series H, I and J Preferred  Stock.  The net
proceeds of the offerings were used for working capital purposes.

   
         The annual dividend  requirements on the Company's  Series A Cumulative
Confertible   Preferred  Stock  ("Series  A  Stock")  is  $3.2  million  payable
quarterly. All quarterly dividends on the Series A Stock due in July and October
31, 1997 in the amounts of $0.50 per share or $803,000 in the aggregate for each
period. Failure to pay any quarterly dividend has resulted in a reduction in the
conversion  price and failure to pay a total of four  quarterly  dividends  will
entitle the  holders of the Series A to elect one  director.  (Because  the sole
holder of all of the outstanding shares of Series F Stock has agreed to sell all
of such shares to the Company for a set price, the Company accrues  dividends on
the  outstanding  shares  of  Series F Stock  but is not  obligated  to make any
payments  until January 31, 1998 or upon the  occurrence  of certain  conditions
under the control of the Company.) Bylaw,  dividends may be paid from surplus or
net  profits for the fiscal  year in which the  dividend is declared  and/or the
preceding  fiscal  year.  There  can be no  assurance  that  future  surplus  or
earnings,  if any, will be adequate to pay dividends on the preferred stock. See
"Description of Capital Stock."


Results of Operations for the Nine Months Ended September 30, 1997 and 1996

         Revenues.  Total  revenues were $28.4 million and $29.0 million for the
nine months  ended  September  30,  1997 and 1996,  respectively.  The  $700,000
decrease in revenue was the result of  decreases  in  productservice  revenue of
$700,000, or 5%, offset by an increase in product revenue of $94,000, or 1%. The
decrease in service revenue was  tattributable  to a decrease of $1.6 million in
the Company's French subsidiary's service revenues, due in part to the weakening
of the U.S.  dollar  against the French franc and to a temporary  slow down in a
major service  contract,  offset by a $1.1 million  increase in domestic service
revenue.  The  disposition in 1996 of Symmetrical  Technologies,  Inc.  ("STI"),
decrease.also  reduced the Company's service revenues by $170,000.  The increase
in product  revenue of $94,000  was the  result of a $2.2  million  increase  in
comparable  Company  U.S.  revenues  offset by a  decrease  of  $640,000  in the
Company's  French  subsidiary's  product revenues and a decrease of $1.5 million
due to the disposition of STI in 1996.

         Profit  Margins.  Profit margins for product sales increased 9% for the
first  nine  months  of 1997 over the same  period  in 1996 as cost of  products
decreased  from 59% to 50% of sales.  The increase in product  sales margins was
due in part to the  disposition  during  1996 of STI,  and an  increase  in both
domestic and French  margins.  Profit margins for service sales decreased 2% for
the nine  months  ended  September  30,  1997 as compared to 1996 as the cost of
services  increased  from 77% to 79% of sales.  The  decrease  in service  sales
margins from 23% to 21% was attributable to the Company's French subsidiary.

         Sales and Marketing13  Sales and marketing  expenses were $10.9 million
or 38% of revenue for the nine months ended September 30, 1997 compared to $11.7
million,  or 40% of  revenue  in 1996.  The  decrease  of  $800,000,  or 6%, was
primarily the result of the Company's disposition of STI during 1996.

         General and Administrative  ("G&A")40 G&A expenses were $4.9 million or
17% of revenue for the nine months  ended  September  30, 1997  compared to $7.5
million,  or 26% of revenue,  in 1996. The decrease of $2.6 million, or 34%, was
primarily  the  result  of the  Company's  efforts  in  cost  reductions  in the
Company's continuing operations.

         Product  Development.  The Company's  expenditures on software research
and development activities for the $0.7nine months ended September 30, 1997 were
$4.5  million,  of which $1.1 million was  capitalized  and $2.33.4  million was
expensed.  Software  research and development  expenditures  for the 1996 period
were $4.25.7 million, of which $1.15 million was capitalized and $3.14.2 million
was expensed. The $1.2 million decrease in research and development expenditures
is  attributable  to the Company's  1996 plan to  consolidate  the various 1View
product  development  groups  into a  common  product  development  organization
operating under a single senior manager.  During 1996, the Company  consolidated
its COLD product  development  groups from three separate  locations to one, and
vacated the excess office space. The Company's  disposition of STI also resulted
in a reduction of $208,000 in research and development expenditures.

         Gain on  Extinguishement  of  Debt.  The  Company's  French  subsidiary
realized a $267,000 gain in connection  with the partial  forgiveness of a grant
made by a French government agency.

         Income Taxes.The Company's income tax benefit for the nine months ended
September 30, 1997 and 1996 of $87,000 and $89,000, respectively,  resulted from
taxable losses generated by the Company's French operations.

         Net Loss.  The Company's  net loss for the nine months ended  September
30, 1997 was $9.1  million as  compared  to a net loss of $15.3  million for the
comparable  period of 1996.  The net loss decrease of $6.2 million for the first
nine months of 1997 as compared to the same period in 1996 is due  primarily  to
the $2.6 million  reduction  in G&A  expenses,  $800,000  reduction in sales and
marketing  expenses,   $700,000  reduction  in  product  development   expenses,
increased profit margins resulting in $880,000  additional gross margin, and the
loss on sale of subsidiary and exchange fee incurred in 1996.

         Net Loss Applicable to Common Stock.  The net loss applicable to common
shares includes  adjustments for dividends and accretion  amounts related to the
Company's  preferred stock. The net loss applicable to common shares was $as12.7
million,  or ($.51) per share,  for the nine months ended  September 30, 1997 as
compared  to $18.1  million or ($.90) per share,  for the  comparable  period of
1996. The decrease is attributable to the decrease in net loss described above.


Liquidity and Capital Resources for the Nine Months Ended September 30, 1997

         As of September 30, 1997, the Company had $3.8 million in cash and cash
equivalents,  as  compared  to $7.6  million  in cash  and cash  equivalents  at
December 31, 1996.  Net working  capital was $6.2 million at September  30, 1997
and $9.9 million at December 31, 1996.

         During the first nine months of 1997,  the Company  redeemed  1,000,000
shares of Series F  proceedsStock  for $3.5 million by using  proceeds  from its
domestic  line of credit,  and drew the  remaining  $1,500,000  from its line of
credit. In addition, the Company issued convertible notes and Series K Stock for
which it received net proceeds of $2.0 million and $2.9 million, respectively.

         For the nine months ended September 30, 1997, the $3.8 million decrease
in cash and cash  equivalents  resulted  from the use of $5.1 million in cash to
fund operating activities, $1.6 million to fund investing activitiesfund, offset
by $3.1 million in cash generated by financing activities.

         The $5.1 million funding of operating  activities  arose primarily with
respect  to a net  loss in  operations.  The  $1.6  million  to  fund  investing
activities arose with respect to capitalized  software development costs and the
purchase  of fixed  assets.  The $3.1  million  in cash  provided  by  financing
activities arose primarily from the proceeds of $5.0 million from borrowing from
the line of credit, $2.0 million from the issuance of convertible notes and $2.9
million from the issuance of Series K Stock,  offset by the $1.8 million payment
of preferred stock dividends, $3.5 million payment on the Series F Stock and the
principle payments on debt and capital lease obligations.

         The adverse  results of operations  that the Company has experienced is
expected to continue at least until the first part of 1998. The Company believes
that its existing cash, potential future proceeds from such additional offerings
of equity  securities as may be required,  and the  anticipated  cash flows from
operations,  should provide sufficient  resources to fund its activities through
the next twelve  months and to  maintain  net  tangible  assets of at least $6.0
million,  which is required for continued inclusion of the Company's  securities
on the Nasdaq  National  Market.  See "Risk  Factors - Continued  Listing on the
Nasdaq  National  Market."  Anticipated  cash flows from  operations are largely
dependent  upon the  Company's  ability  to achieve  its sales and gross  profit
objectives  for its 1View and other  products.  If the Company is unable to meet
these objectives,  it will consider  alternative  sources of liquidity,  such as
additional offerings of equity securities. Although the Company believes that it
can  successfully  implement  its  operating  plan  and,  if  necessary,   raise
additional  capital,  there can be no assurance that  implementation of the plan
will be successful or that financing, if sought, will be available.
    

Recent Events

   
         On December 31, 1996, the Company  entered into a restricted $5 million
line of credit agreement with Fred E. Kassner ("Loan  Agreement") to finance the
buy back of the Series F  Preferred  Stock.  The line of credit  bears a rate of
interest rate at 2% above a commercial lender's fluctuating prime rate. The line
of credit was initially  secured by a lien against all of the domestic  accounts
receivable of the Company pursuant to a security  agreement with the stockholder
("Security  Agreement").  In  connection  with the line of credit,  the  Company
issued to the stockholder warrants to purchase 100,000 shares of Common Stock at
an exercise  price of $3.06 per share,  warrants to  purchase  70,000  shares of
Common  Stock at an exercise  price of $3.06 per share and  warrants to purchase
30,000  shares  of  Common  Stock  at an  exercise  price  of  $2.09  per  share
(collectively, the "Kassner Warrants"). In connection with the Kassner Warrants,
the  Company  granted  the  stockholder   with  one  demand  and  two  piggyback
registration rights, which will become effective on January 1, 1998.

         On June 8,  1997,  the  Company  and the  stockholder  entered  into an
amendment to the Loan Agreement pursuant to which the stockholder  permitted the
Company to use the  proceeds  of the loan for  general  corporate  purposes  and
entered  into  an  amendment  to the  Security  Agreement,  which  expanded  the
stockholder's security to cover, including without limitation,  (1) all personal
property of the Company,  (2) all leases,  licenses,  permits,  (3) all software
products  intellectual property now owned or hereafter developed by the Company,
(4)  all  inventory,   (5)  all  accounts,   contract  rights,   chattel  paper,
instruments, general intangibles, documents and other obligations, (6) all trade
or service n names,  trademarks,  service marks,  logos and all patents,  patent
applications,   copyrights,  licensing  agreements  and  royalty  payments,  (7)
proceeds of the foregoing, and (8) all of the capital stock of Dorotech. Also at
that time, the stockholder agreed to modify and thereby eliminate a provision in
the  Loan   Agreement   that  required  the  Company  to  achieve  and  maintain
profitability by the end of the third quarter of 1997.

         During July and August  1997,  the Company  issued to nominees for Mark
Shoom and Charles G. Kucey (collectively referred to as "Noteholders"), pursuant
to a private  placement  exemption under the Securities Act of 1933, as amended,
8% Convertible  Notes due July 8, 2002 and August 20, 2002 totaling $2.0 million
(the "Convertible Notes"). $1.8 million of the Convertible Notes are convertible
into the  Company's  Common Stock  beginning 45 days after issue at a conversion
price of $1.875 per share and $200,000 of the  Convertible  Notes are converible
with the  Company's  Common Stock  beginning 45 days after issue at a conversion
price of $1.50 per  share,  which were the  prices on the issue  dates.  The net
proceeds of the Convertible Notes have been used for working capital and general
corporate  purposes.  The Company also issued warrants to purchase 36,000 shares
and 4,000  shares of Common  Stock,  in the  aggregate,  to the  Noteholders  at
exercise  prices of $1.875  and $1.50  per  share  ("Note  Warrants").  The Note
Warrants expire on July 8, 2002 and August 20, 2002.

         Interest  on  the  Convertible  Notes  is  payable  at  8%  per  annum,
compounded semi-annually.  The Company has the option of paying interest in cash
or Common Stock at the redemption or conversion price described below.

         The  holders  of the  Convertible  Notes have a  security  interest  in
accounts receivable, inventory, the intellectual property of the 1 View Software
and  on  the  stock  of the  Company's  subsidiary,  Dorotech.  The  payment  of
principal,   premium,   if  any,  and  interest  on  the  Convertible  Notes  is
subordinated  to the senior  indebtedness of the Company held by Fred E. Kassner
who has granted a line of credit to the Company.  As of November  13, 1997,  the
amount of outstanding  indebtedness (including accrued and unpaid interest) owed
by the Company to Mr.
Kassner under this line of credit was $5.036 million.

         Pursuant  to the  terms  of the  Convertible  Notes,  the  Company  was
obligated to file a  registration  statement with the SEC to register the Common
Stock issuable on conversion of the Convertible Notes.
Accordingly, the Company filed this registration statement.

            On or after October 30 (with respect to $1.8 million of  Convertible
Notes),  and  December  12,  1997  (with  respect  to  $200,000  of  Convertible
Notes),the  holders have the right to redeem the convertible  notes plus accrued
interest on one business days' notice to the Company in cash or shares of Common
Stock, at the Company's  election.  On or after October 30 (with respect to $1.8
million of Convertible  Notes), and December 12, 1997, with respect to $200,000,
the Company has the right to redeem the convertible  notes plus accrued interest
on 30 days'  notice  to the  holders  in cash or share of Common  Stock,  at the
holders' election. If shares of Common Stock are used, Common Stock is issued at
a rate of 90% of the  previous 5 trading  days  average  closing bid price.  The
interest is compounded semi-annually.

         See  "Description  of Capital  Stock--Series  K  Convertible  Preferred
Stock" and "Description of Capital Stock - Series L Convertible Preferred Stock"
for a description  of the  securities  sold to Capital  Ventures  International,
Zanett  Lombardier,  Ltd., Bruno Guazzoni and the Zanett Securities  Corporation
("Zanett").

         On July 9, 1997,  the  Company  issued to  nominees  for Mark Shoom and
Charles G. Kucey  (collectively  referred to as  "Noteholders")  8%  convertible
notes that are due on July 8,  2002.  Pursuant  to the terms of the  convertible
cotes,  the  Company was  obligated  to register  the Common  Stock  issuable in
connection with the convertible cotes by September 12, 1997. The net proceeds of
the  convertible  notes ($1.8  million)  have been used for working  capital and
general corporate purposes.  The Company also issued warrants to purchase 36,000
shares of Common Stock,  in the  aggregate,  to the  Noteholders  at an exercise
price of $1.875 per share ("Note Warrants").
The Note Warrants expire on July 8, 2000.

         On August 20, 1997,  the Company  issued to one of the nominees for the
Noteholders  additional  8%  convertible  notes that are due on August 20, 2002.
Pursuant to the terms of these  convertible  notes,  the Company is obligated to
register the Common Stock issuable in connection with the  convertible  notes by
______________, 1997. The net proceeds of these convertible notes were also used
for working  capital and general  corporate  purposes.  The Company  also issued
warrants to purchase  4,000 shares of Common Stock to one of the  Noteholders at
an exercise price of $1.50 per share.  These warrants expire on August 20, 2002.
Interest  on  the  convertible  notes  is  payable  at a rate  of 8% per  annum,
compounded semi-annually.  The Company has the option of paying interest in cash
or Common Stock at the redemption or conversion price described below.

         The  holders  of the  convertible  notes have a  security  interest  in
accounts receivable,  inventory, the intellectual property of the 1View Software
and  on  the  stock  of the  Company's  subsidiary,  Dorotech.  The  payment  of
principal,   premium,   if  any,  and  interest  on  the  Convertible  Notes  is
subordinated  to the senior  indebtedness of the Company held by Fred E. Kassner
who has  granted a line of credit to the  Company.  As of  November,  1997,  the
amount of outstanding  indebtedness (including accrued and unpaid interest) owed
by the Company to Mr. Kassner under this line of credit was $5.036 million.

         Pursuant  to the  terms  of the  convertible  notes,  the  Company  was
obligated to file a registration statement with the SEC convertible notes45 days
The  convertible  notes issued in August are  convertible  into shares of Common
Stock  beginning 45 days after issue (October 4, 1997) at a conversion  price of
$1.50 per share.
         convertible notes issued in JulyThe  convertible notes issued in August
may not be redeemed  prior to December 12, 1997. in the case of the  convertible
notes issued in July,  and on or after  December  12,  1997,  in the case of the
convertible notes issued in August, convertible notes1997 or December 12, as the
case may be,  convertible  notesSee  "Description  of  Capital  Stock - Series K
Convertible  Preferred  Stock" for a description of the  securities  sold to the
Purchasers and Zanett.
    

                                    BUSINESS

   
         Network Imaging  Corporation  ("Network  Imaging" or the "Company") was
incorporated  in Delaware in May 1991. The Company  provides  software  products
supporting  storage,   management  and  distribution.   These  products  provide
businesses   and   government   organizations   with  an  automated   method  of
electronically  storing,  managing and distributing  large volumes of structured
data (text) and unstructured data (diagrams,  documents,  photographs, voice and
full-motion video).
    

         The  Company  is a leader in content  and  storage  management  for all
unstructured  information.  Its flagship product,  the 1View suite,  manages the
storage,  access and distribution of any multimedia (or unstructured) data, such
as diagrams,  documents,  photographs,  voice, and full-motion video. 1View is a
solution for use in distributed,  high transaction, high volume mission critical
applications   across  legacy,   client/server   and   Internet/intranet   based
environments.  The  Company  is also a  software  developer  for  mainframe  and
PC-based  COLD  systems  and a  developer  and  marketer  of storage  management
software  systems.  1View,  InfoAccess(TM),  Treev+(TM) and the Company logo are
trademarks of Network Imaging Corporation.

         United States operations are conducted in Herndon,  Virginia (primarily
the development, marketing and sales activities of the 1View suite and mainframe
COLD products), Minneapolis,  Minnesota and Denver, Colorado (PC COLD products).
European  operations  are  conducted  primarily in Paris,  France  (hierarchical
storage management ("HSM") software and related storage products and engineering
services).

         Traditional  manual filing,  retrieval,  and  distribution  methods are
labor intensive,  slow, require bulky file storage, allow only one person to use
a file at a time and often  result in  misfiled,  damaged or lost  items.  Large
commercial and government  organizations must continually  process large volumes
of  documents  stored in hard copy paper  files  where  there is a need for more
efficient movement of information throughout the enterprise. The information may
take the form of documents,  database  records,  graphics,  video clips,  audio,
computer  aided  design  ("CAD")  and  engineering  drawings,   and  other  such
"information objects" which are distributed  throughout a multi-site enterprise.
To  address  this need for  information  storage,  retrieval,  and  distribution
management, the Company has developed its principal products: the 1View software
application  suite, a family of COLD products,  and the  Doro-family of products
for HSM applications.

   
         The Company uses advances in object management  software to capture and
store  "information  objects" with more advanced indexing and retrieval features
than those  available for paper  documents or  "structured  data." The Company's
information access, object management,  and storage management systems have been
designed to support "open systems standards," which permit hardware and software
from different vendors to operate together on a network.
    


1View

         The Company's 1View suite is designed to answer the information  access
needs of large  organizations.  1View's object  enabling suite of software tools
contains flexible and layered  application  program interfaces  ("APIs"),  which
allow  developers  to  select  the  appropriate  level  of API to suit  customer
solution requirements, provide a bridge to "legacy" systems previously used, and
allow for easy  customization of software systems in comparison to standard file
structures. 1View is an independent platform.

         The 1View suite consists of the following:


         1View: Object Manager is an API toolkit that provides a unique solution
for storing,  managing,  and distributing any type of multimedia document object
in  high  transaction,   high  volume,   client/server   and   Internet/intranet
environments.  It can manage information that originates from a large variety of
sources,  including  scanned  documents,  computer  output,  word  processor  or
spreadfile  sheets,  audio/voice or full motion clips, and photographic  images.
1View:    Object   Manager   helps   companies    seamlessly   and   efficiently
multimedia-enable  existing or new database  applications while preserving their
investments  in legacy  information  systems,  hardware  equipment and personnel
training.

   
         1View: EDM (Engineering Document Management) is a software product with
an  application  that  solves  the  document   management   problems  unique  to
engineering  organizations.  Target customers include manufacturing,  utilities,
transportation and other engineering-based  corporations. The product supports a
variety of document types  including  oversized  engineering  and  architectural
drawings,  project plans,  specifications and blueprints  indexing the documents
according to end-user criteria.
    

         1View:  Workflow is a software product with an easy-to-implement  suite
of  software  tools  designed  to  automate   complex   business   processes  in
client/server  and Web  environments.  It is a rules-based  workflow  management
system designed to allow  integration and automation of work process  management
applications into mainstream  business  practices.  1View:Workflow  provides the
ability to  graphically  represent  and control  business  processes  by linking
together a variety of people  and  software  elements  to  automate  the flow of
documents (objects) throughout an enterprise.

         1View:  WebMOM (Web Multimedia  Object  Manager) is a software  product
that allows companies to build customer  Internet/intranet  applications  easily
and  cost-effectively  using the  1View:Object  Manager  as a  back-end  storage
repository.  It delivers  high  performance  access from Web browsers due to its
caching capabilities, while protecting confidentiality of data by linking to Web
security  mechanisms.  Upon  requests  from Web users,  it locates  the  object,
retrieves  it, adds a MIME header to it, and finally  transfers  it back through
the Web server to the Web browser.  1View:WebMOM supports all major Web browsers
and  servers,  such as Netscape  Navigator,  Netscape  Web  Server,  MS Internet
Explorer, and MS Internet Information Server.

         1View:  COLD/ES is a report  storage and  retrieval  system that offers
high volume,  high speed mission critical print data handling.  It lets the user
maximize  the  power  and  extensive  resources  of the  mainframe  computer  by
off-loading  report management  operations to a cost-effective  dedicated server
and its associated high efficiency data storage subsystem.

   
         Another  product  is a software  product  that  provides a storage  and
retrieval  system for scanned images and other  documents.  It provides a simple
and consistent way to find and view information  regardless of the information's
storage location or internal format. In most cases,  documents are added to this
system using a batch scanning process.  This product is an end-user  application
that runs with 1View:Object  Manager.  1View:Object Manager handles the physical
management of documents as they are being scanned into the system and after they
have been stored on storage  media  while This  product  allows the  end-user to
organize  documents  electronically  in a structure  that is  meaningful  to the
end-user and retrieves information rapidly.
    


Other Products

   
         A significant  portion of the Company's product emphasis is on packaged
software solutions.  COLD software is an important component of several of these
products. COLD technology is widely accepted as a way to permanently archive and
provide for the retrieval of permanent  business  reports  produced by computers
(computer  output).  COLD typically  replaces printed paper reports and Computer
Output  Microfiche (COM or "microfiche")  with high capacity optical disks. Once
written permanently to this unalterable media, COLD provides for on-line viewing
of information such as banking and brokerage statements,  utility bills, payroll
reports and corporate financial journals and reports. COLD technology provides a
more  economical  way to store  the  information  as well as a faster  method to
retrieve  reports.  Optical disk is a much less  expensive  storage  medium than
microfiche or paper. By putting reports back on-line utilizing an organization's
standard  terminals,  workstations,  and networks,  productivity is increased as
compared to manually handling physical paper and microfiche.  The Company is one
of the largest commercial providers of COLD technology.

         The TREEV Division of the Company's  U.S.  operations has developed and
markets  PC-based COLD systems used in over 2,000  community  banks.  TREEV also
markets imaging products to the community bank marketplace including 1View:Unity
a software  product  repackaged  as TREEV  Voyager II. TREEV  Division  provides
"turn-key" hardware and software solutions,  maintenance services for its client
systems, consulting, training, and high quality optical supplies.

         The Company's  French  subsidiary,  Dorotech,  headquartered  in Paris,
develops  and markets a family of  software  products  designed to manage  large
volumes  of  information  and  provides   professional   engineering   services.
Dorotech's software products include DoroStore,  DoroFile, Doro-JB, Dorokey, and
Dorodoc (the "DoroStore  suite").  The DoroStore suite implements  advanced data
and storage management solutions for enterprises with complex networks and large
numbers of servers and  workstations.  The  capabilities  of the DoroStore suite
include: (1) centralized administration capability to implement uniform data and
storage  policies  throughout a  distributed  network,  (2) advanced  backup and
restore  processes to protect and secure data from disasters,  and provide users
with a direct link to retrieving  their  individual  files, (3) On-Line Database
Backup/Restore  ("ODBR")  to manage the backup and  recovery of  databases,  (4)
advanced  archiving  methods  that  allow  retrieval  of files  using  keywords,
phrases, and date ranges,  thereby reducing costly processes involving users and
administrators searching for specific files, (5) hierarchical storage management
for  transparently  and  automatically  storing  data onto  lower  cost  storage
subsystems,  providing  virtually  limitless  network  capacity,  and  (6)  full
security  protection for all  operations.  The DoroStore suite provides a single
utility for administering  heterogeneous  environments in terms of storage space
and data  protection  across networks on any scale, up to and including the very
largest  networks.  The Company is  endeavoring  to sell all of the  outstanding
stock of Dorotech to a third party.  There can be no assurance  that the Company
will be able to do so by January 31, 1998 or at all or on favorable terms.
    

Product Development

   
         The Company's plan to consolidate the various 1View product development
groups into a common product development organization was completed in 1996. The
unified team now operates  under a single  senior  manager and is located at the
Company's  headquarters  in Herndon,  Virginia.  This  consolidation  allows the
organization to operate under a common shared strategy,  which includes both the
1View product suite's  technical  vision and software  development  methodology.
During 1997, the product development group focused on completing product release
plans that are  responsive  to the market and support the  Company's  short term
revenue goals.
    

         The strategic direction for the products is to provide a cohesive suite
of 1View products that will deliver innovative,  intelligent, multimedia content
management  solutions to enable the Company's customers and business partners to
leverage  existing  applications  and exploit  emerging  business  opportunities
across the  Internet/intranet.  This vision has been  accomplished by leveraging
the existing 1View suite of products and adapting them to the Web environment as
well as to database  vendor products such as Sybase's  OmniConnect.  The Company
was an early adopter of the Microsoft's  ActiveX technology and will continue to
migrate  the  existing  toolkits  and API  into  components  that can be used to
rapidly  build new  enterprise  wide  applications  and easily  integrated  into
existing customer applications.

         The Company views the product  development  organization  as one of its
key assets and will  continue to invest in building the group's  infrastructure,
refining the group's  software  development  methodology,  and  implementing the
1View, COLD and storage management products strategy.


Assembly; Sources of Supply

         The  Company  assembles  its  products  at its  facilities  in Herndon,
Virginia, Denver, Colorado, and Paris, France. The Company relies exclusively on
outside suppliers for the hardware  components of its products such as scanners,
printers,  computers  and  optical  disk  drives and  jukeboxes.  Most parts and
components are currently  available from multiple sources at competitive prices.
To date, the Company has not experienced  significant  delays in obtaining parts
and  components,  and although  there can be no assurance,  the Company does not
expect to experience such delays in the future.

Warranty and Service

         Warranties  for hardware sold by the Company are generally  provided by
the  manufacturer.  The Company  typically  provides for its  software  products
warranties  for ninety days and service  contracts  for support and  maintenance
that  usually  cover one year  periods.  The Company  recognizes  revenue  under
service contracts ratably over the contract period.

Competition

   
         Management  believes  that  the  Company's  1View  product  line  is an
innovative  solution  available  for  enterprise  scaleable  content and storage
management in the industry today.  When companies have a clear need for storing,
managing  and   distributing   multimedia   objects  such  as  large   drawings,
photographs,  documents,  video clips,  and audio clips that must:  (a) scale to
many terabytes,  (b) serve thousands of users and (c) work with existing and new
applications,   application   databases  or  universal   database  platforms  in
distributed  heterogeneous  environments,  there is no direct  competition  from
other companies. When only some, but not all, of these requirements must be met,
there  is  competition  from  companies  such  as  FileNet  Corporation,   Wang,
Recognition  International,  Eastman Kodak and other vendors in the  traditional
imaging  and  document  management   markets.   For  smaller  scale  systems  in
centralized  environments  with low  performance  requirements,  the competitive
issue becomes price or company size and stability.
    
         With increasing recognition by companies such as Sybase,  Informix, Sun
Microsystems,  and  Microsoft of the unique  capability  of the Network  Imaging
product  suite,  many  of  those  issues  have  become  less  important  from  a
competitive perspective.

         There is,  however,  the potential for  competition  from the database,
application and storage vendors who in some cases are Network Imaging partners.

         The new Universal Server initiatives from Oracle,  Informix and IBM all
seem to  indicate  support to store and manage  the same  multimedia  content in
markets that Network Imaging serves.

   
         Scaleability  of  content  storage  requirements,   complexity  of  the
environment  (i.e.,  distributed  content  base,  multiplatform,   and  multiple
application  content  access),  and cost  management  of the  storage  resources
(hierarchical  storage  environments)  are real and  significant  issues in this
industry. None of the database vendors completely solve these issues and most of
them have  recognized  that and are working with Network  Imaging on large scale
system proposals. Sybase, Inc. has entered into a reseller agreement to remarket
the 1View  solution as part of their  adaptive  server  initiative.  The Network
Imaging  partner  marketing  program is  targeted to address  these  competitive
issues and make business partners of the apparent competitors.
    
         In the  future,  the  systems  management  companies  such as  Computer
Associates  and Tivoli are  expected  to  recognize  the need for  comprehensive
content and storage management for multimedia as a part of their overall systems
management architecture. Their option to cooperate or compete will depend on how
rapidly they want to enter this market. In a market segment  (Internet/intranet)
poised for explosive  growth,  Network  Imaging has  significant  time to market
advantage over their competitors' software technology.


Backlog Orders

   
         As of  November  2,  1997,  the  Company  had a backlog  of orders  for
approximately  $1,000,000 for its TREEV  Division,  whereas on November 2, 1996,
the Company had a backlog of approximately  $800,000 for its TREEV Division. The
backlog of orders for 1View and COLD exceed several million dollars. The Company
expects that it will fill  approximately  80% of the current  backlog within the
current fiscal year.
    

Marketing and Sales

   
         The Company sells its products  directly,  through its own sales force,
and  indirectly,   through  value  added  resellers,  system  integrators,   and
distributors.  The Company  maintains  sales offices in locations in or near New
York, Boston, Washington D.C., Atlanta, Charlotte, Denver, Detroit, Minneapolis,
Los Angeles, San Francisco, Dallas, Seattle and in Europe, near Paris, France.
    
         The Company has active programs to develop marketing  partnerships with
vendors of complementary  product  technologies such as companies who market and
manufacture  database,   application   development,   systems  management,   and
communication and connectivity middleware.
         The Company also focuses on vertical  market  segments that have proven
requirements  for the Company's  product  line.  These market  segments  include
Telecommunications  and Utilities,  Finance  Banking and Insurance,  Healthcare,
Manufacturing,  and the  Public  Sector.  The  Company  has  developed  vertical
business development programs in these segments to identify sales opportunities,
create product awareness,  and develop contacts for the Company's indirect sales
channels.

         The Company  advertises in numerous major  industries,  vertical market
and  news  publications.  The  Company  markets  diverse  products  to  multiple
industries.  It is not  dependent on any one customer or business  partner for a
major percentage of its business.

Business Dispositions

         During 1994, the Company  committed  itself to a plan of  restructuring
that was designed to improve  operating  results by concentrating  the Company's
resources on the marketing and continued development of its 1View suite and COLD
software  products.  In connection  with its  restructuring  plan,  the Company,
during  1995  and  1996,   disposed  of  a  number  of   operating   units  (the
"Divestitures"),  which  were  not  considered  complimentary  to the  Company's
business.

   
         As a  result  of the  Divestitures,  the  Company  recorded  losses  of
$921,000  and  $9.3  million  in 1996  and  1995,  respectively.  The  aggregate
consideration  received by the Company from the Divestitures was $1.6 million in
cash and $4.3  million in notes  receivable,  of which  $320,000 was reserved as
uncollectible at December 31, 1996.

         The  Company  sold the  assets and  liabilities  of STI  subsidiary  in
September 1996.  During 1995, the Company disposed of the following  operations:
Hunt Valley  Division  (formerly  NSI,  Inc.),  Network  Imaging  (UK  Holdings)
Limited,  Microsouth, Inc., Tekgraf, Inc., P E Systems, Inc., WildSoft Division,
and IBZ.
    

         The Company is endeavoring to sell all  of  the  outstanding  stock  of
Dorotech to a third party.  There can be no  assurance  that the Company will be
able to do so by January 31,  1998 or at all or on  favorable  terms.  See "Risk
Factors--European Operations."


License Agreements and Pricing

   
         The  Company's  software  product  revenues  consist  primarily of fees
generated from license of software products.  In consideration of the payment of
license  fees,  the  Company  generally  grants  nonexclusive,  nontransferable,
perpetual  licenses that are primarily  computer site or user specific.  License
fee arrangements vary depending upon the type of software product being licensed
and  on  the  number  of  users  or  locations  in  the  case  of  client/server
implementations  and on a per CPU basis in the case of mainframe  installations.
The United States list price for the Company's 1View products ranges from $5,000
for a single  product to several  million  dollars  for the entire  suite of the
Company's products.
    

         Customers may generally  obtain support services and maintenance for an
annual fee that is approximately 16% of the then-current annual license fee. The
support and  maintenance  fee is billed  monthly or  annually  and is subject to
changes in software  license list prices.  Resellers of the  Company's  software
products  are  generally  required to collect and remit to the Company 8% of the
Company's then-current annual license fees for maintenance and support services.
In such  cases,  the  Company  only  provides a certain  level of support to the
end-user and general maintenance and support, such as initial calls and queries,
are  performed  by the  reseller.  The Company  also  provides  pre-installation
assistance, systems administration, training and other product-related services,
generally on a time and materials basis.


Proprietary Rights and Licenses

   
         The  Company  regards  its  software  as  proprietary  and  relies on a
combination of trade secret,  copyright and trademark laws, license  agreements,
nondisclosure and other contractual provisions and technical measures to protect
its  proprietary  rights in its products.  The Company  distributes its software
products  under  reseller   agreements  and  software  license  agreements  that
typically  grant  customers  nonexclusive,   nontransferable   licenses  to  the
Company's products and have perpetual terms unless terminated for breach.  Under
these license agreements,  the Company retains the right to market its products.
Use of the licensed software by the end  user/customer is usually  restricted to
the customer's  internal  operations on designated  computers at specified sites
unless the customer  obtains a site  license,  which  restricts  that use of the
software to designated users. Use is subject to terms and conditions prohibiting
unauthorized reproduction or transfer of the software. The Company also seeks to
protect the source code of its software as a trade secret and as an unpublished,
copyrighted work. See "Risk Factors--Intellectual  Property Rights; Infringement
Claims."
    


Facilities

   
         The   Company's   corporate   headquarters,   including  its  principal
administrative,  product development, product management, technical support, and
sales and  marketing  operations,  are  located in 25,600  square feet of office
space in a building in Herndon,  Virginia.  The Company occupies the space under
leases expiring in the year 2000. The Company also leases an aggregate of 55,000
square feet of space in or near Atlanta,  Georgia,  Charlotte,  North  Carolina,
Chicago,  Illinois,  Dallas, Texas, Denver,  Colorado, Los Angeles,  California,
Minneapolis,  Minnesota, New York New York, San Francisco,  California, Seattle,
Washington, and Paris, France. The Company believes that its existing facilities
are suitable and adequate for its present needs and that suitable  space will be
available as needed to accommodate any expansion of operations.
    


Employees

   
         As of November  13,  1997,  the Company  had 234  full-time  employees,
including 78 employees  primarily  engaged in research  and  development,  48 in
technical support and services, 76 in sales and marketing, and 32 in operations,
finance and administration.
    


Legal Proceedings

   
         From time to time,  the Company is involved in  litigation  relating to
claims  arising  out of its  operation  in the normal  course of  business.  The
Company is not  currently a party to any legal  proceedings  other than those in
the normal course of business.
    


                                   MANAGEMENT

Executive Officers and Directors


         The executive officers and directors of the Company,  and their respec-
tive ages at September 2, 1997 are as follows:

     Name                     Age                   Position
     ----                     ---                   --------

James J. Leto (2)              53      President, Chief Executive Officer and
                                        Chairman of the Board

Jorge R. Forgues               42      Senior Vice President of Finance and
                                        Administration,  Chief  Financial
                                        Officer

John M. Flowers                47      Senior Vice President of Engineering

Brian H. Hajost                41      Senior Vice President of Marketing

Mark T. Wasilko                43      Senior Vice President of Business
                                        Alliances

Robert P. Bernardi (2)         46      Director and Assistant Secretary

John F. Burton (1)             46      Director

C. Alan Peyser                 63      Director

Robert Ripp (1)(2)             56      Director
- --------------------


(1)      Member of the Audit Committee.


(2)      Member of the Compensation Committee.


   
         James J. Leto  became  President  and  Chief  Executive  Officer  and a
Director  of the  Company in May 1996 and became  Chairman  of the Board in June
1997. Mr. Leto served as the Chairman and Chief  Executive  Officer of PRC Inc.,
an information  technology company ("PRC"),  from January 1993 to February 1996,
and prior thereto in various capacities as an executive officer of that company.
From January 1989 until February 1992, Mr. Leto served as the Vice President and
General Manager of AT&T Federal Systems  Computer  Division,  a division of AT&T
charged with developing a major system  integration and computer presence in the
federal marketplace.  Mr. Leto first joined AT&T in November 1977. Mr. Leto is a
director of Government Technology Systems, Inc.
    

         Jorge R. Forgues  became Chief  Financial  Officer,  Vice  President of
Finance and  Administration  and  Treasurer  of the  Company in April  1996.  In
January 1997,  Mr. Forgues was promoted to Senior Vice  President.  From October
1993  through  April  1996,  he  served  as the  Vice  President  of  Finance  &
Administration  and Chief  Financial  Officer  of  Globalink,  Inc.,  a computer
software developer that offers foreign language translation software.  From July
1992 to September  1993,  Mr. Forgues served as Director of Accounting at Spirit
Cruises,  Inc.,  and from June 1987 to June 1992 he served as the Vice President
of Finance of Best Programs, Inc., a computer software developer. Mr. Forgues is
a director of On-Site Sourcing Incorporated.

         John M. Flowers, Jr. was appointed Senior Vice President of Engineering
Services in April 1996.  From 1989 to April  1996,  he was with PRC,  serving in
various  capacities,  including  Manager of the Center for  Imaging  Technology,
Chief  Architect for Systems  Integration  Division,  Corporate  Director of the
Imaging Core Competency Program,  and Vice President and Chief Scientist for the
Information Systems Division.

         Brian H. Hajost joined the Company in March 1996, was appointed  Senior
Vice  President of Integrated  Products in April 1996 and was  appointed  Senior
Vice President of Marketing in May 1997.  Form 1985 to 1995, Mr. Hajost was with
Servantis Systems, Inc. (formerly Stockholder Systems,  Inc.) where he served in
various  capacities   including  Securities  Products  Group  Regional  Manager,
Securities  Products Group Regional Director Banking Sales,  Securities  Product
Group Vice President Sales Manager,  Imaging  Technologies  Group Vice President
Sales and  Marketing,  and Imaging  Technologies  Group  Senior  Vice  President
Business Unit Manager.

         Mark T. Wasilko  joined the Company in September  1995,  became  Senior
Vice  President of Marketing  for the Company in October 1995 and was  appointed
Senior Vice  President of Business  Alliances in May 1997.  From January 1994 to
August 1995, Mr.  Wasilko was Vice  President of Corporate  Marketing for Legent
Corporation  ("Legent"),  an independent  software  vendor.  Prior thereto,  Mr.
Wasilko was Senior Vice President for Corporate Marketing at Computer Associates
International, Inc., an independent software vendor, where he had held a variety
of sales and marketing positions since 1982.


         Robert P.  Bernardi  was a  co-founder  of the  Company  and has been a
Director of the Company (and its predecessor) since its inception.  He served as
Chairman of the Board of Directors  from  September  1995 through June 1997. Mr.
Bernardi  served as President of the Company from inception to February 1995 and
as Chief  Executive  Officer from inception to May 1996.  From 1988 to 1990, Mr.
Bernardi  was  an   independent   consultant   in  the   document   imaging  and
telecommunications  fields.  From March 1984 to December 1987, Mr.  Bernardi was
Chairman and Chief Executive Officer of Spectrum Digital Corporation, a publicly
held  telecommunications  equipment  manufacturing company ("Spectrum Digital"),
with overall management responsibilities including marketing, sales, engineering
and finance.


         John F. Burton was appointed to the Board  of  Directors  in  September
1995.  Mr. Burton became  Managing  Director of the Updata Group.  a mergers and
acquisitions investment bank, in March 1997. From October 1996 to February 1997,
he served as the President of Burton Technology Partners, a strategic consulting
and investment company.  Mr. Burton was President and Chief Executive Officer of
Nat Systems,  Inc., a provider of applications  development software from August
1995 to September  1996.  From January  1995 to August 1995,  Mr.  Burton was an
independent  consultant in the applications  software field.  From March 1992 to
January 1995,  Mr. Burton served as Chief  Executive  Officer,  and from 1989 to
January 1995 as President,  Chief Operating  Officer and a Director,  of Legent.
Mr. Burton is also a Director of Banyan Systems,  Inc., MapInfo  Corporation and
Netrix  Corporation.  Mr. Burton was a founding member of the Northern  Virginia
Technology Council.


         C. Alan Peyser became a Director of the Company in May 1996. Mr. Peyser
was appointed  President and Chief Executive Officer of Cable & Wireless,  Inc.,
in October 1996.  From  September  1995 to October 1996,  Mr. Peyser served as a
consultant to Cable & Wireless,  Inc. He is also currently  President of Country
Long  Distance  Corporation  and a member  of the Board of  Directors  of Tridex
Corporation  and TCI  International,  Inc. Mr. Peyser  previously  served as the
Chief  Executive  Officer  and  President  of Cable & Wireless,  Inc.  from 1980
through September 1995.


         Robert Ripp has served as a Director  since October  1994.  Mr. Ripp is
Corporate  Vice  President  and  Chief  Financial   Officer  of  AMP,  Inc.,  an
electronics  manufacturer.  Prior  to  joining  AMP in 1994,  Mr.  Ripp was Vice
President and Treasurer of International Business Machines Corporation, where he
served in various  capacities as a finance  executive from 1964 to 1994. He is a
member of the board of directors of ACE, Limited.





Director Compensation


   
         At the Board's  quarterly  meeting on August 28, 1997,  the Board voted
and  approved the  elimination  of payment for service to the Board and adopted,
subject to shareholder approval,  the Directors Stock Option Plan (the "Director
Stock Option Plan").  Under the Director Stock Option Plan, each director who is
not an  executive  officer of the  Company  will  receive an option to  purchase
30,000  shares of Common Stock vested in 25% each quarter  following the date of
grant,  so that at upon the first  anniversary  of the stock option  grant,  the
option  grant will be fully  vested.  The option  price is equal to 100% of fair
market value on the date of the option grant. Messrs. Ripp, Burton,  Peyser, and
Bernardi were each granted an option for 30,000  shares of the Company's  Common
Stock under that plan  effective  July 1, 1997 with an  exercise  price equal to
100% of fair market value of the Common Stock on June 30, 1997.


         Prior  to  that  meeting,  each  director  of the  Company  who was not
currently employed by the Company,  received a fee of $1,000 for each meeting of
the Board or committee thereof that he attended in person and $250 for each such
meeting  in which he  participated  by  Plantelephone.  Mr.  Ripp has also  been
granted  options on 21,675  shares of Common  Stock at $3.75 per  share,  25,000
shares of Common Stock at $6.82 per share,  and 25,000 shares of Common Stock at
$3.82 per share,  each with a term of 10 years and each of which is  exercisable
on a  cumulative  basis in four  equal  installments  on each of the first  four
anniversaries  of the applicable  date of grant.  Mr. Burton has been granted an
option on 100,000  shares of Common  Stock with an  exercise  price of $3.38 per
share and a term of 10 years. The option vests on May 2, 2002 or, earlier,  upon
the  Company's  entering  into a strategic  partnership  agreement  with a major
software  company as a result of the  assistance of Mr.  Burton.  Mr. Peyser has
been granted an option on 50,000  shares of Common Stock at $3.69 per share with
a term of 10 years and that is exercisable  on a cumulative  basis in four equal
installments on each of the first four  anniversaries  of its date of grant. The
exercise  prices of the options granted to directors were set at the fair market
value of the Common Stock at the time of grant.

         The Company has entered  into a  termination  of  consulting  agreement
("Bernardi  Termination  Agreement")  with  Robert P.  Bernardi,  and BCG,  Inc.
("BCG") (of which Mr.  Bernardi is the sole  stockholder)  that provides for the
termination,  as of October 1, 1997, of the  consulting  agreement  entered into
between  the  parties  as of May  28,  1996.  (See  "Management  -  Compensation
Committee  Interlocks  and  Insider  Participation.")  Under  the  terms of this
agreement,  the Company  agreed to pay BCG  severance pay at the rate of $18,750
per month for the period beginning on October 1, 1997 and ending on September 1,
1998.  The Company  also  granted to Mr.  Bernardi a warrant to purchase  50,000
shares of the Common  Stock at $1.50 per share.  The  warrant has a term of five
years.  Furthermore,  Mr. Bernardi held,  prior to the execution of the Bernardi
Termination Agreement, options to purchase 1,348,325 shares of Common Stock with
exercise  prices  ranging from $2.60 to $6.82 per share.  Under the terms of the
Bernardi  Termination  Agreement,  these options were  converted into options to
purchase 755,747 shares of Common Stock at an exercise price of $1.50 per share,
the market price of the Common Stock on September  17, 1997.  These  options are
not  exercisable for a period of twelve months from October 1, 1997. The Company
also agreed to employ Mr.  Bernardi as an Assistant  Secretary of the Company at
an annual salary of $5,000.  Mr.  Bernardi  will also receive  health and dental
insurance  through  December 31, 2003. The agreement  prohibits Mr. Bernardi for
one year from certain  associations  with any business  that  competes  with the
Company.  Mr.  Bernardi also has the right to cause the Company to register,  at
the Company's  expense,  shares of Common Stock held by Mr. Bernardi or issuable
on exercise  stock options in a  registration  statement on Form S-3 at any time
prior to the  termination  of the Bernardi  Termination  Agreement or within one
year thereafter.
    

Compensation Committee Interlocks and Insider Participation


         During the year ended  December 31, 1996,  the  Company's  Compensation
Committee was composed of directors  Robert P.  Bernardi,  the  Company's  Chief
Executive  Officer  until June 3, 1996 and  currently an employee of the Company
and Robert Ripp, an outside director.  As of September 2, 1997, the Compensation
Committee is composed of outside  directors  Robert P.  Bernardi and Robert Ripp
and James J. Leto, the Company's President and Chief Executive Officer.


   
         The Company entered into consulting  agreements with BCG, Inc.  ("BCG")
(of which Mr.  Bernardi is the sole  stockholder)  that provided for BCG to make
the services of Mr. Bernardi available to the Company.  The consulting agreement
was for an initial term ending  January 31, 1999 and continued from year to year
thereafter  unless  terminated  by  either  the  Company  or Mr.  Bernardi.  The
agreement with BCG provided for an annual consulting fee of $225,000, subject to
increase  upon  review by the Board of  Directors.  The  Company  also agreed to
employ Mr.  Bernardi as Secretary at an annual  salary of $5,000.  The agreement
provided demand  registration  rights to Mr. Bernardi with respect to securities
of the  Company  owned by him or that he may acquire  upon  exercise of options.
Each  registration   right  terminated  on  the  first   anniversary   following
termination of the consulting  agreement.  The agreement  prohibits Mr. Bernardi
during the term of the  agreement  from certain  associations  with any business
that competes with the Company.

         The Company has entered into the Bernardi  Termination  Agreement  with
Robert P. Bernardi, and BCG that provides for the termination,  as of October 1,
1997, of the consulting agreement entered into between the parties as of May 28,
1996. In the Bernardi Termination Agreement, the Company agreed to pay BCG gross
severance pay at the rate of $18,750 per month, beginning on October 1, 1997 and
ending on September 1, 1998. Under the terms of this agreement, the Company also
granted to Mr.  Bernardi a warrant to purchase 50,000 shares of the Common Stock
at $1.50 per share.  The  warrant  has a term of five  years.  Furthermore,  Mr.
Bernardi  held,  prior to the execution of the Bernardi  Termination  Agreement,
options  to  purchase  1,348,325  shares of Common  Stock with  exercise  prices
ranging  from  $2.60  to $6.82  per  share.  Under  the  terms  of the  Bernardi
Termination  Agreement,  these options were  converted  into options to purchase
755,747  shares of Common  Stock at an  exercise  price of $1.50 per share,  the
market price of the Common Stock on September  17, 1997.  These  options are not
exercisable  for a period of twelve  months  from  October 1,  1997.the  date of
execution  of the  Bernardi  Termination  Agreement.  The Company also agreed to
employ Mr. Bernardi as an Assistant Secretary of the Company at an annual salary
of $5,000equal to the net amount  sufficient to pay Mr. Bernardi's annual health
and dental insurance  premiums through December 31, 2003. Mr. Bernardi will also
receive  health and dental  insurance  through  December 31, 2003. The agreement
prohibits Mr. Bernardi for one year from certain  associations with any business
that  competes  with the Company.  Mr.  Bernardi also has the right to cause the
Company to register,  at the Company's  expense,  shares of Common Stock held by
Mr.  Bernardi or issuable on exercise stock options in a registration  statement
on Form S-3 at any time prior to the  termination  of the  Bernardi  Termination
Agreement or within one year thereafter.
    

Summary Compensation Table


         The Summary  Compensation Table below lists the Chief Executive Officer
and the four other most  highly  compensated  executive  officers of the Company
(the  "Named  Executives")  as of the end of 1996  and  their  compensation  for
services in 1996, 1995 and 1994.


   
<TABLE>
<CAPTION>
                                                                                            Long-Term
                                                                                          Compensation
                                                    Annual Compensation                       Awards
                                          ------------------------------------------
                                                                                           Securities
                                                                       Other Annual        Underlying         All Other
 Name and Principal Position    Year      Salary($)     Bonus($)      Compensation($)       Options(#)      Compensation ($)
                                                                            (1)
<S>                             <C>     <C>             <C>           <C>                 <C>              <C>
Robert P. Bernardi(2)........   1996       79,306      $   50,000                                 0        $  107,333(3)
  Chairman of the Board         1995      182,306          50,000                         1,148,325(4)
  and Chief Executive Officer   1994      175,000          64,000                           625,000(5)

James J. Leto................   1996      118,974(6)       34,066                           262,195
  President and Chief           1995
  Executive Officer (7)         1994

Russell D. Hale(8)...........   1996      165,000          11,050                                 0
  Senior Vice President,        1995      165,000          43,329                           250,000
  Federal Sales                 1994       28,135(9)                                              0

Mark T. Wasilko..............   1996      150,000          13,125                            28,049(13)
  Senior Vice President,        1995       48,942(10)                                        57,927
  Marketing                     1994

Brian H. Hajost..............   1996      102,000(11)      26,978                            60,976            42,697(12)
  Senior Vice President,        1995
  Integrated Products           1994
- --------------------
</TABLE>

(1)      Perquisites  and other  personal  benefits,  securities and property is
         less than the lesser of $50,000 and 10% of the total annual  salary and
         bonus for each Named Executive in each year shown.

(2)      Mr.  Bernardi   resigned  as  the  Company's  Chief  Executive  Officer
         effective  May 29,  1996 and as the Company's Chairman of the Board  on
         June 3, 1997.

(3)      Mr. Bernardi became a consultant to the Company upon his resignation as
         the  Company's  Chief  Executive  Officer.   $102,083  constitutes  the
         consulting fees paid to Mr. Bernardi in 1996 and $5,250 constitutes the
         automobile  allowance for Mr.  Bernardi.  Mr.  Bernardi  terminated his
         consulting  agreement  with the Company as of October 1, 1997 under the
         terms of the Bernardi Termination Agreement.

(4)      This number has been adjusted to give effect to the  Bernardi  Termina-
         tion Agreement.

(5)      Terminated pursuant to the Company's 1995 Option Repricing Program.


(6)      Mr. Leto joined the Company as its Chief Executive Officer in May 1996.


(7)      Mr. Leto became Chairman of the Board of the Company on June 3, 1997.


(8)      Mr. Hale resigned as an officer of the Company effective April 1, 1997.


(9)      Mr. Hale joined the Company as an officer in October 1994.


(10)     Mr. Wasilko joined the Company as an officer in September 1995.


(11)     Mr. Hajost joined the Company as an officer in March 1996.


(12)     The amount shown constitutes  temporary  housing  benefits  and  moving
         expenses paid for Mr. Hajost in 1996.

(13)     In August 1997,  the Board of Directors  approved a plan to reprice the
         Company's  outstanding stock options ("1997 Repricing Plan").  The 1997
         Repricing Plan allowed holders of out-of-the  money options,  including
         executive officers,  non-officer employees, and non-director employees,
         to receive a new exercise  price of $1.50 per option share,  the market
         price  on the  date the 1997  Repricing  Plan  was  approved.  The 1997
         Repricing   Plan  also  allowed   executives   and  officers  who  held
         out-of-the-money options to also receive a new exercise price of $1.50,
         but the number of shares covered by these options were reduced pursuant
         to the  Black-Scholes  formula  so  that  there  would  be  approximate
         economic equivalence between old and new options. As a result,  options
         for an  aggregate  of  561,752  out of a total of  1,635,000  shares of
         Common Stock at exercise  prices  ranging from $6.82 to $1.91 per share
         were repriced. The number of shares of Common Stock shown in this table
         have been adjusted to reflect the 1997 Repricing Plan.
    

Option Grants in Last Fiscal Year


   
         No stock options were granted to Messrs.  Bernardi or Hale during 1996.
The  following  table sets forth  certain  information  concerning  the grant of
options to the other Named  Executives in 1996.  The Company has not granted any
stock  appreciation  rights  ("SARs").  The table set forth  below does not give
effect to the 1997 Repricing Plan.
    

<TABLE>
<CAPTION>
                                     Individual Grants
                       ----------------------------------------------
                                        Percent of                                            Potential Realizable
                       Number of           Total                                                Value at Assumed
                       Securities         Options                                            Annual Rates of Stock
                       Underlying       Granted to          Exercise                           Price Appreciation
                       Options         Employees in         or Base       Expiration          for Option Term
                                                                                        -----------------------------
Name                   Granted(#)      Fiscal Year        Price($/Sh)         Date         5%                 10%
- ----                   ----------     --------------      -----------      ---------    -------             -------
<S>                    <C>            <C>                 <C>              <C>          <C>                <C>
James J. Leto........   500,000(1)            34%            $4.22          5/28/06     $1,327,000         $3,363,000
Mark T. Wasilko.....     50,000(1)             3%            $3.82          4/10/06     $  120,120         $  305,000
Brian H. Hajost......    50,000(1)             3%            $3.82          4/15/06     $  120,120         $  305,000
                         50,000(1)             3%            $3.13          9/22/06     $   98,500         $  249,500
- --------------------
</TABLE>

(1)      Each of the  indicated  options was granted  pursuant to the  Company's
         Employee Incentive Stock Option Plan and vests four years from the date
         of grant, or, for the options held by Mr. Leto, upon the acquisition of
         the Company.


Aggregated Option Exercises in Last Year and Year End Option Values


   
         The  following  table  summarizes  the value  realized upon exercise of
outstanding  stock options and the value of the outstanding  options held by the
Chief  Executive  Officer  and the other Named  Executives.  The table set forth
below does not give effect to the 1997 Repricing Plan.
    

<TABLE>
<CAPTION>
                                                            Number of Securities
                                                           Underlying Unexercised             Value of Unexercised
                                                              Options at Fiscal               In-the-Money Options
                                                                 Year-End(#)                at Fiscal-Year-end($)(1)
                          Shares
                       Acquired on        Value
        Name           Exercise(#)     Realized($)     Exercisable      Unexercisable    Exercisable    Unexercisable
        ----           -----------     -----------     -----------      -------------    -----------    -------------
<S>                    <C>             <C>             <C>              <C>              <C>            <C>
Robert P. Bernardi..        0               0             680,582           667,743        $230,000              $0
James J. Leto.......        0               0                   0                 0         500,000               0
Russell M. Hale.....        0               0             125,000           125,000               0               0
Mark T. Wasilko.....        0               0              43,750           131,250               0               0
Brian H. Hajost.....        0               0                   0           100,000               0               0
- --------------------
</TABLE>


(1)      Computed by multiplying the number of options by the difference between
         (i) the per share market value of the Common Stock on December 31, 1996
         and (ii) the exercise price per share.





                 OWNERSHIP OF NETWORK IMAGING CORPORATION STOCK

   
         The following table sets forth certain information,  as of November 13,
1997, with respect to the beneficial  ownership of shares of Common Stock by (i)
each  stockholder  known by the Company to be the beneficial  owner of more than
five percent (5%) of the outstanding  shares of Common Stock; (ii) each director
of the Company; (iii) each Named Executive;  and (iv) all executive officers and
directors as a group. Except as indicated in the footnotes to the table, persons
named in the table have sole  voting and  investment  power with  respect to all
shares of Common Stock that they respectively own  beneficially.  The table does
not include shares of Common Stock that may be issued to the Purchasers because,
except in the event of a required conversion at maturity,  no holder of Series K
Stock or Series L Stock is entitled  to convert  such  securities  to the extent
that the shares to be received by such holder upon  conversion  would cause such
holder  to  beneficially  own more  than  4.9% or 4.99 %,  respectively,  of the
outstanding shares of Common Stock.
    

The  address of each  person who is an  executive  officer  or  director  of the
Company is 500 Huntmar Park Drive, Herndon, Virginia 20170.
   
<TABLE>
<CAPTION>
                                                                             Number of Shares          Percent of
                 Name and Address of Beneficial Owner                      Beneficially Owned (1)          Class
                 ------------------------------------                      ----------------------          -----
<S>                                                                        <C>                             <C>
Fred E. Kassner(2).................................................                2,285,297                8.8
Robert P. Bernardi(3)..............................................                  447,500                1.5
James J. Leto(4)...................................................                   91,816                0.3
Robert M. Sterling, Jr.(5).........................................                  678,500                2.3
Mark T. Wasilko(6).................................................                   21,494                 *
John F. Burton.....................................................                   50,000(7)              *
C. Alan Peyser(8)..................................................                   21,500                 *
Robert Ripp(9).....................................................                   23,332                 *
Brian H. Hajost(10)................................................                   17,248                 *
Directors and executive officers as a group (9) persons                              714,515                2.6
- --------------------
</TABLE>
    


* Less than 1% of the outstanding Common Stock.


   
(1)    Under  applicable  rules  of  the  SEC,  a  person  is  deemed  to be the
       beneficial  owner of share of Common Stock if, among other things,  he or
       she directly or indirectly has or shares voting power or investment power
       with respect to such shares.  A person is also considered to beneficially
       own shares of Common  Stock that he or she does not  actually own but has
       the right to acquire  presently  or within  the next sixty (60) days,  by
       exercise of stock options or otherwise.

(2)    The address of Mr. Kassner is 69 Spring Street, Ramsey, New Jersey 07446.
       Of the total shares shown,  Mr. Kassner has shared voting and dispositive
       power  with  respect  to  1,207,857   shares,   including  80,000  shares
       underlying a warrant,  held by Liberty Travel,  Inc. of which Mr. Kassner
       is an officer, director, and stockholder. Of the shares reported as being
       held directly by Mr. Kassner, 354,000 are issuable upon the  exercise  of
       warrants.

(3)    Includes 755,747 shares issuable upon exercise of options.

(4)    Includes 65,549 shares issuable upon exercise of options.

(5)    Includes 755,747 shares issuable upon  exercise  of  options  and  96,000
       shares  issuable  upon  exercise  of  Redeemable  Common  Stock  Purchase
       Warrants.

(6)    All shares are issuable upon exercise of options.

(7)    All shares are issuable upon exercise of options.

(8)    Includes 12,500 shares issuable upon exercise of options.

(9)    Includes 17,088 shares issuable upon exercise of options.

(10)   Includes 15,244 shares issuable upon exercise of options.
    





                              CERTAIN TRANSACTIONS


   
         The Company  entered into  consulting  agreements with Mr. Bernardi and
BCG,  and with Mr.  Sterling  and  Sterling  Capital  that  provided for BCG and
Sterling Capital Group, Inc. ("Sterling  Capital") (of which Mr. Sterling is the
sole  stockholder)  to make  the  services  of  Messrs.  Bernardi  and  Sterling
available to the Company.  Each of the consulting  agreements was for an initial
term ending January 31, 1999 and continued from year to year  thereafter  unless
terminated by either the Company or either of Messrs. Bernardi or Sterling. Each
of the  agreements  with  BCG  and  Sterling  Capital  provided  for  an  annual
consulting  fee of  $225,000,  subject to  increase  upon review by the Board of
Directors.  The Company  also  agreed to employ Mr.  Bernardi  as  Secretary  or
Assistant Secretary and Mr. Sterling as Assistant Secretary of the Company at an
annual salary of $5,000. The agreements  provided demand  registration rights to
Messrs. Bernardi and Sterling with respect to securities of the Company owned by
them or that they may acquire upon exercise of options.  Each registration right
terminates on the first  anniversary  following  termination  of the  consulting
agreement.  Each of the respective  agreements  prohibited Messrs.  Bernardi and
Sterling  during the term of the agreement  from certain  associations  with any
business that competes with the Company.

       The Company has entered into  termination of consulting  agreements  with
(i)  Robert  M.  Sterling  and  Sterling  Capital,  (ii)  John B.  Mann and Mann
Enterprises, Inc. ("ME") (of which Mr. Mann is the sole stockholder),  and (iii)
Robert  P.  Bernardi  and BCG,  each of which  provide  for the  termination  of
consulting  agreements between the above named parties and the Company effective
October 1, 1997.

         The Company has entered  into a  termination  of  consulting  agreement
("Sterling Termination  Agreement") with Robert M. Sterling and Sterling Capital
that  provides for the  termination,  as of October 1, 1997,  of the  consulting
agreement  entered  into  between the parties as of February 1, 1994.  Under the
terms of this agreement, the Company paid Sterling Capital $58,500 on October 1,
1997 and  agreed to pay gross  severance  pay to  Sterling  Capital at a rate of
$10,000  per month for the  period  beginning  on  October 1, 1997 and ending on
December 1, 1998.  The Company  also agreed to pay Sterling  Capital  $12,000 on
January 1, 1999. The Company also granted to Mr.  Sterling a warrant to purchase
100,000 shares of the Common Stock at $1.50 per share. The warrant has a term of
five years and the  underlying  shares of Common Stock are subject to piggy-back
registration  rights  commencing  one year  after the date of  execution  of the
Sterling  Termination  Agreement.  Furthermore,  Mr. Sterling held, prior to the
execution of the Sterling Termination  Agreement,  options to purchase 1,348,325
shares of Common  Stock with  exercise  prices  ranging  from $2.60 to $3.75 per
share. Under the terms of the Sterling Termination Agreement, these options were
converted into options to purchase 755,747 shares of Common Stock at an exercise
price of $1.50 per share,  the market price of the Common Stock on September 17,
1997.  These options are not  exercisable for a period of twelve months from the
date of execution of the Sterling Termination Agreement. The Company also agreed
to employ Mr.  Sterling as an  Assistant  Secretary  of the Company at an annual
salary equal to the net amount  sufficient to pay Mr.  Sterling's  annual health
and dental insurance premiums through December 31, 2003. The agreement prohibits
Mr.  Sterling  through  October  13,  1998 from  certain  associations  with any
business that competes with the Company.

         The agreement with John B. Mann and ME ("Mann  Termination  Agreement")
terminates  the  agreement  entered into among them and the Company on March 30,
1994.  The  Company  agreed to pay Mann Inc.  $30,000 on  October  1,  1997.  In
addition,  the Company  agreed to pay gross  severance pay at the rate of $5,000
per month for the period beginning on October 1, 1997 and ending on September 1,
1998.  Additionally,  the  Company  agreed to grant to ME a warrant to  purchase
66,667  shares of Common  Stock  for $1.50 per  share,  which has a term of five
years.  The  underlying   shares  of  Common  Stock  are  subject  to  piggyback
registration  rights commencing one year after the date of execution of the Mann
Termination Agreement. Furthermore, Mr. Mann held, prior to the execution of the
Mann Termination  Agreement,  options to purchase 560,340 shares of Common Stock
with exercise  prices ranging from $2.60 to $6.82 per share.  Under the terms of
the Mann  Termination  Agreement,  these options were  converted into options to
purchase 321,170 shares of Common Stock at an exercise price of $1.50 per share,
the market price of the Common Stock on September  17, 1997.  These  options are
not  exercisable for a period of twelve months from the date of execution of the
Mann  Termination  Agreement.  The Company  also agreed to employ Mr. Mann as an
Assistant  Secretary of the Company at an annual  salary equal to the net amount
sufficient to pay Mr. Mann's annual health and dental insurance premiums through
December 31, 2003.  The agreement  prohibits  Mr. Mann through  October 17, 1998
from certain associations with any business that competes with the Company.

         For  a  description  of  the  Bernardi   Termination   Agreement,   see
"Management  --Compensation Committee Interlocks and Insider Participation." For
a description of the convertible notes, related warrants and the Loan Agreement,
see "Management's  Discussion and Analysis of Financial Condition and Results of
Operations  -- Recent  Events."  For a  description  of the Series K Stock,  the
Series L Stock and related warrants, see "Description of Capital Stock -- Series
K  Convertible  Preferred  Stock" and  "Description  of Capital Stock - Series L
Convertible Preferred Stock."



                               SELLING STOCKOLDERS

         The following  table sets forth the names of the Selling  Stockholders,
the  number  of  shares  of  Common  Stock  beneficially  owned by each  Selling
Stockholder  as of December 4, 1997 and the number of Shares that may be offered
for sale pursuant to this offering by each such Selling Stockholder. None of the
Selling   Stockholders   has  held  any  position,   office  or  other  material
relationship  with the  Company or any of its  affiliates  within the past three
years other than as a result of his or its  ownership of the  Convertible  Notes
and the other Company  securities that it holds.  The Shares may be offered from
time to time by the Selling  Stockholders  named  below.  However,  such Selling
Stockholders  are under no obligation to sell all or any portion of such Shares,
nor are the Selling  Stockholders  obligated to sell any such Shares immediately
pursuant to this Registration  Statement.  Because the Selling  Stockholders may
sell all or part of their  Shares,  no estimate can be given as to the number of
shares  of  Common  Stock  that  will be held by any  Selling  Stockholder  upon
termination of any offering made hereby.

<TABLE>
<CAPTION>
                                                                                   Common Stock Beneficially
                                                                                    Owned After Offering(1)
                           Shares of Common                                       -----------------------------
Name of Selling            Stock Beneficially             Common Stock                             Percent of
Stockholder                Owned Prior to Offering        Offered Hereby            Number         Outstanding
- ------------------         -----------------------        --------------            ------         ------------
<S>                        <C>                            <C>                       <C>            <C>

Mark Shoom and
Mark Shoom as
beneficial owner of
shares held by
Wood Gundy in trust
for RRSP 550 98866 19
and
Wood Gundy in
trust for RRSP 550
98867 18                        648,365 (2) (3)            1,053,500 (4)             445,135             1.7%

Charles Kucey and
Charles Kucey as
beneficial owner of
shares held by
Gundyco in
trust for RRSP 550
99119 12 (2)
and
Wood Gundy in trust
for RRSP 55099119
12                              664,248 (2) (3)            1,096,500 (4)             472,252             1.8%
- --------------------------
</TABLE>


(1)      Assumes the sale of all Shares.

(2)      On July 9, 1997 and August 21, 1997,  the Company issued to the Selling
         Stockholders the Convertible  Notes.  The Convertible  Notes are due on
         July 8, 2002 and  August  20,  2002,  respectively.  Mark  Shoom is the
         beneficial  owner of the  Convertible  Notes  issued  to Wood  Gundy in
         aggregate  principal amount of $1,000,000  dated July 9, 1997.  Charles
         Kucey  is the  beneficial  owner of the  Convertible  Notes  issued  to
         Gundyco in aggregate  principal  amount of $800,000  dated July 9, 1997
         and in aggregate  principal  amount of $200,000  dated August 21, 1997.
         Pursuant  to the  terms  of  the  Convertible  Notes,  the  Company  is
         obligated to register the Common Stock issuable upon conversion of each
         Convertible Note.  Convertible Notes issued in the aggregate  principal
         amount of $1,000,000  and $800,000 dated as of July 9, 1997 were issued
         to  Gundyco  in trust  for RRSP 550 98866 19 (for the  benefit  of Mark
         Shoom) and  Gundyco in trust for RRSP 550 99119 12 (for the  benefit of
         Charles  Kucey),   respectively,   and  as  of  December  4,  1997  are
         convertible  into  (including  interest)  568,365 and 446,572 shares of
         Common Stock,  respectively.  Convertible Notes issued in the aggregate
         principal amount of $200,000 dated as of August 20, 1997 were issued to
         Gundyco  in trust for RRSP 550  99119 12 (for the  benefit  of  Charles
         Kucey)  and as of  December  4, 1997 are  convertible  into  (including
         interest) 137,676 shares of Common Stock.

         The Convertible Notes issued in July in the aggregate  principal amount
         of  $1,800,000  are  convertible  into  shares of Common  Stock 45 days
         beginning after issue (August 23, 1997) at a conversion price of $1.875
         per share.  On or after October 30, 1997, the holders have the right to
         redeem these  Convertible  Notes at face value plus accrued interest on
         one  business  day's  notice to the Company in cash or shares of Common
         Stock,  at the Company's  election.  On or after October 30, 1997,  the
         Company has the right to redeem these  Convertible  Notes at face value
         plus  accrued  interest  on 30 days'  notice to the  holders in cash or
         shares of Common Stock, at the holders'  election.  If shares of Common
         Stock are used, Common Stock is issued at a rate of 90% of the previous
         5 trading days average closing bid price on the Nasdaq National Market.

         The  Convertible  Notes  issued in August  in the  aggregate  principal
         amount of $200,000 are convertible  into shares of Common Stock 45 days
         beginning  after issue  (September  4, 1997) at a  conversion  price of
         $1.50 per share.  On or after  December 12, 1997,  the holders have the
         right to redeem  these  Convertible  Notes at face value  plus  accrued
         interest on one business  days' notice to the Company in cash or shares
         of Common Stock,  at the Company's  election.  On or after December 12,
         1997,  the Company has the right to redeem these  Convertible  Notes at
         face value plus  accrued  interest on 30 days' notice to the holders in
         cash or shares of Common Stock, at the holders' election.  If shares of
         Common  Stock are used,  Common Stock is issued at a rate of 90% of the
         previous  5  trading  days  average  closing  bid  price on the  Nasdaq
         National Market.


(3)      Warrants to purchase 20,000 shares of Common Stock dated as of December
         20,  1995 were issued to each Wood Gundy in trust for RRSP 550 98867 18
         (for the  benefit  of Mark  Shoom) and Wood Gundy in trust for RRSP 550
         99119 12 (for the  benefit  of Charles  Kucey).  Warrants  to  purchase
         40,000  shares of Common  Stock dated June 25, 1996 were issued to each
         Mark Shoom and Charles  Kucey.  Warrants to purchase  20,000 and 16,000
         shares of Common  Stock dated as of July 9, 1997 were issued to Gundyco
         in trust  for RRSP 550 98866 19 (for the  benefit  of Mark  Shoom)  and
         Gundyco  in trust for RRSP 550  99119 12 (for the  benefit  of  Charles
         Kucey),  respectively.  A warrant to  purchase  4,000  shares of Common
         Stock  dated as of August  21,  1997 was issued to Gundyco in trust for
         RRSP 550 99119 12 (for the benefit of Charles Kucey). The resale of the
         shares of Common  Stock  issuable on exercise of these  warrants is not
         registered under this Registration Statement.


(4)      Represents the pro rata allocation  between trustees for the benefit of
         each Mark Shoom and  Charles  Kucey of the  2,150,000  shares of Common
         Stock that the Company is registering  hereunder  issuable  pursuant to
         the Convertible Notes based on the outstanding  principal amount of the
         Convertible  Notes held by each.  The 2,150,000  shares of Common Stock
         represent  a  greater  number of  shares  than the  number of shares of
         Common Stock into which the Convertible Notes (including  interest) are
         currently convertible.


                              PLAN OF DISTRIBUTION

         The Shares are being offered on behalf of the Selling Stockholders, and
the Company will not receive any proceeds from this offering.  The Shares may be
sold  or  distributed  from  time to time  by the  Selling  Stockholders,  or by
pledgees,  donees or  tranferees  of, or other  successors  in interest  to, the
Selling Stockholders, directly to one or more purchasers (including pledgees) or
through  brokers,  dealers or  underwriters  who may act solely as agents or may
acquire Shares as principals,  at market prices  prevailing at the time of sale,
at prices related to such prevailing market prices, at negotiated  prices, or at
fixed  prices,  which may be  changed.  The  distribution  of the  Shares may be
effected  in one or  more  of  the  following  methods:  (1)  ordinary  brokers'
transactions,  which may include long or short sales; (2) transactions involving
cross or block trades or otherwise on the Nasdaq National Market or Nasdaq Small
Cap Market;  (3) purchases by brokers,  dealers or underwriters as principal and
resale by such  purchasers for their own accounts  pursuant to this  Prospectus;
(4) "at the market" to or through  market makers or into an existing  market for
the Common Stock;  (5) in other ways not involving  market makers or established
trading markets,  including direct sales to purchasers or sales effected through
agents; (6) through transactions in options, swaps or other derivatives (whether
exchange-listed  or otherwise),  or (7) any combination of the foregoing,  or by
any other legally  available  means.  In addition,  the Selling  Stockholders or
their  successors  in  interest  may  enter  into  hedging   transactions   with
broker-dealers  who may engage in short  sales of shares of Common  Stock in the
course of hedging the positions they assume with the Selling  Stockholders.  The
Selling  Stockholders or their successors in interest may also enter into option
or other  transactions  with  broker-dealers  that  require the delivery by such
broker-dealers of the Shares,  which Shares may be resold thereafter pursuant to
this Prospectus.

         Brokers,   dealers,   underwriters  or  agents   participating  in  the
distribution  of the Shares as agents may  receive  compensation  in the form of
commissions,  discounts  or  concessions  from the Selling  Stockholders  and/or
purchasers of the Shares for whom such  broker-dealers  may act as agent,  or to
whom they may sell as principal,  or both (which compensation as to a particular
broker-dealer  may be less  than or in  excess of  customary  commissions).  The
Selling  Stockholders and any broker-dealers who act in connection with the sale
of Shares hereunder may be deemed to be "underwriters" within the meaning of the
Securities  Act,  and any  commissions  they receive and proceeds of any sale of
Shares may be deemed to be  underwriting  discounts  and  commissions  under the
Securities  Act.  Neither the Company nor any Selling  Stockholder can presently
estimate  the amount of such  compensation.  The  Company  knows of no  existing
arrangements between any Selling Stockholder and any other shareholder,  broker,
dealer, underwriter or agent relating to the sale or distribution of the Shares.

         The Company will pay  substantially all of the expenses incident to the
registration,  offering  and  sale  of the  Shares  to  the  public  other  than
commissions  or  discounts  of  underwriters,  broker-dealers  or agents and the
expenses of counsel to the Selling Stockholders.  Such expenses are estimated to
be $80149,000.
    


                          DESCRIPTION OF CAPITAL STOCK

   
         The following  statements with respect to the Company's  securities are
subject to, and  qualified  in their  entirety  by  reference  to, the  detailed
provisions  of the Company's  Certificate  of  Incorporation  and Bylaws and the
resolutions  adopted  by  the  Board  of  Directors  of  the  Company  ("Board")
establishing the rights,  preferences,  privileges and restrictions  relating to
Series A Stock, the Series F Stock, the Series K Stock and the Series L Stock as
filed under Delaware law (the "Certificates of Designations").
    

Authorized Stock

   
         The Company is authorized to issue up to  100,000,000  shares of Common
Stock, $.0001 par value, of which 25,959,101 shares were outstanding at November
13,  1997,  and  20,000,000  shares of  preferred  stock,  $.0001 par value (the
"Preferred Stock"), of which 1,605,025 shares of Series A Stock,  792,186 shares
of Series F Stock,  and 3,300 shares of Series K Stock were  outstanding on that
date. On December 8, 1997, the Company issued 3,250 shares of Series L Stock.
    

Common Stock

         All holders of Common  Stock are  entitled to one vote per share on any
matter coming before the stockholders for a vote,  unless the matter is one upon
which by express provision of law a different vote is required. The Common Stock
does not have cumulative voting rights,  which means, in effect, that holders of
more than 50% of the shares can generally elect all the directors.

   
         Each  holder  of Common  Stock is  entitled  to  receive  ratably  such
dividends  on the  Common  Stock as may be  declared  by the  Board out of funds
legally available therefor and, in the event of the liquidation,  dissolution or
winding up of the  Company,  is entitled  to share  ratably in all assets of the
Company  remaining  after payment of  liabilities  and payment of amounts due to
holders of capital stock senior to the Common  Stock.  The Board may not declare
dividends  payable to holders of Common  Stock unless and until all accrued cash
dividends  through the most recent past dividend  payment date have been paid in
full to holders of the  Series A and F Stocks.  Holders of Common  Stock have no
conversion,  preemptive or other rights to subscribe for additional  shares, and
there are no redemption  rights or sinking fund  provisions  with respect to the
Common Stock. The outstanding  shares of Common Stock are validly issued,  fully
paid and nonassessable.
    

         The Company has never paid any  dividends  on the Common Stock and does
not anticipate paying any such dividends in the foreseeable future.

Preferred Stock

         The Certificate of Incorporation  authorizes the Board to establish and
designate the classes,  series,  voting powers,  designations,  preferences  and
relative,  participating,  optional or other  rights,  and such  qualifications,
limitations  and  restrictions  of the Preferred Stock as the Board, in its sole
discretion, may determine without further vote or action by the stockholders.

         The rights, preferences, privileges, and restrictions or qualifications
of  different  series of  Preferred  Stock may differ  with  respect to dividend
rates,  amounts  payable  on  liquidation,  voting  rights,  conversion  rights,
redemption  provisions,  sinking fund provisions and other matters. The issuance
of Preferred  Stock could  decrease the amount of earnings and assets  available
for distribution to holders of Common Stock or could adversely affect the rights
and powers, including voting rights, of holders of Common Stock.

         The existence of the Preferred Stock, and the power of the Board to set
its terms and issue a series of Preferred Stock at any time without  stockholder
approval,  could have certain anti-takeover  effects. These effects include that
of making the Company a less attractive  target for a "hostile"  takeover bid or
rendering  more  difficult  or  discouraging  the  making of a merger  proposal,
assumption of control  through the  acquisition of a large block of Common Stock
or removal of incumbent management,  even if such actions could be beneficial to
the stockholders of the Company.

Series A Cumulative Convertible Preferred Stock

         The  issuance  of up to  1,750,000  shares  of  Series A Stock has been
authorized  and  1,605,025  shares  are  outstanding.  The  Series A Stock has a
liquidation  preference  of  $25.00  per  share  plus  all  accrued  and  unpaid
dividends.

   
         The Series A Stock is  convertible  into Common Stock at any time prior
to  redemption  or  exchange.  As of November  13,  1997,  the Series A Stock is
convertible  at the rate of 2.06 shares of Common Stock for each share of Series
A Stock (an effective conversion price of $12.11 per share). The conversion rate
and  conversion  price  are  adjustable  in  certain  circumstances,  which  are
described in the Series A Certificate. Some of those circumstances are described
below.
    

         The Series A Stock, upon 30 days written notice after December 7, 1996,
is redeemable by the Company at $25.00 per share,  plus  accumulated  and unpaid
dividends,  and  exchangeable  by the Company for Common  Stock having a current
market  price of $25.00 per share,  provided in each case that the closing  sale
price of the Common  Stock for at least 20  consecutive  trading days ending not
more than 10 trading days prior to the date notice of the call for redemption or
notice of exchange is given is at least $18.00 per share,  or after  December 7,
1997, at the cash redemption prices (ranging from $26.75 to $25.00) set forth in
the Certificate of  Designations,  plus  accumulated and unpaid  dividends.  The
Company may not redeem by exchange unless all  accumulated and unpaid  dividends
have been paid or funds for payment have been set aside.

         If the  Company  sells  or  issues  Common  Stock or  rights,  options,
warrants or convertible  securities ("Rights") containing the right to subscribe
for or purchase  Common Stock and the sale or issue price of the Common Stock is
less than the lower of the  current  conversion  price or current  market  price
("Current  Price"),  the  conversion  price is adjusted  such that the number of
shares of Common Stock receivable upon conversion of the Series A Stock shall be
the number  determined by  multiplying  (1) the number of shares of Common Stock
receivable  upon  conversion  of the  Series A Stock  immediately  prior to such
issuance and (2) a fraction (not to be less than one) with a numerator  equal to
the product of the number of shares of Common  Stock  outstanding  after  giving
effect to such issuance  (assuming that such Rights had been fully  exercised or
converted)  and the Current Price and a denominator  equal to the sum of (a) the
product of the number of shares of Common Stock outstanding  immediately  before
such issuance and the Current Price and (b) the aggregate consideration received
or deemed  received by the Company for the shares of Common  Stock to be sold or
purchased upon exercise of the Rights.

   
         Cumulative  dividends  on the  Series A Stock at the rate of $2.00  per
share per annum are payable quarterly,  out of funds legally available therefor,
on January 31, April 30, July 31 and October 31 of each year, commencing January
31, 1994.  Failure to pay any  quarterly  dividend will result in a reduction of
$.50 per share in the conversion price. If the Company fails to pay dividends on
the  Series A Stock for four  quarterly  dividend  payment  periods,  holders of
Series A Stock  voting  separately  as a class  will be  entitled  to elect  one
director; such voting rights will be terminated as of the next annual meeting of
stockholders  following  payment of all  accrued  dividends.  In  addition,  the
Company  may not pay  dividends  on, or  redeem,  junior  securities  unless all
accrued and unpaid  dividends on the Series A Stock have been paid.  The Company
failed to pay the quarterly dividend on July 31, and October 31, 1997.
    

         The affirmative vote of a majority of the outstanding  shares of Series
A Stock voting as a single  class is necessary to authorize  any class of senior
or parity  securities  unless,  at that time the Company has the right to redeem
the  Series A Stock  and such  redemption  occurs  before  the  senior or parity
securities are issued.

   
         The  Series A Stock is  senior to the  Series  F, K and L  Stocks.  The
Company is not subject to any  mandatory  redemption  or sinking fund  provision
with  respect  to  Series A Stock.  The  holders  of the  Series A Stock are not
entitled to  preemptive  rights to  subscribe  for or to purchase  any shares or
securities  of any class  which may at any time be issued,  sold or offered  for
sale by the  Company.  The  purchase  agreements  for each of the Series K and L
Stock  requires  that the Company not use the proceeds of that  offering to make
the  quarterly  dividend  payments to the  holders of Series A Stock.  Shares of
Series A Stock redeemed or otherwise  reacquired by the Company shall be retired
by the  Company and shall be  unavailable  for  subsequent  issuance as Series A
Stock.

         In addition, the Company has issued to RAS Securities Corp. ("RAS") and
R.A. Schneider ("RA") representatives'  warrants to purchase, in aggregate,  (i)
up to 140,000  shares of Series A Stock  (112,000  to RAS and 28,000 to RA),  or
(ii) up to  253,624  shares of Common  Stock  (202,809  shares to RAS and 50,725
shares to RA), or (iii) any  combination  of (i) and (ii).  These  warrants  are
exercisable by the holders through December 7, 1998 at an initial exercise price
(subject  to  adjustment)  of $41.25 per shares of Series A Stock and $22.77 per
share of Common Stock. The Company gave to the holders of the warrants piggyback
registration  rights expiring  December 7, 2000.  Under the terms of the warrant
agreement,  the  shares  of Series A Stock  underlying  this  warrant  cannot be
redeemed  by the  Company  even if the  Company  has  called  all or part of the
outstanding Series A Stock for redemption.  Accordingly,  the Company is seeking
to obtain the consent of RAS and  Schneider to an amendment to the RAS Agreement
that  would  terminate  this  provision  of the RAS  Agreement.  There can be no
assurance that RAS and Schneider will consent to such an amendment.

         See "Risk Factors" - Amendment to Certificate of Designations of Series
A Stock" for a description  of certain  proposed  changes to the  Certificate of
Designations of the Series A Stock.
    

Acquisition Preferred Stock

         In connection  with the  acquisition  of Dorotech,  the Company  issued
2,092,186 shares of Series B Convertible Preferred Stock ("Series B Stock") to a
corporate  stockholder of Dorotech.  The Series B Stock was entitled to the same
cash dividends as were paid on the Common Stock,  if any, was  convertible  into
Common Stock commencing six months after it was issued on a share basis (subject
to anti-dilution  adjustments),  had a liquidation value of $9.00 per share, and
had no voting  rights,  except  those  required by law.  Four series of Series B
Stock were authorized,  and all had  substantially  the same terms.  Each of the
first three series provided that if it had not been  transferred by the original
holder to an unaffiliated third party prior to the time it became convertible at
the end of a  six-month  period  following  its  issuance,  it would  have  been
automatically exchanged for the next series, unless the holder elected otherwise
by prior  written  notice  to the  Company.  The  fourth  series  provided  that
immediately prior to the time it became convertible, it would have been redeemed
by the Company for $9.00 per share, unless the holder had transferred the shares
to an unaffiliated  third party or elected not to redeem by prior written notice
to the  Company.  Any  shares of any of the  Series B Stock  transferred  by the
original  holder to an  unaffiliated  third  party  would  thereafter  have been
redeemable by the Company for Common Stock at the  conversion  rate in effect at
the time of redemption. The Series B Stock was junior to the Series A Stock.

         The original holder converted 300,000 shares of the Series B Stock into
Common Stock in April 1994. In July 1994, the Company  entered into an agreement
with  the  holder  and an  affiliate  of the  holder,  which  was a  prospective
transferee of the Series B Stock and the Common  Stock,  in which the holder and
the affiliate agreed, among other things, to extend the cash redemption date for
the  Preferred  Stock from  October  1, 1995 to  October  1,  1996.  In order to
accomplish  the  extension,  the Company  agreed to offer to exchange a Series C
Stock  for the  Series B Stock  and the  holder  of the  Series B Stock  and its
affiliate  agreed to accept the exchange.  The  provisions of the Series C Stock
and the Series B Stock  (collectively,  the "Acquisition  Preferred Stock") were
the same in all material respects except for the cash redemption date.

   
         In March 1996, the Company and the holder of the Acquisition  Preferred
Stock exchanged the Acquisition Preferred Stock for 1,792,186 shares of Series F
Stock and in  connection  therewith  all  authorized  shares of the  Acquisition
Preferred Stock were returned to the status of authorized preferred stock of the
Company of no  designated  class or series.  The Series F Stock is junior to the
Series A Stock and  senior  to the  Series K Stock  and the  Series L Stock.  In
connection with the exchange of the Acquisition Preferred Stock for the Series F
Stock, the Company paid the holder a fee of $650,000 plus expenses and agreed to
obtain the consent of the holder prior to issuing any unsecured  long-term debt.
The Company also agreed to extend the holder's  registration  rights to June 30,
1999,  assist the holder with a private  placement  of the Series F Stock or the
Common Stock into which it is  convertible,  and extend  observer  rights to the
holder with respect to regular meetings of the Board.
    

         The Series F Stock has no voting  rights,  except that the  affirmative
vote of a  majority  of the  outstanding  shares of  Series F Stock  voting as a
single  class is  necessary  with  respect to the  amendment  of its terms,  the
issuance of senior and parity  securities,  the  redemption of parity and junior
securities and other matters required by law.

         The Series F Stock is convertible into Common Stock six months after it
is issued on a share for share basis (subject to antidilution adjustments). Four
series of Series F Stock have been authorized,  and all have  substantially  the
same terms.  Each of the first three series provides that, at the end of the six
month period following its issuance, it will be automatically  exchanged for the
next series,  unless the holder elects  otherwise by prior written notice to the
Company.  The fourth series  provides that it will be redeemed by the Company on
January  2,  1998 for $9 per  share  plus  accrued  and  unpaid  dividends  (the
"Redemption  Price"),  unless the holder  elects not to redeem by prior  written
notice to the Company.

   
         Beginning  October 1, 1996,  the Series F Stock is  entitled to receive
dividends  in an amount equal to the greater of 10% per annum or the annual rate
of any dividend paid on the Company's  Common Stock.  Dividends accrue daily and
be payable on the last day of June, September,  December and March commencing on
December 31, 1996.  Because the sole holder of all of the outstanding  shares of
Series F Stock has agreed to sell all of such  shares to the  Company  for a set
price,  the Company  accrues  dividends  on the  outstanding  shares of Series F
Stock,  but is not obligated to make any payments until January 31, 1998 or upon
the occurance of certain conditions under the control of the Company.  See "Risk
Factors -- European Operations."

         In the event of a change in control of the Company,  the Series F Stock
becomes  convertible  at the rate  described  above  and the then  holder of the
Series F Stock may elect to redeem at the Redemption Price;  provided,  however,
that, if the acquiror has a class of securities  registered  pursuant to Section
12 of the Exchange Act, and has outstanding  voting stock held by non-affiliates
with an  aggregate  market  value of at least $100  million  and if the  Company
agrees to pay the holder in cash the  excess,  if any, of the  Redemption  Price
over  the  transaction  consideration,  the  holder  will  not  be  entitled  to
redemption  and will be deemed to have elected to convert the Series F Stock.  A
change in  control  is deemed to occur if  substantially  all the  assets of the
Company  are  sold,  if the  Company  is  merged or  consolidated  with  another
corporation,  if any person  acquires 50% or more of the  Company's  outstanding
voting  securities or if during any period of two consecutive  years individuals
who at the beginning of such period constitute the Board cease for any reason to
constitute at least a majority thereof, unless the election of each director who
was not a director at the  beginning of such period has been approved in advance
by  directors  representing  at  least a  majority  of the  directors  who  were
directors at the  beginning of the period or whose  election was  previously  so
approved.  For  purposes of  conversion,  a change in control is deemed to occur
when  the  Company  enters  into an  agreement  to  merge,  consolidate  or sell
substantially all its assets or when a tender offer is commenced for 50% or more
of the outstanding voting securities of the Company.
    


         The then  holders of the Series F Stock may also  redeem some or all of
the Series F Stock if the Company is in arrears  with  respect to two  quarterly
dividend  payments  or  defaults in its  agreements  relating to Board  observer
status,  the issuance of long-term debt or the extension of voting rights to the
holders of Series F Stock.

         On  December  31,  1996,  the  Company  and the holder  entered  into a
purchase  agreement  whereby  the  Company  agreed  to  repurchase  all  of  the
outstanding shares of Series F Stock. See "Risk  Factors--European  Operations."
That agreement provided for certain payment terms, and in the event that payment
is not made in accordance with those terms,  and the default is not cured within
five  business  days,  the holder has the right to realize on its first  ranking
pledge on all of the  outstanding  stock of  Dorotech.  If the  Company  has not
effected a sale of Dorotech by January 31,  1998,  and the Company is in default
to the holder, the holder is at liberty to sell all of the Dorotech shares owned
by the Company  and  withhold  all amounts due and payable to the holder  before
paying back excess money, if any, to the Company.


Series K Convertible Preferred Stock

   
         On July 28, 1997, the Company issued 3,300 units  ("Units")  consisting
of (1) one share of Series K Stock and (2)  warrants  to  purchase  75 shares of
Common  Stock at an  exercise  price of $2.40 per share  ("Investor  Warrants").
Accordingly, on July 28, 1997, the Company issued 3,300 shares of Series K Stock
and Investor Warrants to purchase 247,500 shares of Common Stock. As a result of
the  issuance  of 3,300  Units,  the  Company  issued to The  Zanett  Securities
Corporation ("Zanett") for its services as placement agent, warrants to purchase
162,462  shares of Common Stock at an exercise price of $1.625 per share ("Agent
Warrants").  The  Investor  Warrants and the Agent  Warrants  expire on July 27,
2002.  The terms of the  Series K Stock,  the  Investor  Warrants  and the Agent
Warrants were determined by the Board.

         The net  proceeds  of the 3,300  Units  ($2.9  million)  have been used
for working capital and general corporate purposes.

         Under the Registration Rights Agreement dated as of July 28, 1997 among
the Company, the Purchasers and Zanett  ("Registration  Rights Agreement"),  the
Company has granted each Purchaser and Zanett registration  rights,  whereby the
Company is obligated to file a  registration  statement  with the SEC as soon as
practicable  after  each  closing,  but in no  event  later  than  the  60th day
following  each such closing,  registering at least 135% of the shares of Common
Stock issuable on conversion of, or othewise with respect to, the Series K Stock
and on exercise of or otherwide  pursuant to the Investor Warrants and the Agent
Warrants.  This registration  statement has been declared  effective by the SEC.
Until such time as such  registration  statements are declared  effective by the
SEC, the holders of the Series K Stock  ("Holders") and the holders the Investor
Warrants and the Agent  Warrants may not transfer such  securities or the Common
Stock issuable in connection therewith unless they comply with an exemption from
such registration requirements.

         Conversion  Rights.  Each share of Series K Stock is convertible at the
option of the Holder  into the number of shares of Common  Stock  determined  by
dividing the initial  purchase price of $1,000 by the "Conversion  Price," which
is the lesser of (a) the Fixed  Conversion  Price (which initially is $2.00) and
(b) the lowest closing sale price for the Common Stock on any single trading day
during the ten trading days immediately  preceding the conversion  multiplied by
the "Conversion  Percentage."  The "Conversion  Percentage" is (a) 105% prior to
the 61st day following July 28, 1997 (the "First Closing Date"), (b) 96% for the
period  between the 61st and the 90th day following the First Closing Date,  (c)
85% for the  period  between  the 91st and the  180th  day  following  the First
Closing Date, and (d) 81% for the period after the 180th day following the First
Closing Date. In the event the  Company's  Common Stock is no longer  designated
for quotation on the Nasdaq  National  Market  ("Nasdaq")  and is designated for
quotation on the Nasdaq Small Cap Market, the Conversion  Percentage for each of
the periods set forth above is permanently reduced by 2%.

         Under  the  requirements  of a newly  issued  SEC staff  position,  the
carrying  value  of the  Series  K  Stock  was  increased  by  $774,000,  or the
corresponding amount allocated to beneficial conversion feature described below.
The Company also recorded a related $774,000  non-cash charge to preferred stock
dividends.  In addition,  as required under the newly issued SEC staff position,
the Company would record similar  non-cash  charges to preferred stock dividends
for all future offerings with below market conversion features.

         If  (1) a  registration  statement  described  above  is  not  declared
effective by the SEC by the 150th day  following  the date it was required to be
filed under the Registration  Rights Agreement  ("Registration  Deadline"),  (2)
after the registration  statement is declared effective by the SEC, sales of the
shares of Common Stock  registered  thereunder  cannot be made or (3) the Common
Stock is not listed or included for  quotation  on Nasdaq,  the Nasdaq Small Cap
Market,  the New York Stock  Exchange  ("NYSE") or the American  Stock  Exchange
("AMEX"),  then each of the Conversion  Percentages are permanently reduced. The
Conversion Percentages are permanently reduced by an amount equal to the product
of (i) 2% and (ii) the sum of (a) the  number of months  (prorated  for  partial
months) after the  Registration  Deadline and prior to the date the registration
statement  is  declared  effective  by the  SEC and (b)  the  number  of  months
(prorated for partial months) that sales cannot be made pursuant to an effective
registration  statement  or the  Common  Stock is not  listed  or  included  for
quotation on Nasdaq,  the Nasdaq Small Cap Market,  the NYSE or the AMEX.  There
are certain  exceptions to this provision set forth in the  Registration  Rights
Agreement.  In addition,  the  aggregate  reductions  to each of the  Conversion
Percentages  for failure to have the Common Stock  listed on Nasdaq,  the Nasdaq
Small Cap Market, the NYSE or AMEX cannot exceed 10%.

         The  Conversion  Price is  adjusted  if there is a stock  split,  stock
dividend,  combination,  reclassification  or similar  event with respect to the
Common Stock,  if certain  distributions  with respect to shares of Common Stock
are made, if certain purchase rights are distributed and in the event of certain
mergers, certain consolidations, sale or transfer of all or substantially all of
the Company's assets and certain share exchanges.

         If a Holder  tenders his or her shares of Series K Stock for conversion
and does not receive certificates for all of the shares of Common Stock to which
such Holder is entitled (except in certain  specified  circumstances),  then the
Fixed Conversion Price is thereafter reduced to the lesser of (1) the then Fixed
Conversion Price (prior to the adjustment required by this sentence) and (2) the
lowest  Conversion Price in effect during the period beginning on the conversion
date and  ending on the date the  shares of Common  Stock are  delivered  to the
Holder. If the Company states that it will not deliver freely tradable shares of
Common Stock on  conversion  of the Series K Stock (other than in  circumstances
permitted by the Registration  Rights  Agreement),  then the Conversion Price is
thereafter  reduced to the lowest  Conversion Price in effect at any time during
the period  beginning  on the date of the default  occurs and ending on the date
such default is cured. In addition,  certain  conversion default payments accrue
under Article VI of the Series K Certificate.

         Subject to the  provisions  regarding  the Cap Amount and provided that
all shares of Common Stock issuable on conversion of all  outstanding  shares of
Series K Stock are authorized  and reserved for issuance,  registered for resale
under the Securities  Act of 1933, as amended,  and are eligible to be traded on
the Nasdaq,  the NYSE or the AMEX,  each share of Series K Stock  outstanding on
the fourth anniversary of the First Closing Date is automatically converted into
Common Stock.

         The  Series K Stock has a  liquidation  preference  of $1,000 per share
plus the accrued  "Premium." The Premium is 7% multiplied $1,000 multiplied by a
fraction  (1) the  numerator  is the number of days a share of Series K Stock is
outstanding  and (2) the  denominator of which is 365. The Premium is payable at
the time of conversion or redemption in cash or shares of Common Stock.

         The  Series K  Certificate  provides  that in no event  shall the total
number of shares of Common  Stock issued upon  conversion  of the Series K Stock
exceed the maximum  number of shares of Common  Stock that the Company may issue
pursuant to Rule 4460(i) of the Nasdaq or any successor rule ("Cap Amount"). The
Cap Amount is  allocated  pro rata among the  Holders.  The Company has obtained
approval  from the holders of Common  Stock to issue  shares of Common  Stock in
connection with the Series K Stock, the Investor Warrants and the Agent Warrants
in excess of the amounts permitted by Nasdaq Rule 4460(i)(1)(D).

         The  exercise  price of the Investor  Warrants  and the Agent  Warrants
(collectively,  "Warrants") is adjusted in the event the Company issues,  grants
or  sells  any  warrants,   rights  or  options   (whether  or  not  immediately
exercisable) to purchase Common Stock or securities that are convertible into or
exchangeable  for  Common  Stock at a price  per  share  that is not  based on a
percentage of the market price of the Common Stock  ("Fixed  Price") or that may
be converted  into or  exchanged  for Common Stock at a Fixed Price that is less
than the then exercise price of such Warrants. In such event, the exercise price
of the Warrants is reduced to such Fixed Price and the number of shares issuable
on exercise  of the  Warrants is adjusted so that it equals the number of shares
issuable under the Warrants  immediately  prior to the adjustment  multiplied by
the per share  exercise  price prior to the  adjustment  divided by the exercise
price after the adjustment.

         In  the  event  of  stock  split,  stock  dividend,   recapitalization,
reorganization,  reclassification  or other subdivision of the Common Stock, the
exercise price of the Warrants and the number of shares of Common Stock issuable
on exercise of the Warrants are proportionately  adjusted. The exercise price of
the Warrants and the number of shares  issuable on exercise are also adjusted in
the event of certain  mergers  and  consolidations,  in the event of any sale or
conveyance of all or substantially  all of the Company's assets, in the event of
certain  distributions  of its assets and in the event the  Company  distributes
certain purchase rights.

         Dividends.  The Series K Stock does not bear  dividends and there is no
provision for a sinking fund; accordingly, there are no provisions in the Series
K Certificate  restricting  repurchase or redemption of the Series K Stock while
there is a dividend or sinking fund arrearage.  However,  the Premium accrues as
noted above.

         Ranking.  Shares of Series K Stock rank  prior to the Common  Stock and
any class or series of capital  stock created after the creation of the Series K
Stock  (unless  consent of the  Holders is  obtained  as  described  below under
"Voting  Rights")  and ranks pari passu with the Series L Stock and any class or
series created after the creation of the Series K Stock that specifically states
that it ranks  pari passu  with the  Series K Stock and where the  Holders  have
approved  the  issuance of such  securities  as  described  below under  "Voting
Rights." The Series K Stock ranks junior to the Series A Stock,  and Series F-1,
F-2, F-3 and F-4 Stock.

         Voting Rights. The Series K Stock generally has no voting rights except
as otherwise  provided by the Delaware  General  Corporation Law.  However,  the
approval of the holders of a majority of the then outstanding shares of Series K
Stock is required to: (1) alter or change the rights,  preferences or privileges
of the Series K Stock, (2) alter or change the rights, preferences or privileges
of any  capital  stock of the  Company  so as to  adversely  affect the Series K
Stock,  (3) create any new class or series of capital  stock ranking prior to or
pari passu with the Series K Stock, (4) increase the authorized number of shares
of Series K Stock, (5) issue any shares of Series K Stock other than pursuant to
the  securities  purchase  agreement  datd July 28, 1997  ("Securities  Purchase
Agreement"), (6) issue any additional shares of any securities ranking senior to
the  Series  K  Stock  or (7)  redeem,  or  declare  or pay a cash  dividend  or
distribution on, any securities junior to the Series K Stock.

         In the  event the  Holders  approve a change  described  in clause  (1)
above, a dissenting  Holder has the right for a period of 30 days to convert its
shares of Series K Stock  pursuant to the terms of the Series K  Certificate  as
they existed prior to the change.

         Except in the event of a required conversion at maturity,  no Holder is
entitled to receive  shares of Common Stock on  conversion of its Series K Stock
to the  extent  that the sum of (1) the  shares  of Common  Stock  owned by such
Holder  and its  affiliates  and (2) the  shares of  Common  Stock  issuable  on
conversion  of the Series K Stock would result in  beneficial  ownership by such
Holder and its affiliates of more than 4.9% of the outstanding  shares of Common
Stock.  Beneficial  ownership for this purpose is determined in accordance  with
Section 13(d) of the Exchange Act. This restriction cannot be amended or deleted
unless the  holders of a majority of the Common  Stock and each Holder  approves
such amendment or deletion.

         Redemption  Rights.  In the event the unissued  portion of any Holder's
Cap  Amount  is less than 135% of the  number  of  shares of Common  Stock  then
issuable upon  conversion of such Holder's  Series K Stock and the Company fails
to eliminate  the  prohibitions  that have  resulted in the existence of the Cap
Amount within 90 days, then each Holder may (1) require (with the consent of the
holders  of 50% of the  outstanding  shares of Series K Stock)  the  Company  to
terminate  the  listing  of the  Common  Stock on Nasdaq and to cause the Common
Stock to be  eligible  for  trading  on the  Nasdaq  Small Cap  Market or on the
over-the-counter  electronic  bulletin  board,  at the option of the  requesting
Holder,  or (2) require the Company to issue Common Stock at a Conversion  Price
equal to the average of the closing prices of the Common Stock on the five prior
trading  days.  In addition,  the Holder has the right to require the Company to
redeem for cash at an amount equal to the  "Redemption  Amount" a portion of the
Holder's  Series K Stock such that,  after giving effect to such  purchase,  the
then  unissued  portion of the  Holder's  Cap Amount  exceeds  135% of the total
number of shares of Common  Stock then  issuable on  conversion  of its Series K
Stock. The Redemption  Amount per share of Series K Stock equals (1) $1,000 plus
the accrued  Premium plus all  conversion  default  payments  required under the
Series K Certificate,  multiplied by (2) the highest closing price of the Common
Stock  during  the period  beginning  on the date of the  redemption  notice and
ending on the date of redemption,  divided by (3) the Conversion Price in effect
on the date of the redemption notice.

         The terms of the Series K Stock  provide the Holders  with the right to
require the Company to redeem its Series K Stock at the Redemption Amount (1) if
the Company  fails to issue shares of Common Stock on conversion of the Series K
Stock other than in certain specified circumstances all of which are in the sole
control of the Company, (2) if the Common Stock is suspended from trading on any
of, or is not  listed  on at least  one of,  the New York  Stock  Exchange,  the
American  Stock  Exchange,  the Nasdaq  National  Market or the Nasdaq Small Cap
Market for an  aggregate of 10 trading  days in any nine month  period,  (3) the
registration  statement  required  to be filed  under  the  Registration  Rights
Agreement is not declared  effective by the SEC by January 31, 1998 or cannot be
utilized  by the Holders  for an  aggregate  of more than 30 days after June 30,
1998, (4) the Company fails to remove any restrictive legend on shares of Common
Stock issued on conversion of the Series K Stock when required by the Securities
Purchase Agreement or Registration Rights Agreement, (5) the Company states that
it will not issue shares of Common Stock to Holders in accordance with the terms
of the Series K Certificate  (other than in  circumstances  where other remedies
are provided in the Series K Certificate), or (6) the Company shall (a) sell all
or  substantially  all of its assets,  (b) merger or  consolidate  with  another
entity,  or (c) have 50% or more of the voting power of its capital  stock owned
beneficially  by any one person or group within the meaning of Section  13(d) of
the Exchange Act.

         The Company and the Holders  entered  into an agreement on November 30,
1997  wherein the Holders  agreed to not  exercise a right of  redemption  under
certain  circumstances  and  subject to certain  conditions  (the  "Agreement").
Specifically,  the Holders  agreed not to exercise a right of  redemption in the
circumstance  described  above so long as (i) the  Company has not, at any time,
decreased  the  number of shares of Common  Stock  reserved  for  issuance  with
respect to the Series K Stock  ("Reserved  Amount") below  12,500,000  shares of
Common Stock;  (ii) the Company shall have taken immediate  action following the
trigger date to increase the Reserved  Amount to 200% of the number of shares of
Common Stock then issuable upon  conversion of the  outstanding  Series K Stock;
and (iii) the Company  continues  to use its good faith best efforts to increase
the  Reserved  Amount to 200% of the  number of  shares  of  Common  Stock  then
issuable upon conversion of the outstanding  Series K Stock.  The parties agreed
that the  Company  will be deemed to have used "its good faith best  efforts" to
increase  the  Reserved  Amount so long as it solicits  shareholder  approval to
authorize the issuance of  additional  shares of Common Stock no less than three
times during each 12 month period following the trigger date.

         Further,  pursuant to that  Agreement,  the Holders will not exercise a
right of redemption if the Common Stock is suspended  from trading on any of, or
is not  listed on at least one of,  the New York Stock  Exchange,  the  American
Stock Exchange, the Nasdaq National Market or the Nasdaq Small Cap Market for an
aggregate of 10 trading days in any nine month period,  and in such circumstance
the Company  would be required  to pay to the Holders  within five (5)  business
days of the  occurrence of that  redemption  event,  as liquidated  damages,  an
amount equal to 25% of the aggregate face amount of the shares of Series K Stock
then held by each Holder. The liquidated  damages are payable,  at the Company's
option,  in cash or shares of Common  Stock,  such stock  based upon a price per
share equal to 50% of the lowest closing price of the Common Stock during the 10
consecutive trading day period immediately preceding the date of such redemption
event. Under the Agreement,  the Company is obligated to keep reserved 3,000,000
shares of Common Stock to satisfy its obligation  with respect to the liquidated
damages.  In the event  that the number of shares  required  to be issued by the
Company  with  respect to the amount of  liquidated  damages  exceeds  3,000,000
shares of Common  Stock,  and the Company does not have a  sufficient  number of
shares of Common  Stock  authorized  and  available  for issuance to satisfy its
obligation with respect to the liquidated  damages,  the Company shall issue and
deliver to the Holders all 3,000,000 shares of Common Stock so reserved for that
purpose and, upon such  issuance,  the Holders shall have no right of redemption
upon a Redemption  Event as specified in the  Certificate  of Designation to the
Series K Stock,  but  shall  retain  all  other  remedies  to which  they may be
entitled  at law or in equity,  which  remedies  shall not  include the right of
redemption. The Holders also agreed that they would have no right to require the
Company to effect a redemption of their outstanding shares of Preferred Stock if
the registration  statement  required to be filed by the Company,  pursuant to a
registration  rights  agreement  entered into between the parties,  has not been
declared  effective by January 31, 1998, or such registration  statement,  after
being  declared  effective,  cannot be  utilized  by the Holders of the Series K
Preferred Stock for the resale of their registrable  securities for an aggregate
of more than 30 days after June 30, 1998;  however,  upon the  occurrence of any
such event and while any of the events  continue,  the Company agrees to provide
that the permanent  reductions to the  conversion  percentages  set forth in the
Registration Rights Agreement shall accrue at the rate of two hundreds (.02) per
week instead of two hundreds (.02) per month.  Lastly, the Holders agreed not to
exercise a right of  redemption  upon an event where the Company has 50% or more
of the voting  power of its  capital  stock  owned  beneficially  by one person,
entity or group (as such term is used under Section 13(d) of the Exchange  Act),
so long as the Company has not approved,  recommended or otherwise  consented to
the transaction which triggered that event.

         The  Agreement  provides  that all  subsequent  holders of the Series K
Stock  shall  be  bound  by the  terms of the  Agreement,  and the  Holders  are
prohibited from  transferring any shares of the Series K Stock unless,  prior to
the transfer (i) the Company is  furnished  with written  notice of the name and
address of such transferee;  (ii) at or before the time the Company receives the
written  notice  contemplated  by clause (i) of this  sentence,  the  transferee
agrees in  writing  for the  benefit  of the  Company  to be bound by all of the
provisions  contained  in the  Agreement  following  such  transfer,  (iii) such
transfer shall have been made in accordance with the applicable  requirements of
the  Securities  Purchase  Agreement,   the  Certificate  of  Designation,   the
Securities  Act and  applicable  state  securities  laws,  and (iv) the  further
transfer  or  disposition  of such  Series  K Stock by the  transferee  (and any
subsequent  transferees)  is  restricted  pursuant  to  the  provisions  of  the
Agreement.

         In the event that the Company  fails to perform its  obligations  under
the  Agreement,  it is then  required to pay the  Redemption  Amount,  and if it
should fail to do so, the Company is further  obligated  to (1) pay  interest on
such amount at the rate of 24% per annum until such  Holder's  Series K Stock is
redeemed and (2) such Holder has the right to require the Company to convert the
Redemption  Amount plus  accrued  interest  into  shares of Common  Stock at the
lowest  Conversion  Price in effect during the period  beginning on the date the
Holder submitted its redemption notice and ending on the date of conversion.

         The  Company has the right to redeem all (but not less than all) of the
outstanding  Series K Stock  (other  than shares that are subject to a notice of
conversion) at any time when it is not in material  violation of its obligations
under  the  Series K  Certificate,  the  Securities  Purchase  Agreement  or the
Registration  Rights Agreement at the "Optional  Redemption Amount." The Company
can only exercise this right once. The Optional  Redemption  Amount per share of
Series K Stock is the  greater of (1) the sum of the face  amount,  the  accrued
Premium  and  all  conversion  default  payments  accrued  through  the  date of
redemption and (2) (a) the sum of $1,000, the accrued Premium and all conversion
default payments required under the Series K Certificate,  multiplied by (b) the
volume  weighted  average  sales  price of the Common  Stock on the  trading day
immediately  preceeding  the  optional  redemption  notice,  divided  by (c) the
Conversion Price in effect on the date of the optional redemption notice. In the
event the Company fails to pay any Holder its Optional  Redemption Amount,  then
(1) the Holder is  entitled  to  interest  on such amount at the rate of 24% per
annum  until  the  later  of the date  such  Holder's  Series K Stock  was to be
redeemed or until the Company  notifies  the Holder that it will not redeem such
Holder's Series K Stock and (2) such Holder has the right to require the Company
to  convert  such  Holder's  Series K Stock into  shares of Common  Stock at the
lowest  Conversion  Price in effect during the period  beginning on the date the
Company  elected  to redeem  such  shares and  ending on the 20th  trading  date
following the date such Series K Stock was to be redeemed.


Series L Convertible Preferred Stock

         On  December  8,  1997,  the  Company  issued  3,250  units   ("Units")
consisting  of (1) one share of Series L Stock and (2)  warrants  to purchase 75
shares  of Common  Stock at an  exercise  price of $1.65  per  share  ("December
Investor Warrants").  Accordingly, on December 8, 1997, the Company issued 3,250
shares of Series L Stock and  December  Investor  Warrants to  purchase  243,750
shares of Common Stock. As a result of the issuance of 3,250 Units,  the Company
issued to The Zanett  Securities  Corporation  ("Zanett")  for its  services  as
placement  agent,  warrants to  purchase  160,000  shares of Common  Stock at an
exercise price of $1.625 per share  ("December  Agent  Warrants").  The December
Investor  Warrants and the December Agent  Warrants  expire on December 7, 2002.
The terms of the Series L Stock, the December Investor Warrants and the December
Agent Warrants were determined by the Board.

         Pursuant to the terms of the Securities  Purchase Agreement dated as of
December 8, 1997 ("December  Securities  Purchase  Agreement") among the Company
and Capital Ventures International,  Zanett Lombardier,  Ltd. and Bruno Guazzoni
(the "Purchasers"),  the Purchasers may purchase up to an additional 3,000 Units
if the Company  satisfies  certain  other  conditions  (one of which is that the
Common Stock remain listed on the Nasdaq  National  Market),  at two  additional
closings  (up to 1,500  Units  at each  closing).  Under  the  Placement  Agency
Agreement  dated July 2, 1997  between the  Company  and Zanett,  the Company is
obligated to issue additional December Agent Warrants to Zanett to purchase such
number of shares of Common Stock as is equal to 8% of the  quotient  obtained by
dividing  the  aggregate  purchase  price of the  shares  of  Series L Stock and
December Investor Warrants issued to the Purchasers at such additional  closings
by $1.625.  The initial  exercise price of the December Agent Warrants is $1.625
per share.

         The net proceeds of the 3,250 Units ($2.99  million) have been, and the
net  proceeds  of any  additional  issuance  of Units will be,  used for working
capital and general corporate purposes.

         Under the  Registration  Rights  Agreement dated as of December 8, 1997
among the Company,  the Purchasers  and Zanett  ("December  Registration  Rights
Agreement"),  the Company has granted  each  Purchaser  and Zanett  registration
rights,  whereby the Company is obligated to file a registration  statement with
the SEC as soon as  practicable  after each closing,  but in no event later than
the 60th day  following  each such  closing,  registering  at least  135% of the
shares of Common Stock  issuable on conversion of, or otherwise with respect to,
the Series L Stock and on exercise  of, or  otherwise  pursuant to, the December
Investor  Warrants  and the  December  Agent  Warrants.  Until such time as such
registration  statements  are declared  effective by the SEC, the holders of the
Series L Stock ("Holders") and the holders of the December Investor Warrants and
the December Agent Warrants may not transfer such securities or the Common Stock
issuable in connection  therewith unless they comply with an exemption from such
registration requirements.

         Conversion  Rights.  Each share of Series L Stock is convertible at the
option of the Holder  into the number of shares of Common  Stock  determined  by
dividing the initial  purchase price of $1,000 by the "Conversion  Price," which
is the lesser of (a) the Fixed  Conversion Price (which initially is $1.375) and
(b) the lowest closing sale price for the Common Stock on any single trading day
during the ten trading days immediately  preceding the conversion  multiplied by
the "Conversion Percentage." The "Conversion Percentage" is (a) 85% prior to the
48th day following  December 8, 1997 (the "First Closing Date"), and (b) 81% for
the period on or after the 48th day  following  the First  Closing  Date. In the
event the Company's  Common Stock is no longer  designated  for quotation on the
Nasdaq National Market  ("Nasdaq") and is designated for quotation on the Nasdaq
Small Cap Market,  the  Conversion  Percentage for each of the periods set forth
above is  permanently  reduced  by 2%.  In  addition,  if the  second  and third
closings under the December  Securities  Purchase Agreement do not occur because
the  Company  failed to  obtain  stockholder  approval  of the  issuance  of the
securities  in the second and third  closings  in  accordance  with  Nasdaq Rule
4460(i),  the Conversion  Percentage  for each period is permanently  reduced by
10%.

         Under  the  requirements  of a newly  issued  SEC staff  position,  the
carrying  value  of the  Series  L  Stock  was  increased  by  $772,000,  or the
corresponding amount allocated to beneficial conversion feature described below.
The Company also recorded a related $772,000  non-cash charge to preferred stock
dividends.  In addition,  as required under the newly issued SEC staff position,
the Company would record similar  non-cash  charges to preferred stock dividends
for all future offerings with below market conversion features.

         If  (1) a  registration  statement  described  above  is  not  declared
effective by the SEC by the 150th day  following  the date it was required to be
filed under the December Registration Rights Agreement (the 90th day in the case
of a registration  statement on Form S-3) ("Registration  Deadline"),  (2) after
the registration statement is declared effective by the SEC, sales of the shares
of Common Stock registered  thereunder cannot be made or (3) the Common Stock is
not listed or included for quotation on Nasdaq, the Nasdaq Small Cap Market, the
New York Stock Exchange ("NYSE") or the American Stock Exchange  ("AMEX"),  then
each of the  Conversion  Percentages  are  permanently  reduced.  The Conversion
Percentages are permanently  reduced by an amount equal to the product of (i) 2%
and (ii) the sum of (a) the number of months (prorated for partial months) after
the Registration  Deadline and prior to the date the  registration  statement is
declared effective by the SEC and (b) the number of months (prorated for partial
months)  that  sales  cannot  be  made  pursuant  to an  effective  registration
statement or the Common Stock is not listed or included for quotation on Nasdaq,
the Nasdaq Small Cap Market,  the NYSE or the AMEX. There are certain exceptions
to this provision set forth in the December  Registration  Rights Agreement.  In
addition,  the aggregate  reductions to each of the Conversion  Percentages  for
failure to have the Common Stock listed on Nasdaq,  the Nasdaq Small Cap Market,
the NYSE or AMEX cannot  exceed 10%. In addition,  if any required  registration
statement  has not been  declared  effective on or before the 60th day following
the applicable Registration Deadline, or if, after the registration statement is
declared  effective,  it cannot  be  utilized  for more  than 30 days  after the
earlier of the date the Company first  becomes  eligible to use Form S-3 or June
30, 1998,  each of the Conversion  Percentages  applicable  during such time are
permanently reduced by 2% per week rather than 2% per month.

         The  Conversion  Price is  adjusted  if there is a stock  split,  stock
dividend,  combination,  reclassification  or similar  event with respect to the
Common Stock,  if certain  distributions  with respect to shares of Common Stock
are made, if certain purchase rights are distributed and in the event of certain
mergers, certain consolidations, sale or transfer of all or substantially all of
the Company's assets and certain share exchanges.

         If a Holder  tenders his or her shares of Series L Stock for conversion
and does not receive certificates for all of the shares of Common Stock to which
such Holder is entitled (except in certain  specified  circumstances),  then the
Fixed Conversion Price is thereafter reduced to the lesser of (1) the then Fixed
Conversion Price (prior to the adjustment required by this sentence) and (2) the
lowest  Conversion Price in effect during the period beginning on the conversion
date and  ending on the date the  shares of Common  Stock are  delivered  to the
Holder. If the Company states that it will not deliver freely tradable shares of
Common Stock on  conversion  of the Series L Stock (other than in  circumstances
permitted by the December  Registration  Rights Agreement),  then the Conversion
Price is thereafter reduced to the lowest Conversion Price in effect at any time
during the period  beginning on the date of the default occurs and ending on the
date such default is cured. In addition,  certain  conversion  default  payments
accrue under Article VI of the Series L Certificate.

         Subject to the  provisions  regarding  the Cap Amount and provided that
all shares of Common Stock issuable on conversion of all  outstanding  shares of
Series L Stock are authorized  and reserved for issuance,  registered for resale
under the Securities  Act of 1933, as amended,  and are eligible to be traded on
the Nasdaq,  the NYSE or the AMEX,  each share of Series L Stock  outstanding on
the fourth anniversary of the First Closing Date is automatically converted into
Common Stock.

         The  Series L Stock has a  liquidation  preference  of $1,000 per share
plus the accrued  "Premium." The Premium is 7% multiplied $1,000 multiplied by a
fraction  (1) the  numerator  is the number of days a share of Series L Stock is
outstanding  and (2) the  denominator of which is 365. The Premium is payable at
the time of conversion or redemption in cash or shares of Common Stock.

         The  Series L  Certificate  provides  that in no event  shall the total
number of shares of Common  Stock issued upon  conversion  of the Series L Stock
exceed the maximum  number of shares of Common  Stock that the Company may issue
pursuant to Rule 4460(i) of the Nasdaq or any successor rule ("Cap Amount"). The
Cap  Amount is  allocated  pro rata among the  Holders.  The  Company  will seek
approval  from the holders of Common  Stock to issue  shares of Common  Stock in
connection  with the Series L Stock,  the  December  Investor  Warrants  and the
December  Agent  Warrants  in excess of the  amounts  permitted  by Nasdaq  Rule
4460(i)(1)(D).

         The exercise price of the December  Investor  Warrants and the December
Agent Warrants (collectively,  "December Warrants") is adjusted in the event the
Company issues, grants or sells any warrants,  rights or options (whether or not
immediately  exercisable)  to  purchase  Common  Stock  or  securities  that are
convertible  into or exchangeable  for Common Stock at a price per share that is
not based on a  percentage  of the  market  price of the  Common  Stock  ("Fixed
Price") or that may be converted  into or exchanged  for Common Stock at a Fixed
Price that is less than the then exercise  price of such December  Warrants.  In
such event, the exercise price of the December Warrants is reduced to such Fixed
Price and the number of shares issuable on exercise of the December  Warrants is
adjusted  so that it equals the  number of shares  issuable  under the  December
Warrants  immediately  prior  to the  adjustment  multiplied  by the  per  share
exercise price prior to the  adjustment  divided by the exercise price after the
adjustment.

         In  the  event  of  stock  split,  stock  dividend,   recapitalization,
reorganization,  reclassification  or other subdivision of the Common Stock, the
exercise price of the December Warrants and the number of shares of Common Stock
issuable on exercise of the December Warrants are proportionately  adjusted. The
exercise  price of the December  Warrants  and the number of shares  issuable on
exercise are also adjusted in the event of certain  mergers and  consolidations,
in the  event  of any  sale or  conveyance  of all or  substantially  all of the
Company's assets, in the event of certain distributions of its assets and in the
event the Company distributes certain purchase rights.

         Dividends.  The Series L Stock does not bear  dividends and there is no
provision for a sinking fund; accordingly, there are no provisions in the Series
L Certificate  restricting  repurchase or redemption of the Series L Stock while
there is a dividend or sinking fund arrearage.  However,  the Premium accrues as
noted above.

         Ranking.  Shares of Series L Stock rank  prior to the Common  Stock and
any class or series of capital  stock created after the creation of the Series L
Stock  (unless  consent of the  Holders is  obtained  as  described  below under
"Voting  Rights")  and ranks pari passu with the Series K Stock and any class or
series created after the creation of the Series L Stock that specifically states
that it ranks  pari passu  with the  Series L Stock and where the  Holders  have
approved  the  issuance of such  securities  as  described  below under  "Voting
Rights." The Series L Stock ranks junior to the Series A Stock,  and Series F-1,
F-2, F-3 and F-4 Stock.

         Voting Rights. The Series L Stock generally has no voting rights except
as otherwise  provided by the Delaware  General  Corporation Law.  However,  the
approval of the holders of a majority of the then outstanding shares of Series L
Stock is required to: (1) alter or change the rights,  preferences or privileges
of the Series L Stock, (2) alter or change the rights, preferences or privileges
of any  capital  stock of the  Company  so as to  adversely  affect the Series L
Stock,  (3) create any new class or series of capital  stock ranking prior to or
pari passu with the Series L Stock, (4) increase the authorized number of shares
of Series L Stock, (5) issue any shares of Series L Stock other than pursuant to
the December Securities  Purchase Agreement,  (6) issue any additional shares of
any securities ranking senior to the Series L Stock or (7) redeem, or declare or
pay a cash dividend or  distribution  on, any securities  junior to the Series L
Stock.

         In the  event the  Holders  approve a change  described  in clause  (1)
above, a dissenting  Holder has the right for a period of 30 days to convert its
shares of Series L Stock  pursuant to the terms of the Series L  Certificate  as
they existed prior to the change.

         Except in the event of a required conversion at maturity,  no Holder is
entitled to receive  shares of Common Stock on  conversion of its Series L Stock
to the  extent  that the sum of (1) the  shares  of Common  Stock  owned by such
Holder  and its  affiliates  and (2) the  shares of  Common  Stock  issuable  on
conversion  of the Series L Stock would result in  beneficial  ownership by such
Holder and its affiliates of more than 4.99% of the outstanding shares of Common
Stock.  Beneficial  ownership for this purpose is determined in accordance  with
Section 13(d) of the Exchange Act. This restriction cannot be amended or deleted
unless the  holders of a majority of the Common  Stock and each Holder  approves
such amendment or deletion.

         Redemption  Rights.  In the event the unissued  portion of any Holder's
Cap  Amount  is less than 135% of the  number  of  shares of Common  Stock  then
issuable upon  conversion of such Holder's  Series L Stock and the Company fails
to eliminate  the  prohibitions  that have  resulted in the existence of the Cap
Amount within 90 days, then each Holder may (1) require (with the consent of the
holders  of 50% of the  outstanding  shares of Series L Stock)  the  Company  to
terminate  the  listing  of the  Common  Stock on Nasdaq and to cause the Common
Stock to be  eligible  for  trading  on the  Nasdaq  Small Cap  Market or on the
over-the-counter  electronic  bulletin  board,  at the option of the  requesting
Holder,  or (2) require the Company to issue Common Stock at a Conversion  Price
equal to the average of the closing prices of the Common Stock on the five prior
trading  days.  In  addition,  subject to the  provisions  discussed in the next
paragraph, the Holder has the right to require the Company to redeem for cash at
an amount equal to the  "Redemption  Amount" a portion of the Holder's  Series L
Stock such that, after giving effect to such purchase, the then unissued portion
of the Holder's Cap Amount  exceeds 135% of the total number of shares of Common
Stock then issuable on conversion of its Series L Stock.  The Redemption  Amount
per share of Series L Stock equals (1) $1,000 plus the accrued  Premium plus all
conversion default payments required under the Series L Certificate,  multiplied
by (2) the highest closing price of the Common Stock during the period beginning
on the date of the  redemption  notice  and  ending  on the date of  redemption,
divided  by (3) the  Conversion  Price in effect  on the date of the  redemption
notice.

         However,  the Holders  may not  exercise a right of  redemption  in the
circumstance  described  above so long as (i) the  Company has not, at any time,
decreased  the  number of shares of Common  Stock  reserved  for  issuance  with
respect to the Series L Stock  ("Reserved  Amount") below  12,500,000  shares of
Common Stock;  (ii) the Company shall have taken immediate  action following the
trigger date to increase the Reserved  Amount to 200% of the number of shares of
Common Stock then issuable upon  conversion of the  outstanding  Series L Stock;
and (iii) the Company  continues  to use its good faith best efforts to increase
the  Reserved  Amount to 200% of the  number of  shares  of  Common  Stock  then
issuable upon conversion of the outstanding  Series L Stock. The Company will be
deemed to have used "its good faith  best  efforts"  to  increase  the  Reserved
Amount so long as it solicits  shareholder approval to authorize the issuance of
additional  shares of Common Stock no less than three times during each 12 month
period following the trigger date.

         The terms of the Series L Stock  provide the Holders  with the right to
require the Company to redeem its Series L Stock at the Redemption Amount (1) if
the Company  fails to issue shares of Common Stock on conversion of the Series L
Stock other than in certain specified circumstances all of which are in the sole
control of the Company,  (2) the Company fails to remove any restrictive  legend
on shares of  Common  Stock  issued on  conversion  of the  Series L Stock  when
required  by  the  December   Securities  Purchase  Agreement  or  the  December
Registration  Rights  Agreement,  (3) the Company  states that it will not issue
shares of Common Stock to Holders in  accordance  with the terms of the Series L
Certificate  (other than in  circumstances  where other remedies are provided in
the  Series  L  Certificate),   or  (4)  the  Company  shall  (a)  sell  all  or
substantially all of its assets,  (b) merger or consolidate with another entity,
or (c) have approved,  recommended or otherwise  consented to any transaction or
series of  transactions  which results in 50% or more of the voting power of its
capital  stock being owned  beneficially  by any one person or group  within the
meaning of Section 13(d) of the Exchange Act.

         The Holders do not have a right of  redemption  if the Common  Stock is
suspended  from  trading on any of, or is not listed on at least one of, the New
York Stock Exchange,  the American Stock Exchange, the Nasdaq National Market or
the  Nasdaq  Small Cap Market for an  aggregate  of 10 trading  days in any nine
month  period,  and in such  circumstance  the Company is required to pay to the
Holders  within five (5)  business  days of the  occurrence  of that  redemption
event,  as  liquidated  damages,  an amount equal to 25% of the  aggregate  face
amount of the shares of Series L Stock then held by each Holder.  The liquidated
damages are payable, at the Company's option, in cash or shares of Common Stock,
such stock based upon a price per share equal to 50% of the lowest closing price
of the Common Stock  during the 10  consecutive  trading day period  immediately
preceding the date of such  redemption  event.  The Company is obligated to keep
reserved 3,000,000 shares of Common Stock to satisfy its obligation with respect
to the liquidated damages. In the event that the number of shares required to be
issued by the Company with respect to the amount of liquidated  damages  exceeds
3,000,000  shares of Common  Stock,  and the Company  does not have a sufficient
number of shares of Common  Stock  authorized  and  available  for  issuance  to
satisfy its obligation with respect to the liquidated damages, the Company shall
issue and  deliver  to the  Holders  all  3,000,000  shares  of Common  Stock so
reserved for that purpose and,  upon such  issuance,  the Holders  shall have no
right of  redemption,  but shall retain all other  remedies to which they may be
entitled  at law or in equity,  which  remedies  shall not  include the right of
redemption.

         In the event that the Company is required to pay the Redemption Amount,
and if it should  fail to do so, the  Company is  further  obligated  to (1) pay
interest on such amount at the rate of 24% per annum until such Holder's  Series
L Stock is redeemed  and (2) such Holder has the right to require the Company to
convert the Redemption  Amount plus accrued interest into shares of Common Stock
at the lowest Conversion Price in effect during the period beginning on the date
the Holder submitted its redemption notice and ending on the date of conversion.

         The  Company has the right to redeem all (but not less than all) of the
outstanding  Series L Stock  (other  than shares that are subject to a notice of
conversion) at any time when it is not in material  violation of its obligations
under the Series L Certificate,  the December  Securities  Purchase Agreement or
the December  Registration Rights Agreement at the "Optional Redemption Amount."
The Company can only exercise this right once.  The Optional  Redemption  Amount
per share of Series L Stock is the  greater  of (1) the sum of the face  amount,
the accrued Premium and all conversion default payments accrued through the date
of  redemption  and (2)  (a) the sum of  $1,000,  the  accrued  Premium  and all
conversion default payments required under the Series L Certificate,  multiplied
by (b) the  volume  weighted  average  sales  price of the  Common  Stock on the
trading day immediately  preceeding the optional  redemption notice,  divided by
(c) the  Conversion  Price  in  effect  on the date of the  optional  redemption
notice. In the event the Company fails to pay any Holder its Optional Redemption
Amount,  then (1) the Holder is  entitled to interest on such amount at the rate
of 24% per annum until the later of the date such Holder's Series L Stock was to
be  redeemed or until the  Company  notifies  the Holder that it will not redeem
such  Holder's  Series L Stock and (2) such  Holder has the right to require the
Company to convert such  Holder's  Series L Stock into shares of Common Stock at
the lowest  Conversion  Price in effect during the period  beginning on the date
the Company  elected to redeem such shares and ending on the 20th  trading  date
following the date such Series L Stock was to be redeemed.

                  On July 28, 1997,  the Company  issued  3,300 units  ("Units")
consisting  of (1) one share of Series K Stock and (2)  warrants  to purchase 75
shares  of Common  Stock at an  exercise  price of $2.40  per  share  ("Investor
Warrants").  Accordingly,  on July 28, 1997,  the Company issued 3,300 shares of
Series K Stock and Investor Warrants to purchase 247,500 shares of Common Stock.
As a result of the  issuance of 3,300  Units,  the Company  issued to The Zanett
Securities  Corporation ("Zanett") for its services as placement agent, warrants
to purchase  162,462  shares of Common Stock at an exercise  price of $1.625 per
share ("Agent Warrants"). The Investor Warrants and the Agent Warrants expire on
July 27, 2002.  The terms of the Series K Stock,  the Investor  Warrants and the
Agent Warrants were determined by the Board.

         Pursuant to the terms of the Securities  Purchase Agreement dated as of
July 28,  1997  ("Securities  Purchase  Agreement")  among the  Company  and the
Purchasers,  the Purchasers are required to purchase 3,000  additional  Units if
the Company achieves certain performance  milestones and satisfies certain other
conditions  (one of which is that the Common Stock  remain  listed on the Nasdaq
National  Market) and the  Purchasers  have the option to purchase an additional
4,700 Units, at two additional  closings.  Under the Placement  Agency Agreement
dated July 2, 1997  between the Company and Zanett,  the Company is obligated to
issue  additional  Agent Warrants to Zanett to purchase such number of shares of
Common  Stock  as is  equal  to 8% of the  quotient  obtained  by  dividing  the
aggregate  purchase price of the shares of Series K Stock and Investor  Warrants
issued to the  Purchasers  at such  additional  closings  divided by the initial
exercise price of the Agent Warrants ($1.625 per share).

         The net proceeds of the 3,300 Units ($2.9  million) have been,  and the
net  proceeds  of any  additional  issuance  of Units will be,  used for working
capital and general corporate purposes.

         Under the Registration Rights Agreement dated as of July 28, 1997 among
the Company, the Purchasers and Zanett  ("Registration  Rights Agreement"),  the
Company has granted each Purchaser and Zanett registration  rights,  whereby the
Company is obligated to file a  registration  statement  with the SEC as soon as
practicable  after  each  closing,  but in no  event  later  than  the  60th day
following  each such closing,  registering at least 135% of the shares of Common
Stock  issuable on conversion of, and as dividends on, the Series K Stock and on
exercise of the Investor  Warrants  and the Agent  Warrants.  This  registration
statement has been filed with, but has not been declared  effective by, the SEC.
Until such time as such  registration  statements are declared  effective by the
SEC, the holders of the Series K Stock  ("Holders") and the holders the Investor
Warrants and the Agent  Warrants may not transfer such  securities or the Common
Stock issuable in connection therewith unless they comply with an exemption from
such registration requirements.

         Conversion  Rights.  Each share of Series K Stock is convertible at the
option of the Holder  into the number of shares of Common  Stock  determined  by
dividing the initial  purchase price of $1,000 by the "Conversion  Price," which
is the lesser of (a) the Fixed  Conversion  Price (which initially is $2.00) and
(b) the lowest closing sale price for the Common Stock on any single trading day
during the ten trading days immediately  preceding the conversion  multiplied by
the "Conversion  Percentage."  The "Conversion  Percentage" is (a) 105% prior to
the 61st day following July 28, 1997 (the "First Closing Date"), (b) 96% for the
period  between the 61st and the 90th day following the First Closing Date,  (c)
85% for the  period  between  the 91st and the  180th  day  following  the First
Closing Date, and (d) 81% for the period after the 180th day following the First
Closing Date. In the event the  Company's  Common Stock is no longer  designated
for quotation on the Nasdaq  National  Market  ("Nasdaq")  and is designated for
quotation on the Nasdaq Small Cap Market, the Conversion  Percentage for each of
the periods set forth above is permanently reduced by 2%.

         Under  the  requirements  of a newly  issued  SEC staff  position,  the
carrying  value  of the  Series  K  Stock  was  increased  by  $774,000,  or the
corresponding amount allocated to beneficial conversion feature described below.
The Company also recorded a related $774,000  non-cash charge to preferred stock
dividends.  In addition,  as required under the newly issued SEC staff position,
the Company would record similar  non-cash  charges to preferred stock dividends
for all future offerings with below market conversion features.

         If  (1) a  registration  statement  described  above  is  not  declared
effective by the SEC by the 150th day  following  the date it was required to be
filed under the Registration  Rights Agreement  ("Registration  Deadline"),  (2)
after the registration  statement is declared effective by the SEC, sales of the
shares of Common Stock  registered  thereunder  cannot be made or (3) the Common
Stock is not listed or included for  quotation  on Nasdaq,  the Nasdaq Small Cap
Market,  the New York Stock  Exchange  ("NYSE") or the American  Stock  Exchange
("AMEX"),  then each of the Conversion  Percentages are permanently reduced. The
Conversion Percentages are permanently reduced by an amount equal to the product
of (i) 2% and (ii) the sum of (a) the  number of months  (prorated  for  partial
months) after the  Registration  Deadline and prior to the date the registration
statement  is  declared  effective  by the  SEC and (b)  the  number  of  months
(prorated for partial months) that sales cannot be made pursuant to an effective
registration  statement  or the  Common  Stock is not  listed  or  included  for
quotation on Nasdaq,  the Nasdaq Small Cap Market,  the NYSE or the AMEX.  There
are certain  exceptions to this provision set forth in the  Registration  Rights
Agreement.  In addition,  the  aggregate  reductions  to each of the  Conversion
Percentages  for failure to have the Common Stock  listed on Nasdaq,  the Nasdaq
Small Cap Market, the NYSE or AMEX cannot exceed 10%.

         The  Conversion  Price is  adjusted  if there is a stock  split,  stock
dividend,  combination,  reclassification  or similar  event with respect to the
Common Stock,  if certain  distributions  with respect to shares of Common Stock
are made, if certain purchase rights are distributed and in the event of certain
mergers, certain consolidations, sale or transfer of all or substantially all of
the Company's assets and certain share exchanges.

         If a Holder  tenders his or her shares of Series K Stock for conversion
and does not receive certificates for all of the shares of Common Stock to which
such Holder is entitled (except in certain  specified  circumstances),  then the
Fixed Conversion Price is thereafter reduced to the lesser of (1) the then Fixed
Conversion Price (prior to the adjustment required by this sentence) and (2) the
lowest  Conversion Price in effect during the period beginning on the conversion
date and  ending on the date the  shares of Common  Stock are  delivered  to the
Holder. If the Company states that it will not deliver freely tradable shares of
Common Stock on  conversion  of the Series K Stock (other than in  circumstances
permitted by the Registration  Rights  Agreement),  then the Conversion Price is
thereafter  reduced to the lowest  Conversion Price in effect at any time during
the period  beginning  on the date of the default  occurs and ending on the date
such default is cured. In addition,  certain  conversion default payments accrue
under Article VI of the Series K Certificate.

         Subject to the  provisions  regarding  the Cap Amount and provided that
all shares of Common Stock issuable on conversion of all  outstanding  shares of
Series K Stock are authorized  and reserved for issuance,  registered for resale
under the Securities  Act of 1933, as amended,  and are eligible to be traded on
the Nasdaq,  the NYSE or the AMEX,  each share of Series K Stock  outstanding on
the fourth anniversary of the First Closing Date is automatically converted into
Common Stock.

         The  Series K Stock has a  liquidation  preference  of $1,000 per share
plus the accrued  "Premium." The Premium is 7% multiplied $1,000 multiplied by a
fraction  (1) the  numerator  is the number of days a share of Series K Stock is
outstanding  and (2) the  denominator of which is 365. The Premium is payable at
the time of conversion or redemption in cash or shares of Common Stock.

         The  Series K  Certificate  provides  that in no event  shall the total
number of shares of Common  Stock issued upon  conversion  of the Series K Stock
exceed the maximum  number of shares of Common  Stock that the Company may issue
pursuant to Rule 4460(i) of the Nasdaq or any successor rule ("Cap Amount"). The
Cap Amount is  allocated  pro rata  among the  Holders.  The  Company is seeking
approval  from the holders of Common  Stock to issue  shares of Common  Stock in
connection  with the Series K Stock and the  Warrants  in excess of the  amounts
permitted by Nasdaq Rule 4460(i)(1)(D).

         The  exercise  price of the Investor  Warrants  and the Agent  Warrants
(collectively,  "Warrants") is adjusted in the event the Company issues,  grants
or  sells  any  warrants,   rights  or  options   (whether  or  not  immediately
exercisable) to purchase Common Stock or securities that are convertible into or
exchangeable  for  Common  Stock at a price  per  share  that is not  based on a
percentage of the market price of the Common Stock  ("Fixed  Price") or that may
be converted  into or  exchanged  for Common Stock at a Fixed Price that is less
than the then exercise price of such Warrants. In such event, the exercise price
of the Warrants is reduced to such Fixed Price and the number of shares issuable
on exercise  of the  Warrants is adjusted so that it equals the number of shares
issuable under the Warrants  immediately  prior to the adjustment  multiplied by
the per share  exercise  price prior to the  adjustment  divided by the exercise
price after the adjustment.

         In  the  event  of  stock  split,  stock  dividend,   recapitalization,
reorganization,  reclassification  or other subdivision of the Common Stock, the
exercise price of the Warrants and the number of shares of Common Stock issuable
on exercise of the Warrants are proportionately  adjusted. The exercise price of
the Warrants and the number of shares  issuable on exercise are also adjusted in
the event of certain  mergers  and  consolidations,  in the event of any sale or
conveyance of all or substantially  all of the Company's assets, in the event of
certain  distributions  of its assets and in the event the  Company  distributes
certain purchase rights.

         Dividends.  The Series K Stock does not bear  dividends and there is no
provision for a sinking fund; accordingly, there are no provisions in the Series
K Certificate  restricting  repurchase or redemption of the Series K Stock while
there is a dividend or sinking fund arrearage.  However,  the Premium accrues as
noted above.

         Ranking.  Shares of Series K Stock rank  prior to the Common  Stock and
any class or series of capital  stock created after the creation of the Series K
Stock  (unless  consent of the  Holders is  obtained  as  described  below under
"Voting Rights") and ranks pari passu with any class or series created after the
creation of the Series K Stock that specifically states that it ranks pari passu
with the Series K Stock and where the Holders have approved the issuance of such
securities as described  below under  "Voting  Rights." The Series K Stock ranks
junior to the Series A Stock, and Series F-1, F-2, F-3 and F-4 Stock.

         Voting Rights. The Series K Stock generally has no voting rights except
as otherwise  provided by the Delaware  General  Corporation Law.  However,  the
approval of the holders of a majority of the then outstanding shares of Series K
Stock is required to: (1) alter or change the rights,  preferences or privileges
of the Series K Stock, (2) alter or change the rights, preferences or privileges
of any  capital  stock of the  Company  so as to  adversely  affect the Series K
Stock,  (3) create any new class or series of capital  stock ranking prior to or
pari passu with the Series K Stock, (4) increase the authorized number of shares
of Series K Stock, (5) issue any shares of Series K Stock other than pursuant to
the  Securities  Purchase  Agreement,  (6)  issue any  additional  shares of any
securities ranking senior to the Series K Stock or (7) redeem, or declare or pay
a cash dividend or distribution on, any securities junior to the Series K Stock.

         In the  event the  Holders  approve a change  described  in clause  (1)
above, a dissenting  Holder has the right for a period of 30 days to convert its
shares of Series K Stock  pursuant to the terms of the Series K  Certificate  as
they existed prior to the change.

         Except in the event of a required conversion at maturity,  no Holder is
entitled to receive  shares of Common Stock on  conversion of its Series K Stock
to the  extent  that the sum of (1) the  shares  of Common  Stock  owned by such
Holder  and its  affiliates  and (2) the  shares of  Common  Stock  issuable  on
conversion  of the Series K Stock would result in  beneficial  ownership by such
Holder and its affiliates of more than 4.9% of the outstanding  shares of Common
Stock.  Beneficial  ownership for this purpose is determined in accordance  with
Section 13(d) of the Exchange Act. This restriction cannot be amended or deleted
unless the  holders of a majority of the Common  Stock and each Holder  approves
such amendment or deletion.

         Redemption  Rights.  In the event the unissued  portion of any Holder's
Cap  Amount  is less than 135% of the  number  of  shares of Common  Stock  then
issuable upon  conversion of such Holder's  Series K Stock and the Company fails
to eliminate  the  prohibitions  that have  resulted in the existence of the Cap
Amount within 90 days, then each Holder may (1) require (with the consent of the
holders  of 50% of the  outstanding  shares of Series K Stock)  the  Company  to
terminate  the  listing  of the  Common  Stock on Nasdaq and to cause the Common
Stock to be  eligible  for  trading  on the  Nasdaq  Small Cap  Market or on the
over-the-counter  electronic  bulletin  board,  at the option of the  requesting
Holder,  or (2) require the Company to issue Common Stock at a Conversion  Price
equal to the average of the closing prices of the Common Stock on the five prior
trading  days.  In addition,  the Holder has the right to require the Company to
redeem for cash at an amount equal to the  "Redemption  Amount" a portion of the
Holder's  Series K Stock such that,  after giving effect to such  purchase,  the
then  unissued  portion of the  Holder's  Cap Amount  exceeds  135% of the total
number of shares of Common  Stock then  issuable on  conversion  of its Series K
Stock. The Redemption  Amount per share of Series K Stock equals (1) $1,000 plus
the accrued  Premium plus all  conversion  default  payments  required under the
Series K Certificate,  multiplied by (2) the highest closing price of the Common
Stock  during  the period  beginning  on the date of the  redemption  notice and
ending on the date of redemption,  divided by (3) the Conversion Price in effect
on the date of the  redemption  notice.  The parties  entered  into an agreement
whereby  the  Holder  agreed  not to  exercise  a right  of  redemption  in such
circumstance  so long as (i) the  Company has not,  at any time,  decreased  the
Reserve Amount below 12,500,000  shares of Common Stock;  (ii) the Company shall
have taken immediate  action following the trigger date to increase the Reserved
Amount  to 200% of the  number of shares of  Common  Stock  then  issuable  upon
conversion of the outstanding  Preferred Stock; and (iii) the Company  continues
to use its good faith best efforts to increase  the  Reserved  Amount to 200% of
the  number of shares of Common  Stock  then  issuable  upon  conversion  of the
outstanding  Preferred Stock. The parties agreed that the Company will be deemed
to have used "its good faith best  efforts" to increase the  Reserved  Amount so
long as it solicits shareholder approval to authorize the issuance of additional
shares of Common  Stock no less than three (3) times during each 12 month period
following the trigger date.

         A Holder also has the right to require the Company to redeem its Series
K Stock at the  Redemption  Amount (1) if the Company  fails to issue  shares of
Common Stock on conversion of the Series K Stock other than in certain specified
circumstances,  (2) the  registration  statement  required to be filed under the
Registration  Rights  Agreement is not declared  effective by the SEC by January
31, 1998 or cannot be utilized by the Holders for an  aggregate  of more than 30
days after June 30, 1998, (3) the Company fails to remove any restrictive legend
on shares of  Common  Stock  issued on  conversion  of the  Series K Stock  when
required by the Securities  Purchase Agreement or Registration Rights Agreement,
(4) the Company  states that it will not issue shares of Common Stock to Holders
in  accordance  with  the  terms  of the  Series K  Certificate  (other  than in
circumstances where other remedies are provided in the Series K Certificate), or
(5) the  Company  shall (a) sell all or  substantially  all of its  assets,  (b)
merger or consolidate with another entity, or (c) have 50% or more of the voting
power of its capital stock owned  beneficially by any one person or group within
the meaning of Section  13(d) of the  Exchange  Act.  The holders  agreed not to
excerise a right of redemption if the Common Stock is suspended  from trading on
any of, or is not listed on at least one of, the New York  Stock  Exchange,  the
American  Stock  Exchange,  the Nasdaq  National  Market or the Nasdaq Small Cap
Market for an aggregate of 10 trading days in any nine month period, and in such
circumstance  the  stockholders  would be  entitled  to receive  within five (5)
business days of the occurrence of a redemption event, as liquidated  damages an
amount equal to 25% of the aggregate face amount of the shares of Series K Stock
then held by each  stockholder.  The  liquidated  damages  are  payable,  at the
Company's  option,  in cash or shares of Common  Stock,  such stock based upon a
price per share  equal to 50% of the lowest  closing  price of the Common  Stock
during the 10 consecutive  trading day period immediately  preceding the date of
such  redemption  event.  Additionally,  the Company has agreed to keep reserved
3,000,000  shares of Common Stock to satisfy its obligation  with respect to the
liquidated damages. In the event that the number of shares required to be issued
by the  Company  with  respect  to the  amount  of  liquidated  damages  exceeds
3,000,000  shares of Common  Stock,  and the Company  does not have a sufficient
number of shares of Common  Stock  authorized  and  available  for  issuance  to
satisfy its obligation with respect to the liquidated damages, the Company shall
issue and deliver to the  stockholders  all 3,000,000  shares of Common Stock so
reserved for that purpose and, upon such issuance,  the stockholders  shall have
no right of redemption  upon a Redemption  Event as specified in the Certificate
of  Designation  to the Series K Stock,  but shall retain all other  remedies to
which they may be entitled at law or in equity which  remedies shall not include
the right of redemption. The stockholders also agreed not to exercise a right of
redemption if the  registration  statement  required to be filed by the Company,
pursuant to a registration  rights  agreement  entered into between the parties,
has not been  declared  effective  by January  31,  1998,  or such  registration
statement, after being declared effective,  cannot be utilized by the holders of
the Series K Preferred Stock for the resale of their securities for an aggregate
of more than 30 days after June 30, 1998,  however, in any such events and while
any of such events  continues,  the Company agrees to provide that the permanent
reductions to the conversion  percentages set forth in the  registration  rights
agreement shall accrue at the rate of two hundreds (.02) per week instead of two
hundreds  (.02) per month.  The  stockholders  further  agreed not to exercise a
right of  redemption  upon an event  where  the  Company  has 50% or more of the
voting power of its capital stock owned  beneficially  by one person,  entity or
group (as such term is used under Section 13(d) of the  Securities  Exchange Act
of 1934, as amended),  so long as the Company has not approved,  recommended  or
otherwise consented to the transaction which triggered that event. . The parties
have agreed that all subsequent  holders of the Series K Stock shall be bound by
the  terms  of  the  amendment,   and  the  parties  shall  be  responsible  for
communicating the terms of the amendment to any such subsequent holders.

         In the event the  Company  fails to perform its  obligations  under the
agreements between the parties and fail to pay any Holder its Redemption Amount,
then (1) the Holder is  entitled  to  interest on such amount at the rate of 24%
per annum until such Holder's Series K Stock is redeemed and (2) such Holder has
the right to require the Company to convert the  Redemption  Amount plus accrued
interest  into shares of Common Stock at the lowest  Conversion  Price in effect
during the period  beginning  on the date the Holder  submitted  its  redemption
notice and ending on the date of conversion.

         The  Company has the right to redeem all (but not less than all) of the
outstanding  Series K Stock  (other  than shares that are subject to a notice of
conversion) at any time when it is not in material  violation of its obligations
under  the  Series K  Certificate,  the  Securities  Purchase  Agreement  or the
Registration  Rights Agreement at the "Optional  Redemption Amount." The Company
can only exercise this right once. The Optional  Redemption  Amount per share of
Series K Stock is the  greater of (1) the sum of the face  amount,  the  accrued
Premium  and  all  conversion  default  payments  accrued  through  the  date of
redemption and (2) (a) the sum of $1,000, the accrued Premium and all conversion
default payments required under the Series K Certificate,  multiplied by (b) the
volume  weighted  average  sales  price of the Common  Stock on the  trading day
immediately  preceeding  the  optional  redemption  notice,  divided  by (c) the
Conversion Price in effect on the date of the optional redemption notice. In the
event the Company fails to pay any Holder its Optional  Redemption Amount,  then
(1) the Holder is  entitled  to  interest  on such amount at the rate of 24% per
annum  until  the  later  of the date  such  Holder's  Series K Stock  was to be
redeemed or until the Company  notifies  the Holder that it will not redeem such
Holder's Series K Stock and (2) such Holder has the right to require the Company
to  convert  such  Holder's  Series K Stock into  shares of Common  Stock at the
lowest  Conversion  Price in effect during the period  beginning on the date the
Company  elected  to redeem  such  shares and  ending on the 20th  trading  date
following the date such Series K Stock was to be redeemed.


         On July 28, 1997, the Company issued 3,300 units  ("Units")  consisting
of (1) one share of Series K Stock and (2)  warrants  to  purchase  75 shares of
Common  Stock at an  exercise  price of $2.40 per share  ("Investor  Warrants").
Accordingly, on July 28, 1997, the Company issued 3,300 shares of Series K Stock
and Investor Warrants to purchase 247,500 shares of Common Stock. As a result of
the  issuance  of 3,300  Units,  the  Company  issued to The  Zanett  Securities
Corporation  ("Zanett")Zanett,  for its services as placement agent, warrants to
purchase 162,462 shares of Common Stock at an exercise price of $1.625 per share
("Agent Warrants").  The Investor Warrants and the Agent Warrants expire on July
27, 2002. The terms of the Series K Stock,  the Investor  Warrants and the Agent
Warrants were determined by the Board.

         Pursuant to the terms of the Securities  Purchase Agreement dated as of
July 28,  1997  ("Securities  Purchase  Agreement")  among the  Company  and the
purchasers of the Units ("Purchasers")Purchasers, the Purchasers are required to
purchase 3,000  additional  Units if the Company  achieves  certain  performance
milestones  and  satisfies  certain other  conditions  (one of which is that the
Common Stock remain listed on the Nasdaq  National  Market),  and the Purchasers
have the option to purchase an  additional  4,700 Units by February 15, 1998, at
two additional closings. Under the Placement Agency Agreement dated July 2, 1997
between the Company and Zanett,  the Company is  obligated  to issue  additional
Agent Warrants to Zanett to purchase such number of shares of Common Stock as is
equal to 8% of the quotient obtained by dividing the aggregate purchase price of
the shares of Series K Stock and Investor  Warrants  issued to the Purchasers at
such  additional  closings  divided by the initial  exercise  price of the Agent
Warrants ($1.625 per share).

         The net proceeds of the 3,300 Units ($2.9  million) have been,  and the
net  proceeds  of any  additional  issuance  of Units will be,  used for working
capital and general corporate purposes.

         Under the Registration Rights Agreement dated as of July 28, 1997 among
the Company, the Purchasers and Zanett  ("Registration  Rights Agreement"),  the
Company has granted each Purchaser and Zanett registration  rights,  whereby the
Company is obligated to file a  registration  statement  with the SEC as soon as
practicable  after  each  closing,  but in no  event  later  than  the  60th day
following  each such closing,  registering at least 135% of the shares of Common
Stock  issuable on conversion of, and as dividends on, the Series K Stock and on
exercise of the Investor  Warrants  and the Agent  Warrants.  This  registration
statement has been filed with, but has not been declared  effective by, the SEC.
Until such time as such  registration  statements are declared  effective by the
SEC, the holders of the Series K Stock  ("Holders") and the holders the Investor
Warrants and the Agent  Warrants may not transfer such  securities or the Common
Stock issuable in connection therewith unless they comply with an exemption from
such registration requirements.

         Conversion  Rights.  Each share of Series K Stock is convertible at the
option of the Holder  into the number of shares of Common  Stock  determined  by
dividing the initial  purchase price of $1,000 by the "Conversion  Price," which
is the lesser of (a) the Fixed  Conversion  Price (which initially is $2.00) and
(b) the lowest closing sale price for the Common Stock on any single trading day
during the ten trading days immediately  preceding the conversion  multiplied by
the "Conversion  Percentage."  The "Conversion  Percentage" is (a) 105% prior to
the 61st day following July 28, 1997 (the "First Closing Date"), (b) 96% for the
period  between the 61st and the 90th day following the First Closing Date,  (c)
85% for the  period  between  the 91st and the  180th  day  following  the First
Closing Date, and (d) 81% for the period after the 180th day following the First
Closing Date. In the event the  Company's  Common Stock is no longer  designated
for quotation on the Nasdaq  National  Market  ("Nasdaq")  and is designated for
quotation on the Nasdaq Small Cap Market, the Conversion  Percentage for each of
the periods set forth above is permanently reduced by 2%.

         Under  the  requirements  of a newly  issued  SEC staff  position,  the
carrying  value  of the  Series  K  Stock  was  increased  by  $774,000,  or the
corresponding amount allocated to beneficial conversion feature described below.
The Company also recorded a related $774,000  non-cash charge to preferred stock
dividends.  In addition,  as required under the newly issued SEC staff position,
the Company would record similar  non-cash  charges to preferred stock dividends
for all future offerings with below market conversion features.

         If  (1) a  registration  statement  described  above  is  not  declared
effective by the SEC by the 150th day  following  the date it was required to be
filed under the Registration  Rights Agreement  ("Registration  Deadline"),  (2)
after the registration  statement is declared effective by the SEC, sales of the
shares of Common Stock  registered  thereunder  cannot be made or (3) the Common
Stock is not listed or included for  quotation  on Nasdaq,  the Nasdaq Small Cap
Market,  the New York Stock  Exchange  ("NYSE") or the American  Stock  Exchange
("AMEX"),  then each of the Conversion  Percentages are permanently reduced. The
Conversion Percentages are permanently reduced by an amount equal to the product
of (i) 2% and (ii) the sum of (a) the  number of months  (prorated  for  partial
months) after the  Registration  Deadline and prior to the date the registration
statement  is  declared  effective  by the  SEC and (b)  the  number  of  months
(prorated for partial months) that sales cannot be made pursuant to an effective
registration  statement  or the  Common  Stock is not  listed  or  included  for
quotation on Nasdaq,  the Nasdaq Small Cap Market,  the NYSE or the AMEX.  There
are certain  exceptions to this provision set forth in the  Registration  Rights
Agreement.  In addition,  the  aggregate  reductions  to each of the  Conversion
Percentages  for failure to have the Common Stock  listed on Nasdaq,  the Nasdaq
Small Cap Market, the NYSE or AMEX cannot exceed 10%.

         The  Conversion  Price is  adjusted  if there is a stock  split,  stock
dividend,  combination,  reclassification  or similar  event with respect to the
Common Stock,  if certain  distributions  with respect to shares of Common Stock
are made, if certain purchase rights are distributed and in the event of certain
mergers, certain consolidations, sale or transfer of all or substantially all of
the Company's assets and certain share exchanges.

         If a Holder  tenders his or her shares of Series K Stock for conversion
and does not receive certificates for all of the shares of Common Stock to which
such Holder is entitled (except in certain  specified  circumstances),  then the
Fixed Conversion Price is thereafter reduced to the lesser of (1) the then Fixed
Conversion Price (prior to the adjustment required by this sentence) and (2) the
lowest  Conversion Price in effect during the period beginning on the conversion
date and  ending on the date the  shares of Common  Stock are  delivered  to the
Holder.  If the Company states that it will not deliver freely  tradeable shares
of Common Stock on conversion of the Series K Stock (other than in circumstances
permitted by the Registration  Rights  Agreement),  then the Conversion Price is
thereafter  reduced to the lowest  Conversion Price in effect at any time during
the period  beginning  on the date of the default  occurs and ending on the date
such default is cured. In addition,  certain  conversion default payments accrue
under Article VI of the Series K Certificate.

         Subject to the  provisions  regarding  the Cap Amount and provided that
all shares of Common Stock issuable on conversion of all  outstanding  shares of
Series K Stock are authorized  and reserved for issuance,  registered for resale
under the Securities  Act of 1933, as amended,  and are eligible to be traded on
the Nasdaq,  the NYSE or the AMEX,  each share of Series K Stock  outstanding on
the fourth anniversary of the First Closing Date is automatically converted into
Common Stock.

         The  Series K Stock has a  liquidation  preference  of $1,000 per share
plus the accrued  "Premium." The Premium is 7% multiplied $1,000 multiplied by a
fraction  (1) the  numerator  is the number of days a share of Series K Stock is
outstanding  and (2) the  denominator of which is 365. The Premium is payable at
the time of conversion or redemption in cash or shares of Common Stock.

         The  Series K  Certificate  provides  that in no event  shall the total
number of shares of Common  Stock issued upon  conversion  of the Series K Stock
exceed the maximum  number of shares of Common  Stock that the Company may issue
pursuant to Rule 4460(i) of the Nasdaq or any successor rule ("Cap Amount"). The
Cap Amount is  allocated  pro rata among the  Holders.  The Company has obtained
approval  from the holders of Common  Stock to issue  shares of Common  Stock in
connection  with the Series K Stock and the  Warrants  in excess of the  amounts
permitted by Nasdaq Rule 4460(i)(1)(D).

         The  exercise  price of the Investor  Warrants  and the Agent  Warrants
(collectively,  "Warrants") is adjusted in the event the Company issues,  grants
or  sells  any  warrants,   rights  or  options   (whether  or  not  immediately
exercisable) to purchase Common Stock or securities that are convertible into or
exchangeable  for  Common  Stock at a price  per  share  that is not  based on a
percentage of the market price of the Common Stock  ("Fixed  Price") or that may
be converted  into or  exchanged  for Common Stock at a Fixed Price that is less
than the then exercise price of such Warrants. In such event, the exercise price
of the Warrants is reduced to such Fixed Price and the number of shares issuable
on exercise  of the  Warrants is adjusted so that it equals the number of shares
issuable under the Warrants  immediately  prior to the adjustment  multiplied by
the per share  exercise  price prior to the  adjustment  divided by the exercise
price after the adjustment.

         In  the  event  of  stock  split,  stock  dividend,   recapitalization,
reorganization,  reclassification  or other subdivision of the Common Stock, the
exercise price of the Warrants and the number of shares of Common Stock issuable
on exercise of the Warrants are proportionately  adjusted. The exercise price of
the Warrants and the number of shares  issuable on exercise are also adjusted in
the event of certain  mergers  and  consolidations,  in the event of any sale or
conveyance of all or substantially  all of the Company's assets, in the event of
certain  distributions  of its assets and in the event the  Company  distributes
certain purchase rights.

         Dividends.  The Series K Stock does not bear  dividends and there is no
provision for a sinking fund; accordingly, there are no provisions in the Series
K Certificate  restricting  repurchase or redemption of the Series K Stock while
there is a dividend or sinking fund arrearage.  However,  the Premium accrues as
noted above.

         Ranking.  Shares of Series K Stock rank  prior to the Common  Stock and
any class or series of capital  stock created after the creation of the Series K
Stock  (unless  consent of the  Holders is  obtained  as  described  below under
"Voting Rights") and ranks pari passu with any class or series created after the
creation of the Series K Stock that specifically states that it ranks pari passu
with the Series K Stock and where the Holders have approved the issuance of such
securities as described  below under  "Voting  Rights." The Series K Stock ranks
junior to the Series A Stock,  and the Series F-1,  F-2, F-3 and F-4 Stock.  and
Series H Stock.

         Voting Rights. The Series K Stock generally has no voting rights except
as otherwise  provided by the Delaware  General  Corporation Law.  However,  the
approval of the holders of a majority of the then outstanding shares of Series K
Stock is required to: (1) alter or change the rights,  preferences or privileges
of the Series K Stock, (2) alter or change the rights, preferences or privileges
of any  capital  stock of the  Company  so as to  adversely  affect the Series K
Stock,  (3) create any new class or series of capital  stock ranking prior to or
pari passu with the Series K Stock, (4) increase the authorized number of shares
of Series K Stock, (5) issue any shares of Series K Stock other than pursuant to
the  Securities  Purchase  Agreement,  (6)  issue any  additional  shares of any
securities ranking senior to the Series K Stock or (7) redeem, or declare or pay
a cash dividend or distribution on, any securities junior to the Series K Stock.

         In the  event the  Holders  approve a change  described  in clause  (1)
above, a dissenting  Holder has the right for a period of 30 days to convert its
shares of Series K Stock  pursuant to the terms of the Series K  Certificate  as
they existed prior to the change.

         Except in the event of a required conversion at maturity,  no Holder is
entitled to receive  shares of Common Stock on  conversion of its Series K Stock
to the  extent  that the sum of (1) the  shares  of Common  Stock  owned by such
Holder  and its  affiliates  and (2) the  shares of  Common  Stock  issuable  on
conversion  of the Series K Stock would result in  beneficial  ownership by such
Holder and its affiliates of more than 4.9% of the outstanding  shares of Common
Stock.  Beneficial  ownership for this purpose is determined in accordance  with
Section 13(d) of the Exchange Act. This restriction cannot be amended or deleted
unless the  holders of a majority of the Common  Stock and each Holder  approves
such amendment or deletion.

         Redemption  Rights.  In the event the unissued  portion of any Holder's
Cap  Amount  is less than 135% of the  number  of  shares of Common  Stock  then
issuable upon  conversion of such Holder's  Series K Stock and the Company fails
to eliminate  the  prohibitions  that have  resulted in the existence of the Cap
Amount within 90 days, then each Holder may (1) require (with the consent of the
holders  of 50% of the  outstanding  shares of Series K Stock)  the  Company  to
terminate  the  listing  of the  Common  Stock on Nasdaq and to cause the Common
Stock to be  eligible  for  trading  on the  Nasdaq  Small Cap  Market or on the
over-the-counter  electronic  bulletin  board,  at the option of the  requesting
Holder,  or (2) require the Company to issue Common Stock at a Conversion  Price
equal to the average of the closing prices of the Common Stock on the five prior
trading  days.  In addition,  the Holder has the right to require the Company to
redeem for cash at an amount equal to the  "Redemption  Amount" a portion of the
Holder's  Series K Stock such that,  after giving effect to such  purchase,  the
then  unissued  portion of the  Holder's  Cap Amount  exceeds  135% of the total
number of shares of Common  Stock then  issuable on  conversion  of its Series K
Stock. The Redemption  Amount per share of Series K Stock equals (1) $1,000 plus
the accrued  Premium plus all  conversion  default  payments  required under the
Series K Certificate,  multiplied by (2) the highest closing price of the Common
Stock  during  the period  beginning  on the date of the  redemption  notice and
ending on the date of redemption,  divided by (3) the Conversion Price in effect
on the date of the  redemption  notice.  The parties  entered  into an agreement
whereby the Holder could not effect a redemption  in such  circumstance  so long
and (i) the Company has not, at any time,  decreased  the Reserved  Amount below
12,500,000  shares of Common Stock;  (ii) the Company shall have taken immediate
action following the trigger date to increase the reserved amount to 200% of the
number of shares of Common Stock then issuable upon  conversions  of outstanding
Preferred  Stock;  and (iii) the  Company  continues  to use its good faith best
efforts  to  increase  the  Reserved  Amount to 200% of the  number of shares of
Common Stock then issuable upon conversion of the outstanding  Preferred  Stock.
23451934Exchange  Act.  The parties  entered  into an  agreement  whereby if the
Common Stock is  suspended  from trading on any of, or is not listed on at least
one of, the NYSE,  the AMEX,  the  Nasdaq or the Nasdaq  Small Cap Market for an
aggregate  of ten trading  days in any nine month  period,  the Holders  will be
entitled  to  receive  liquidation  damages  in an  amount  equal  to 25% of the
aggregate Face Amount of the shares of Preferred Stock held by each Holder.  The
liquidation  damages are payable,  at the Company's option, in cash or shares of
Common  Stock , such shares at a price equal to 50% of the  then-current  market
value. Limitation of Liability
    

         Pursuant  to the  Company's  Certificate  of  Incorporation  and  under
Delaware law,  directors of the Company are not liable for monetary  damages for
breach  of their  fiduciary  duty as  directors  except  (i) for a breach of the
director's duty of loyalty to the Company or its stockholders,  (ii) for acts or
omissions  by the  director  not in good  faith  or  which  involve  intentional
misconduct  or a knowing  violation  of law,  (iii) for a willful  or  negligent
declaration  of an unlawful  dividend,  stock purchase or redemption or (iv) for
transactions from which the director derived an improper personal benefit.

Transfer Agent and Registrar

         The  Transfer  Agent and  Registrar  for the Common  Stock and Series A
Stock is American Stock Transfer & Trust Company,  40 Wall Street, New York, New
York 10005.


Anti-takeover Effects of Provisions of the Certificate of Incorporation
         and Delaware Law

   
         The following provisions of the Company's  Certificate of Incorporation
and Bylaws could discourage potential  acquisition  proposals and could delay or
prevent a change in control of the Company.  Such  provisions  also may have the
effect of preventing changes in the management of the Company. See "Risk Factors
- -Certain  Anti-takeover  Provisions of Certificate of Incorporation and Delaware
Law."
    

         Preferred Stock. The Company's Certificate of Incorporation  authorizes
20,000,000  shares of Preferred Stock with a par value of $0.0001.  The Board of
Directors is  authorized  to provide for the issuance of the shares of Preferred
Stock in series,  and by filing a certificate  pursuant to the applicable law of
the State of Delaware, to establish from time to time the number of shares to be
included in each such series, and to fix the designations,  powers,  preferences
and rights of the shares of each such series and the qualifications, limitations
or  restrictions  thereof.  In the event of a proposed  merger,  tender offer or
other  attempt to gain  control  of the  Company  of which  management  does not
approve,  it might be  possible  for the Board of  Directors  to  authorize  the
issuance of a series of preferred stock with rights and  preferences  that could
impede  the  completion  of such a  transaction.  See  "Risk  Factors  - Certain
Anti-takeover Provisions of Certificate of Incorporation and Delaware Law."

   
         Delaware  Anti-Takeover  Statute. The Company is subject to Section 203
of the Delaware General  Corporation Law, which,  subject to certain exceptions,
prohibits a Delaware  corporation from engaging in any business combination with
any interested  shareholder  for a period of three years following the date that
such shareholder  became an interested  shareholder,  unless:  (1) prior to such
date,  the board of directors of the  corporation  approved  either the business
combination  or the  transaction  that resulted in the  shareholder  becoming an
interested  shareholder;  (2) upon consummation of the transaction that resulted
in  the  shareholder   becoming  an  interested   shareholder,   the  interested
shareholder  owned  at  least  85%  of  the  voting  stock  of  the  corporation
outstanding  at the time the  transaction  commenced,  excluding for purposes of
determining the number of shares  outstanding  those shares owned (i) by persons
who are directors  and also  officers and (ii) by employee  stock plans in which
employee participants do not have the right to determine  confidentially whether
shares held subject to the plan will be tendered in a tender or exchange  offer,
or (3) on or subsequent to such date the business combination is approved by the
board  of  directors  and  authorized  at  an  annual  or  special   meeting  of
shareholders, and not by written consent, by the affirmative vote of at least 66
2/3% of the  outstanding  voting  stock  that  is not  owned  by the  interested
shareholder.
    

         Section 203 defines  business  combination  when used in reference to a
corporation  and any  interested  shareholder  to  include:  (i) any  merger  or
consolidation  of the  corporation  with the interested  shareholder or with any
other  corporation  if the merger or  consolidation  is caused by the interested
shareholder and, as a result of the  transaction,  Section 203(a) does not apply
to  the  surviving  corporation;  (ii)  any  sale,  lease,  exchange,  mortgage,
transfer,  pledge or other disposition  involving the interested  shareholder of
10% or  more  of the  assets  of  the  corporation;  (iii)  subject  to  certain
exceptions,  any  transaction  that  results in the  issuance or transfer by the
corporation of any stock of the corporation to the interested shareholder;  (iv)
any transaction  involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation owned
by the interested shareholder;  or (v) any receipt by the interested shareholder
of the benefit of any loans,  advances,  guarantees,  pledges or other financial
benefits provided by or through the corporation. In general, Section 203 defines
an interested  shareholder as any entity or person  beneficially owns, or within
three  years  did  own,  15% or  more of the  outstanding  voting  stock  of the
corporation  and  any  entity  or  person  affiliated  with  or  controlling  or
controlled by such entity or person.

                             INDEPENDENT ACCOUNTANTS

         The Board, upon the  recommendation  of the Audit Committee,  appointed
Ernst & Young  LLP,  independent  accountants,  as  auditors  of the  Company to
examine and report to stockholders on the consolidated  financial  statements of
the Company and it subsidiaries  for the year ended on December 31, 1996 and for
the year ending  December 31, 1997.  Ernst & Young LLP  currently  serves as the
Company's independent accountants.

         The Company  engaged Ernst & Young LLP on July 10, 1996 as  independent
accountants to examine the consolidated  financial statements of the Company for
the year ended December 31, 1996.  Ernst & Young LLP replaced  Price  Waterhouse
LLP.  The  Company's  decision  to  retain  Ernst & Young  LLP as the  Company's
principal  independent  accountants  and  discontinue  the  engagement  of Price
Waterhouse  LLP was  ratified,  confirmed  and approved by the  Company's  Audit
Committee at a meeting held on August 1, 1996.

         The  Company   dismissed  Price   Waterhouse  LLP  as  its  independent
accountants on July 10, 1996.  The reports of Price  Waterhouse LLP on financial
statements  for the fiscal years ended  December 31, 1995 and 1994  contained no
adverse  opinion or  disclaimer of opinion and were not qualified or modified as
to  uncertainty,  audit scope or accounting  principles.  In connection with its
audits for the fiscal years ended  December 31, 1995 and 1994,  and through July
10, 1996, there were no disagreements with Price Waterhouse LLP on any matter of
accounting principles or practices,  financial statement disclosure, or auditing
scope or procedure,  which  disagreements if not resolved to the satisfaction of
Price  Waterhouse LLP would have caused them to make reference  thereto in their
report on the financial statements for such years.

         During the fiscal  years ended  December  31, 1995 and 1994 and through
July 10, 1996,  Price  Waterhouse  LLP  communicated  certain  internal  control
matters to the Company that meet the definition of reportable events (as defined
in Regulation  S-K Item  304(a)(1)(iv)).  For the fiscal year ended December 31,
1994, such reportable  events involved  recommendations  that the Company should
ensure  compliance  with its revenue  recognition  policies  and should  further
ensure that  significant  and/or  unusual  accounting  and reporting  issues are
addressed and documented on a timely basis.


                                  LEGAL MATTERS

         The  legality of shares of Common Stock  offered  hereby will be passed
upon for the Company by Kirkpatrick & Lockhart LLP, Washington, D.C.


                                     EXPERTS

         The consolidated financial statements of Network Imaging Corporation at
December 31, 1996 and for the year then ended,  appearing in the  Prospectus and
Registration  Statement  have been  audited  by Ernst & Young  LLP,  independent
auditors as set forth in their report thereon appearing  elsewhere  herein,  and
are included in reliance  upon such reports  given the authority of such firm as
experts in accounting and auditing.

   
         The consolidated financial statements of Network Imaging Corporation at
December 31, 1995 and for each of the two years in the period ended December 31,
1995 included in this Prospectus have been so included in reliance on the report
of Price  Waterhouse LLP,  independent  accountantsa,  given on the authority of
saids firm as experts in auditing and accounting.
    


                             ADDITIONAL INFORMATION

         This  Prospectus  does not contain all of the  information set forth in
the Registration  Statement and the exhibits and schedules  thereto.  Statements
contained  in this  Prospectus  as to the  contents of any contract or any other
document referred to are not necessarily complete and in each instance reference
is made to the copy of such  contract or other  document  filed as an exhibit to
the Registration Statement,  each such statement being qualified in all respects
by such  reference.  Further  information  with  respect to the  Company and the
Common  Stock  offered  hereby is included or  incorporated  by reference in the
Registration Statement and exhibits.

   
         Network Imaging is subject to the informational  reporting requirements
of the Exchange Act, and in accordance therewith files reports, proxy statements
and other  information  with the SEC. Such reports,  proxy  statements and other
information  can be inspected  and copied at the public  reference  rooms of the
SEC, 450 Fifth Street,  N.W., Room 1024,  Washington,  D.C. 20549, and copies of
such materials can be obtained by mail from the Public Reference  Section of the
SEC, 450 Fifth Street,  N.W., Room 1024,  Washington,  D.C. 20549, at prescribed
rates.  In addition,  copies of such  materials are available for inspection and
reproduction  at the  public  reference  facilities  of the SEC at its New  York
regional  office,  7 World  Trade  Center,  New York,  New York 10048 and at its
Chicago regional office,  Northwestern  Atrium Center,  500 West Madison Street,
Suite 1400,  Chicago,  Illinois  60661-2511.  The SEC also  maintains a Web site
(http://www.sec.gov) that contains reports, proxy and information statements and
other information  regarding  registrants that file electronically with the SEC.
The Company's  Common Stock,  Series A Stock,  and Public Warrants are listed on
the Nasdaq National  Market.  Reports,  proxy  statements and other  information
concerning  the Company can also be  inspected at Nasdaq,  1735 K Street,  N.W.,
Washington, D.C. 20036.
    






<PAGE>
                          INDEX TO FINANCIAL STATEMENTS

                                                                       Page

Reports of Independent Accountants                                      F-2

Consolidated Balance Sheets as of December 31, 1996 and 1995            F-4

Consolidated Statements of Operations for the years ended
         December 31, 1996, 1995 and 1994                               F-5

Consolidated Statements of Changes in Stockholders' Equity
         for the years ended December 31, 1996, 1995 and 1994           F-6

Consolidated Statements of Cash Flows for the years ended
         December 31, 1996, 1995 and 1994                               F-7

Notes to Consolidated Financial Statements                              F-8


   
Consolidated Balance Sheets at September 30, 1997 (unaudited) and
         December 31, 1995                                              F-24

Consolidated Statements of Operations (unaudited) for the three
         months ended September 30, 1997 and 1996                       F-25


Consolidated Statements of Operations (unaudited) for the nine
         months ended Septmber 30, 1997 and 1996                        F-26


Consolidated Statements of Changes in Stockholders' Equity
         (unaudited) for the nine months ended September 30, 1997       F-27

Consolidated Statement of Cash Flows (unaudited) for the nine
         months ended September 30, 1997 and 1996                       F-28

Notes to Consolidated Financial Statements                              F-29
    



                                       F-1

<PAGE>






                         Report of Independent Auditors

Board of Directors
Network Imaging Corporation


We have audited the accompanying  consolidated  balance sheet of Network Imaging
Corporation  (the  "Company"),   as  of  December  31,  1996,  and  the  related
consolidated  statement of operations,  stockholders'  equity and cash flows for
the year then ended.  These financial  statements are the  responsibility of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that out audit provides a reasonable basis for our opinion.

In our opinion, the financial statement referred to above present fairly, in all
material  respects,  the  consolidated  financial  position  of Network  Imaging
Corporation  at  December  31,  1996,  and the  consolidated  results  of  their
operations and their cash flows for the year ended in conformity  with generally
accepted accounting principles.


/S/ Ernst & Young LLP
February 14, 1997
















                                       F-2
<PAGE>



                        REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and
Stockholders of Network Imaging Corporation

In our opinion,  the  accompanying  consolidated  balance  sheet and the related
consolidated statements of operations, of changes in stockholders' equity and of
cash flows present fairly, in all materials respects,  the financial position of
Network Imaging  Corporation and its  subsidiaries at December 31, 1995, and the
results  of their  operations  and their cash flows for each of the two years in
the period ended  December 31,  1995,  in  conformity  with  generally  accepted
accounting principles.  These financial statements are the responsibility of the
Company's  management;  our  responsibility  is to  express  an opinion on these
financial  statements  based on our  audits.  We  conducted  our audits of these
statements  in accordance  with  generally  accepted  auditing  standards  which
require that we plan and perform the audit to obtain reasonable  assurance about
whether the financial  statements  are free of material  misstatement.  An audit
includes  examining,  on a test  basis,  evidence  supporting  the  amounts  and
disclosures in the financial  statements,  assessing the  accounting  principles
used and  significant  estimates made by management,  and evaluating the overall
financial statement presentation.  We believe that our audits prove a reasonable
basis for the opinion expressed above.


/S/ Price Waterhouse, LLP
Washington, D.C.
March 29, 1996

















                                       F-3
<PAGE>
<TABLE>

                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
               (In thousands, except share and per share amounts)

<CAPTION>
                                                              December 31,
                                                           1996          1995
                                                         ---------    ---------
<S>                                                      <C>          <C>
                           ASSETS

Current assets:
 Cash and cash equivalents                               $   7,601    $   9,359
 Short-term investments - restricted                          --          3,052
 Accounts and notes receivable, net                         13,243       16,300
 Inventories                                                 1,503        3,464
 Prepaid expenses and other                                  2,362        3,543
                                                         ---------    ---------
   Total current assets                                     24,709       35,718
Fixed assets, net                                            2,887        3,769
Long-term notes receivable, net                              1,979        1,215
Software development costs and
 purchased technology, net                                   3,813        4,630
Goodwill, net                                                3,237        4,468
Other assets                                                   153          164
                                                         ---------    ---------
   Total assets                                          $  36,778    $  49,964
                                                         =========    =========


                  LIABILITIES & STOCKHOLDERS' EQUITY

Current liabilities:
 Current debt maturities and
  obligations under capital leases                       $   2,063    $   5,365
 Accounts payable                                            3,185        6,201
 Accrued compensation and related
  expenses                                                   1,891        2,638
 Deferred revenue                                            3,789        4,408
 Other accrued expenses                                      3,888        3,652
                                                         ---------    ---------
   Total current liabilities                                14,816       22,264
Long-term debt and obligations
 under capital leases                                           88        1,264
Deferred income taxes                                          300          773
                                                         ---------    ---------
   Total liabilities                                        15,204       24,301
Commitments
Redeemable Series F preferred
 stock, 1,792,186 shares issued
 and outstanding                                             9,857       15,478
Stockholders' equity:
 Preferred stock, $.0001 par
  value, 20,000,000 shares
  authorized; 1,605,675 and
  1,605,228 shares issued and
  outstanding
 Common stock, $.0001 par value,
  50,000,000 shares authorized;
  22,896,612 and 18,637,226
  shares issued and outstanding                                  2            2
 Additional paid-in-capital                                124,429      105,065
 Accumulated deficit                                      (113,098)     (95,757)
 Translation adjustment                                        384          875
                                                         ---------    ---------
   Total stockholders' equity                               11,717       10,185
                                                         ---------    ---------
   Total liabilities and stockholders' equity            $  36,778    $  49,964
                                                         =========    =========
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                      F-4
<PAGE>
<TABLE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                            Years ended December 31,
               (In thousands, except share and per share amounts)

<CAPTION>
                                       1996            1995            1994
                                   ------------    ------------    ------------
<S>                                <C>             <C>             <C>
 Revenue:
  Products                         $     18,336    $     47,508    $     49,867
  Services                               21,141          21,643          17,161
                                   ------------    ------------    ------------
                                         39,477          69,151          67,028
                                   ------------    ------------    ------------
Costs and expenses:
  Cost of products sold                   9,953          29,263          36,757
  Cost of services provided              14,421          13,135          11,432
  Product development                     6,500           7,058           4,666
  Selling, general and
   administrative                        24,956          35,679          36,765
  Exchange fee and gain on
   sale of asset, net                       619            --              --
  Purchased in-process
   research and development                --              --             8,821
  Settlement with stockholders             --             1,642            --
  Loss on closure and sale of
   subsidiaries, net                        921           9,274            --
  Restructuring costs                      (175)         (1,433)          1,654
  Capitalized software
   write-off                               --              --             8,743
                                   ------------    ------------    ------------
                                         57,195          94,618         108,838
                                   ------------    ------------    ------------
Loss before investment and
 interest income and income
  taxes                                 (17,718)        (25,467)        (41,810)
  Investment and interest
   income, net                              309             224             579
                                   ------------    ------------    ------------
Loss before income taxes                (17,409)        (25,243)        (41,231)
  Income tax benefit                        (68)           (280)         (1,606)
                                   ------------    ------------    ------------
Net loss                                (17,341)        (24,963)        (39,625)
                                   ------------    ------------    ------------

Preferred stock
 preferences                             (3,730)         (9,933)         (4,496)
                                   ------------    ------------    ------------
Net loss applicable to
 common shares                     $    (21,071)   $    (34,896)   $    (44,121)
                                   ============    ============    ============

Net loss per common share          $      (1.02)   $      (2.41)   $      (3.56)
                                   ============    ============    ============

Weighted average shares
 outstanding                         20,681,694      14,502,399      12,391,225
                                   ============    ============    ============
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                      F-5
<PAGE>
<TABLE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
            CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
              For the years ended December 31, 1996, 1995 and 1994
                      (In thousands, except share amounts)


<CAPTION>
                                                                                                         Additional
                                                  Preferred Stock                Common Stock              paid-in      Accumulated
                                              Shares            Amt.        Shares            Amt.         capital        Deficit
                                            -----------     -----------   -----------     -----------    -----------    -----------
<S>                                         <C>             <C>           <C>             <C>            <C>            <C>
Balance December 31, 1993                    1,400,000     $      --        10,542,105    $         1    $    74,153    $   (31,169)
Issuance of preferred stock,
 net of offering costs
 of $673                                       205,025                                                         4,453
Issuance of common stock,
net of offering costs of $39                                                 2,786,070                        19,184
Conversion of preferred stock                                                  300,000                         2,303
Accretion of preferred stock                                                                                  (1,286)
Dividends on preferred stock                                                                                  (3,210)
Translation adjustment
Net loss                                                                                                                    (39,625)
                                           -----------     -----------     -----------    -----------    -----------    -----------
Balance December 31, 1994                    1,605,025            --        13,628,175              1         95,597        (70,794)

Issuance of preferred stock,
 net of offering costs of $1,790                 2,174     $      --                                          19,949
Conversion of preferred stock                     (885)                      2,276,237
Redemption of preferred stock                   (1,086)                                                      (15,600)
Issuance of common stock, net
 of offering costs of $941                                                   2,732,814              1          9,198
Accretion of preferred stock                                                                                    (869)
Dividends on preferred stock                                                                                  (3,210)
Translation adjustment
Net loss                                                                                                                    (24,963)
                                           -----------     -----------     -----------    -----------    -----------    -----------
Balance December 31, 1995                    1,605,228            --        18,637,226              2        105,065        (95,757)
Issuance of common stock, net
 of offering costs of $376                                                   1,902,487                         6,149
Issuance of preferred stock,
 net of offering costs
 of $209                                         1,100     $      --                                          10,791
Issuance of warrants for
 line of credit                                                                                                  192
Buy-Back adjustment of
 Redeemable Series F
 preferred stock                                                                                               5,962
Conversion of preferred stock                     (653)                      2,356,899
Accretion of preferred stock                                                                                    (341)
Dividends on preferred stock                                                                                  (3,389)
Translation adjustment
Net loss                                                                                                                    (17,341)
                                           -----------     -----------     -----------    -----------    -----------    -----------
Balance December 31, 1996                    1,605,675     $      --        22,896,612    $         2    $   124,429    $  (113,098)
                                           ===========     ===========     ===========    ===========    ===========    ===========




                                                    Translation
                                                    Adjustment          Total
                                                    ----------        ---------
<S>                                                 <C>               <C>
Balance December 31, 1993                            $   (191)         $ 42,794
Issuance of preferred stock,
 net of offering costs
 of $673                                                                  4,453
Issuance of common stock,
net of offering costs of $39                                             19,184
Conversion of preferred stock                                             2,303
Accretion of preferred stock                                             (1,286)
Dividends on preferred stock                                             (3,210)
Translation adjustment                                    543               543
Net loss                                                                (39,625)
                                                     --------          --------
Balance December 31, 1994                                 352            25,156

Issuance of preferred stock,
 net of offering costs of $1,790                                         19,949
Conversion of preferred stock                                             --
Redemption of preferred stock                                           (15,600)
Issuance of common stock, net
 of offering costs of $941                                                9,199
Accretion of preferred stock                                               (869)
Dividends on preferred stock                                             (3,210)
Translation adjustment                                    523               523
Net loss                                                                (24,963)
                                                     --------          --------
Balance December 31, 1995                                 875            10,185

Issuance of common stock, net
 of offering costs of $376                                                6,149
Issuance of preferred stock,
 net of offering costs
 of $209                                                                 10,791
Issuance of warrants for
 line of credit                                                             192
Buy-Back adjustment of
 Redeemable Series F
 preferred stock                                                          5,962
Conversion of preferred stock                                              --
Accretion of preferred stock                                               (341)
Dividends on preferred stock                                             (3,389)
Translation adjustment                                   (491)             (491)
Net loss                                                                (17,341)
                                                     --------          --------
Balance December 31, 1996                            $    384          $ 11,717
                                                     ========          ========
</TABLE>




   The accompanying notes are an integral part of these financial statements.

                                      F-6
<PAGE>
<TABLE>

                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                            Years Ended December 31,
                                 (In thousands)

<CAPTION>
                                               1996         1995         1994
                                             --------     --------     --------
<S>                                          <C>          <C>          <C>
Cash flows from operating
 activities:
 Net loss                                    $(17,341)    $(24,963)    $(39,625)
 Adjustments to reconcile
  net loss to net cash
  used in operating activities:
   Depreciation and amortization                5,793        6,270        6,085
   Purchased in-process
    research and development                     --           --          8,821
   Restructuring costs                           (175)      (1,433)       1,654
   Loss on closure and sale
    of subsidiaries                               921        9,274         --
   Impairment of spare parts
    inventory                                    --            276         --
   Capitalized software
    write-off                                    --           --          8,743
   Goodwill write-off                            --           --            953
   Stock Settlement                              --            787         --
   Realized gain on sale of
    short-term investments                       (108)        (151)        --
   Unrealized holding loss on
    short-term investments                       --           --            437
   Changes in assets and
    liabilities:
    Accounts and notes receivable               1,871       (1,350)      (1,174)
    Inventories                                   313          988       (2,305)
    Prepaid expenses and other                    937       (1,681)        (694)
    Accounts payable                           (3,353)        (313)       1,433
    Accrued compensation and
     related expenses                              54        2,107       (3,540)
    Deferred revenues                            (449)       1,521        2,651
    Deferred income taxes                        (246)        (331)      (1,223)
                                             --------     --------     --------
Net cash used in operating
 activities                                   (11,783)      (8,999)     (17,784)
                                             --------     --------     --------

Cash flows from investing
 activities:
 Sale (purchase) of short-term
  investments                                     111       12,731      (12,973)
 Capitalized software
  development and license costs                (1,979)      (1,784)      (6,966)
 Purchases of fixed assets                     (1,068)      (1,522)      (3,559)
 Business divestitures/
  acquisitions and related costs                  299          154       (3,640)
                                             --------     --------     --------
Net cash (used in) provided by
 investing activities                          (2,637)       9,579      (27,138)
                                             --------     --------     --------

Cash flows from financing
 activities:
 Proceeds from issuance of
  common stock, net                             6,149        8,412        3,057
 Proceeds from issuance
  preferred stock, net                         10,791       19,949        4,453
 Redemption of Series D
  preferred stock                                --        (15,600)        --
 Cash dividends paid on
  Series A preferred stock                     (3,210)      (3,210)      (2,830)
 Proceeds from borrowings
  and purchase of short-term
  investments, net                               --           (869)       3,537
 Proceeds from sale and
  leaseback of fixed assets                       196          226        2,413
 Principal payments on capital
  lease obligations                              (913)        (817)         (87)
 Principal payments on debt                      (270)      (3,382)      (1,526)
                                             --------     --------     --------
Net cash provided by
 financing activities                          12,743        4,709        9,017
                                             --------     --------     --------

Effect of exchange rate changes
 on cash and cash equivalents                     (81)          81          130
Net (decrease) increase in
 cash and cash equivalents                     (1,758)       5,370      (35,775)
Cash and cash equivalents at
 beginning of year                              9,359        3,989       39,764
                                             --------     --------     --------
Cash and cash equivalents
 at end of year                              $  7,601     $  9,359     $  3,989
                                              ========     ========     ========

Supplemental Cash Flow
 Information:
  Interest paid                              $    278     $    712     $    490
  Income taxes paid                          $    209     $    151     $    401
</TABLE>





   The accompanying notes are an integral part of these financial statements.

                                      F-7
<PAGE>



                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                        December 31, 1996, 1995 and 1994

Network Imaging Corporation  ("Network Imaging" or the "Company") is a developer
and  marketer  of content  and  storage  management  software  for  unstructured
information.  Its flagship product, the 1View suite, manages the storage, access
and  distribution  of  any  multimedia   data,  such  as  diagrams,   documents,
photographs,  voice,  and  full-motion  video.  1View is a  solution  for use in
distributed,  high transaction, high volume mission critical applications across
legacy,  client/server and Internet/intranet based environments.  The Company is
also a software  developer for mainframe and PC based  Computer  Output to Laser
Disk  ("COLD")  systems  and a  developer  and  marketer  of storage  management
software systems.

In 1996, the Company's  operations were approximately evenly divided between the
United States and Europe.  U.S.  operations  were  conducted in or near Herndon,
Virginia  (primarily  the  development  of the 1View  suite  and COLD  family of
storage  products),  Minneapolis,   Minnesota  and  Denver,  Colorado.  European
operations were conducted near Paris,  France  (hierarchical  storage management
software and related storage products and engineering services).


NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

         Principles of consolidation --

The consolidated  financial  statements  include the accounts of Network Imaging
Corporation and its subsidiaries.  All significant intercompany transactions and
balances have been eliminated.

         Cash equivalents and short-term investments --

The Company  considers  all highly  liquid debt  instruments  purchased  with an
original  maturity of three months or less to be cash  equivalents.  At December
31, 1995,  restricted  short-term  investments are categorized as "available for
sale"  securities whose carrying amount  approximates  fair value because of the
short-term maturity of the investments.

         Revenue recognition --

The Company  recognizes  software revenue in accordance with the AICPA Statement
of Position  91-1,  "Software  Revenue  Recognition".  Revenue from hardware and
software sales related to the Company's  1View(TM) and COLD software products is
recognized when the product is delivered to the customer.  The Company  accounts
for insignificant  vendor  obligations and post-contract  support at the time of
product delivery by accruing such costs at the time of sale.

Revenue  from  hardware  and  software  contracts  with  significant  completion
services involving  technically  difficult issues for the attainment of customer
acceptance is  recognized  upon customer  acceptance.  Revenue from  maintenance
contracts is recognized ratably over the terms of the contracts.

                                       F-8
<PAGE>

For  labor  intensive   contracts  which  require   significant   production  or
customization,  the Company  accounts for such revenue in accordance  with AICPA
Statement of Position 81-1, "Accounting for Performance of Construction-type and
Certain  Production-type  Contracts," using the percentage of completion method.
Losses, if any, are recognized in the period that such losses are determined.

         Inventories --

Inventories  are  stated  at the  lower of  cost,  determined  on the  first-in,
first-out method, or market.

         Fixed assets --

Fixed assets are stated at cost, net of accumulated  depreciation.  Depreciation
is computed using  straight-line  and  accelerated  methods over the life of the
related asset,  generally three years. Leasehold improvements are amortized over
the shorter of the estimated useful life of the improvements or the terms of the
related lease.

         Software development and license costs --

The Company  capitalizes  certain software  development costs in accordance with
Statement of Financial Accounting Standards No. 86, "Accounting for the Costs of
Computer  Software to Be Sold,  Leased or Otherwise  Marketed," ("SFAS 86"). The
Company  capitalizes  certain acquired  software licenses (see Note 5) which are
incorporated into the Company's products.  Amortization of software  development
and license costs is provided on an individual  product basis over the estimated
life of the  products of three years  beginning  when the related  products  are
available for general release. Costs for research and development incurred prior
to establishing  technological  feasibility of software products, or after their
commercial   release,   are  expensed  in  the  period  incurred.   The  Company
periodically   assesses   capitalized  software  amounts  and,  when  less  than
anticipated net realizable value, charges any such excess to expense.

         Goodwill --

The excess of the  purchase  price  over the fair value of the net  identifiable
tangible and intangible  assets of businesses  acquired is being  amortized on a
straight-line basis over seven to ten years.  Amortization expense in 1996, 1995
and  1994  was $1.1  million,  $1.3  million  and  $1.2  million,  respectively.
Accumulated  amortization  as of December 31, 1996 and 1995 was $3.1 million and
$1.9 million, respectively. In accordance with Statement of Financial Accounting
Standards No. 121, the Company routinely evaluates recoverability of goodwill by
comparing future  undiscounted cash flows to the recorded carrying value. During
1994,  the Company  determined  that  goodwill  from  certain  acquisitions  was
impaired and accordingly expensed $953,000.

         Product warranty --

Warranties  for  hardware  sold by the  Company  are  generally  provided by the
manufacturer.  The Company provides warranties and service contracts for certain
products and accrues related expenses based on actual claims history.



                                       F-9
<PAGE>

         Income taxes --

The  Company's  income  taxes are  presented  in  accordance  with  Statement of
Financial  Accounting  Standards No. 109,  "Accounting  for Income Taxes" ("SFAS
109") which requires  recognition of deferred tax liabilities and assets for the
expected  future  tax  consequences  of events  that have been  included  in the
financial  statements or tax returns.  Under SFAS 109,  deferred tax liabilities
and  assets  are  determined  based  on the  difference  between  the  financial
statement  and tax basis of assets and  liabilities,  using enacted tax rates in
effect for the year in which the differences are expected to reverse.

         Foreign currency translation --


   
The  functional  currency of the Company's  foreign  operation is the applicable
local  currency.  Consequently,  for the  operation  outside the United  States,
assets and  liabilities are translated into United States dollars using exchange
rates in effect at the balance  sheet date and revenues  and expenses  using the
average  exchange rate during the period.  The gains and losses  resulting  from
such translations are included as a component of stockholders' equity. Since the
Company's French subsidiary operates almost entirely within France,  exposure to
foreign exchange risk is limited.
    


         Net loss per common share --

Net loss  applicable  to  common  shares  includes  adjustments  for  dividends,
accretion and redemption  amounts related to the Company's  preferred stock. Net
loss per common share is computed  using the weighted  average  number of common
shares and common share equivalents, unless antidilutive, outstanding during the
year.

         Use of estimates--

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.
         Stock Based Compensation --

Effective January 1, 1996, the Company adopted Statement of Financial Accounting
Standards No. 123, "Accounting for Stock-Based Compensation" ("SFAS 123"), which
allows companies which have stock-based compensation arrangements with employees
to adopt a new fair-value basis of accounting for stock options and other equity
instruments,  or to  continue  to apply  the  existing  accounting  rules  under
Accounting  Principles  Board  Opinion No. 25,  "Accounting  for Stock Issued to
Employees"  but  with  additional  disclosure.   The  Company  has  adopted  the
disclosure provisions of SFAS 123 and therefore, the effect of adopting SFAS 123
did not have impact on its  financial  position,  results of  operations or cash
flows as of, or for the year ended, December 31, 1996 (see Note 9).


                                      F-10
<PAGE>

         Reclassifications --

Certain  reclassifications have been made to the prior year financial statements
in order to conform to the current year presentation.

NOTE 2 - SHORT-TERM INVESTMENTS

Restricted short-term investments at December 31, 1995 consisted of certificates
of deposit,  which served  primarily as  collateral  for the  Company's  line of
credit that was repaid on March 31,  1996.  There was no  short-term  investment
balance at December 31, 1996.

NOTE 3 - RECEIVABLES

Receivables consist of the following:

                                                               December 31,
                                                           1996           1995
                                                             (in thousands)

Trade accounts receivable                                $  9,814      $ 11,549
Unbilled receivables                                        3,488         3,538
Notes receivable                                            2,475         2,808
Employee receivables                                          112           614
Other receivables                                             188           539
                                                         --------      --------
                                                           16,077        19,048
Allowance for uncollectible accounts receivable              (535)         (183)
Allowance for uncollectible notes receivable                 (320)       (1,350)
                                                         --------      --------
                                                           15,222        17,515

   
Less: Current receivables, net                            (13,243)      (16,300)
                                                         --------      --------
Long-term receivables, net                               $  1,979      $  1,215
                                                         ========      ========
    


The  Company's  notes  receivable  balance of $2.5  million at December 31, 1996
includes $1,950,000 of notes resulting from the divestitures of previously owned
operating units (the  "Divestitures") made during 1995 and 1996 (see Note 6) and
$525,000 of notes receivable from former  stockholders of a subsidiary  acquired
in 1994.

NOTE 4 - FIXED ASSETS

Fixed assets consist of the following:

                                      F-11

                                                               December 31,
                                                           1996           1995
                                                              (in thousands)


   
Computer and office equipment                            $ 4,953        $ 3,911
Furniture and leasehold improvements                       1,131          1,199
Furniture, fixtures and equipment
 under capital leases                                      2,482          2,559
                                                         -------        -------
                                                           8,566          7,669
Less: Accumulated depreciation                            (5,679)        (3,900)
                                                         -------        -------
                                                         $ 2,887        $ 3,769
                                                         =======        =======
    

Depreciation and amortization expense related to fixed assets in 1996, 1995, and
1994  totaled  $1.7  million,  $2.1  million,  and $1.7  million,  respectively.
Included in depreciation and amortization  expense in 1996, 1995 , and 1994 were
$580,000,  $704,000,  and $150,000 of  amortization  expense  related to capital
leases, respectively.


NOTE 5 - SOFTWARE DEVELOPMENT AND PURCHASED TECHNOLOGY

Capitalized  software  development  and  purchased  technology  consists  of the
following:
                                                            December 31,
                                                        1996              1995
                                                            (in thousands)

Internally developed                                  $  8,517         $  7,064
Purchased technology                                     3,149            2,910
                                                      --------         --------
                                                        11,666            9,974
Less:  Accumulated amortization                         (7,853)          (5,344)
                                                      --------         --------
                                                      $  3,813         $  4,630
                                                      ========         ========

During 1996, 1995 and 1994, amortization of capitalized software development and
license costs totaled $2.6 million, $2.7 million and $3.0 million, respectively,
and was included in cost of products sold. The Company  expensed $3.4 million of
purchased  technology  and $721,000 of  capitalized  software in 1995 due to the
Divestitures.  During 1994,  the Company also charged to expense $8.7 million in
capitalized software and purchased technology.  The charge includes $5.3 million
resulting from the 1994  restructuring plan related to products  abandoned.  The
remaining  $3.4  million  charge,   in  1994,   relates  to  net   realizability
adjustments.

NOTE 6 - DIVESTITURES OF BUSINESSES

During 1996 and 1995, the Company engaged in a series of Divestitures  resulting
in losses of  $921,000  and $9.3  million  in 1996 and 1995,  respectively.  The
Company received as consideration from the dispositions, cash and notes totaling
$1.5 million and $4.3 million in 1996 and 1995, respectively.






                                      F-12

The following  unaudited pro forma information assumes that the 1996 disposition
of the Symmetrical  Technologies,  Inc. subsidiary occurred January 1, 1996. The
unaudited pro forma information is not necessarily  indicative of the results of
future  operations  or the  actual  results  that would  have  occurred  had the
transactions  taken  place at  January  1,  1996  (in  thousands,  except  share
amounts):

Revenue                                                   $ 37,812
Net loss                                                  $(16,251)
Net loss per common share                                 $  (0.97)


NOTE 7 - OTHER ACCRUED EXPENSES

Other accrued expenses consist of the following:

   
                                                                December 31,
                                                              1996         1995
                                                                (in thousands)

Accrued restructuring costs (see Note 12)                    $ --         $  324
Accrued preferred dividends                                     714          527
Accrued income and other taxes                                1,667        1,667
Other                                                         1,507        1,134
                                                             ------       ------
                                                             $3,888       $3,652
                                                             ======       ======
    

NOTE 8 - BORROWING ARRANGEMENTS

Borrowings consist of the following:
                                                                 December 31,
                                                             1996         1995
                                                              (in thousands)
   
Lines of credit                                            $   --       $ 3,276


Capital lease obligations
 bearing interest ranging from
    11.7% to 12.7%                                             957        1,702

                                      F-13

Term loans from French government
 agencies, non-interest bearing,
 due at various dates through 1997                           1,098        1,162

Term notes with financial
 institutions, bearing interest
 ranging from 8.8% to 10%, due
 at various dates through 1997                                  96          489

                                                             2,151        6,629
                                                           -------      -------
Less:  Amounts due in one year                              (2,063)      (5,365)
                                                           -------      -------
Long-term debt and capital lease obligations               $    88      $ 1,264
                                                           =======      =======

    


At December 31, 1996, the Company  maintained lines of credit which provided for
borrowings up to $6.0 million, of which $5.0 million was issued by a stockholder
of the Company and $1.0 million was issued by a French  governmental  agency. On
December 31,  1996,  the Company  entered  into a restricted  $5 million line of
credit  agreement  with a  stockholder  (the  "Stockholder  line of  credit") to
finance the buy back of the Series F Preferred  Stock.  The Stockholder  line of
credit bears interest at the prime rate (8.25% at December 31, 1996) plus 2% and
is secured by the domestic accounts  receivable of the Company,  $6.4 million at
December 31, 1996.  In connection  with the  Stockholder  line of credit,  which
expires on September 30, 1998, the Company  issued  warrants for the purchase of
200,000 shares of Common Stock. The fair value of the warrants is $192,000 which
will be amortized over the term of the Stockholder  line of credit as additional
interest expense.  The Company repaid and terminated its previous line of credit
with a bank on March 31, 1996.

The French Line of Credit is secured by  accounts  receivable  of the  Company's
French  operations and bears interest at the French  interbank  monetary  market
rate (3.29% at December 31, 1996) plus 3%. The line of credit terminates May 31,
1997.  At December 31, 1996,  there were no borrowings  outstanding  against the
line of credit.

The Company  leases  certain of its furniture and equipment  under capital lease
arrangements.  Future  minimum lease  payments  under these capital  leases are:
1997, $925,000; 1998, $88,000; 1999, $10,000 and 2000, $7,000. Of the $1,030,000
total lease payments, $73,000 represents interest.

NOTE 9 - STOCKHOLDERS' EQUITY

         Common stock --

In March 1996,  the Company  completed a private  placement of 934,634 shares of
Common Stock,  together with warrants to purchase an additional 64,000 shares of
Common Stock,  pursuant to Regulation D under the  Securities  Act of 1933.  Net
proceeds  from  the  offering  were  $3.0  million.   The  Company  subsequently
registered  the Common  Stock and Common  Stock  issuable  upon  exercise of the
warrants under the Securities Act of 1933.



                                      F-14


In March and June 1996,  the  Company  also issued  421,040 and 404,611  shares,
respectively,  of Common Stock pursuant to Regulation S under the Securities Act
of 1933.  Proceeds  from the  offerings  were  $1.7  million  and $1.3  million,
respectively.

         Series A preferred stock --


   
The Series A  Cumulative  Convertible  Preferred  Stock  ("Series A  Preferred")
stockholders are entitled to cumulative dividends at the rate of $2.00 per share
per year,  payable  quarterly,  and could initially convert to common stock at a
rate of 1.8116  shares  of  common  for each  share of  Series A  Preferred  (an
effective initial conversion price of $13.80),  subject to adjustment in certain
circumstances. In 1996, the Company paid $3.2 million in dividends to the Series
A Preferred stockholders. The Series A Preferred stockholders vote as a class to
approve or disapprove any issuance of any securities senior to or on parity with
the Series A Preferred with respect to dividends or distributions.  The Series A
Preferred has a liquidation  preference  of $25.00 per share,  plus  accumulated
unpaid  dividends.  At December 31, 1996, the Series A Preferred was convertible
into 2,907,663 shares of Common Stock.
    

         Series E and G Preferred Stock--

The three shares of Series E Convertible Preferred Stock outstanding at December
31, 1995 were converted  during 1996 into 10,389 shares of Common Stock.  During
1996, all 200 shares of Series G Convertible Preferred Stock were converted into
551,546 shares of Common Stock.

         Series H and I Preferred Stock --

In June 1996, the Company completed two offerings,  one pursuant to Regulation S
under the Securities Act of 1933 of 300 shares of Series H Convertible Preferred
Stock and  warrants to purchase  80,000  shares of Common  Stock,  and the other
pursuant  to  Regulation  D under the  Securities  Act of 1933 of 300  shares of
Series I Convertible  Preferred  Stock,  both at $10,000 per share from which it
received net proceeds of $5.9  million.  The proceeds have been used for working
capital and  general  corporate  purposes.  In  connection  with the sale of the
Series I Convertible  Preferred Stock, the Company agreed to register the Series
I Preferred  Stock and the Common Stock  issuable upon exercise of the Series I.
At December 31, 1996, 40 shares of Series H Preferred  Stock had been  converted
into  116,082  shares of Common  Stock and all 300 shares of Series I  Preferred
Stock had been converted into 1,272,214  shares of Common Stock. At December 31,
1996, the remaining  shares of Series H Preferred  Stock were  convertible  into
885,956 shares of Common Stock.





                                      F-15


The Series H Preferred Stock has a per share liquidation preference, subordinate
to the  liquidation  preferences  of the other series of  previously  issued and
outstanding  Preferred Stocks of an amount per share equal to the sum of $10,000
plus 12% per annum simple  interest  thereon  since the date of  issuance.  Each
share is  convertible  at the option of the holder  into the number of shares of
Common  Stock  determined  by dividing an amount  equal to the initial  purchase
price of $10,000 by $3.50.  Commencing  on December  27,  1996,  the Company may
redeem the shares at the initial purchase price, if the holder does not exercise
his  conversion  rights,  and the holder may submit the shares for redemption at
that price, in which case the Company may elect to pay the cash redemption price
or issue a number of shares of Common Stock equal to that price,  with the value
of the Common Stock being  determined  by its average  closing bid price for the
five trading days  immediately  preceding the notice of redemption (the "Average
Bid  Price").  The Series H Preferred  Stock has a dividend  rate of 8% which is
payable  at the time of  conversion  or  redemption  in cash or shares of Common
Stock,  as elected by the  Company,  with the value of the  Common  Stock  being
determined by the Average Bid Price.

The Series I Preferred Stock had a per share liquidation preference, subordinate
to the  liquidation  preferences  of the other series of  previously  issued and
outstanding Preferred Stocks, of an amount per share equal to the sum of $10,000
plus an amount equal to accrued but unpaid dividends per share since the date of
issuance. Each share was convertible at the option of the holder into the number
of shares of Common Stock ("Conversion Shares") determined by dividing an amount
equal to the initial purchase price of $10,000 by the lesser of $4.00 and 81% of
the average bid price.  The Series I Preferred  Stock had a dividend  rate of 6%
which was paid at the time of conversion into shares of Common Stock, as elected
by the Company.

         Series J Preferred Stock --

In September  1996, the Company  completed an offering  pursuant to Regulation D
under  the  Securities  Act of 1933,  of 500  shares  of  Series  J  Convertible
Preferred Stock at $10,000 per share from which it received net proceeds of $5.0
million.  The proceeds have been used for working capital and general  corporate
purposes.  In  connection  with the sale of the Series J  Convertible  Preferred
Stock,  the  Company  agreed to register  the Series J  Preferred  Stock and the
Common Stock  issuable upon exercise of the Series J. At December 31, 1996,  110
shares of Series J Preferred  Stock had been  converted  into 406,668  shares of
Common  Stock  and the  remaining  shares  of  Series  J  Preferred  Stock  were
convertible into 1,295,372 shares of Common Stock.

The Series J Preferred Stock has a per share liquidation preference, subordinate
to the  liquidation  preferences  of the other series of  previously  issued and
outstanding Preferred Stocks, of an amount per share equal to the sum of $10,000
plus an amount equal to accrued but unpaid dividends per share since the date of
issuance.  Each share is convertible at the option of the holder into the number
of shares of Common Stock ("Conversion Shares") determined by dividing



                                      F-16



   
an amount equal to the initial purchase price of $10,000 plus accrued but unpaid
dividends per share since the date of issuance by the lesser of $3.25 and 81% of
the  average  closing  bid price per share of the Common  Stock for the five (5)
trading days immediately preceding the notice of conversion ("Conversion Average
Bid  Price").  The Company  may,  commencing  on  September  30,  1997,  require
conversion if the Series J Preferred Stock and underlying Common Stock have been
registered  under the  Securities  Act for at least ten trading  days.  When the
Conversion  Average Bid Price is less than $3.25,  the  Company,  subject to the
rights of senior securities regarding redemption,  may redeem shares of Series J
Preferred  Stock  submitted  for  conversion  at a price per share  equal to the
amount  determined  by  multiplying  the  number  of  Conversion  Shares  by the
Conversion  Average Bid Price.  The Series J Preferred Stock has a dividend rate
of 6% which is payable at the time of conversion or redemption in cash or shares
of Common Stock, as elected by the Company.
    


         Stock purchase warrants --

The Company has the following warrants outstanding at December 31, 1996:

<TABLE>
<CAPTION>

Warrants              Warrants          Exercise                                    Outstanding         Shares Issuable
Issuance              Issued           Price Range                Expiration       Dec. 31, 1996         Upon Exercise
- -------- ----------------------------------------------           ----------       -------------         --------------
<S>                 <C>               <C>                      <C>                    <C>                   <C>
Pre-IPO               148,993            $1.00                       May 1997             33,663              33,663
IPO Units           1,595,000            $5.993                      May 1997            654,392             850,710
Placement             397,472         $5.71-$14.88              May 1997-Oct. 1998       307,472             467,082
Other                 350,334         $3.063-$7.00             Jan. 1997-June 2001      275,334             275,334
Series A preferred    140,000           $22.77                     December 1998         140,000             253,624
Series D preferred    227,068            $7.57                      July 2000             27,068             227,068
Series E preferred     34,400            $7.20                      July 2000             34,400              34,400
Private Placement     179,400          $3.50-$4.00                Nov.-Dec. 2000         179,400             179,400
Series G preferred     40,000            $3.75                     December 2000          40,000              40,000
Series H Preferred     80,000            $3.50                      June 2001             80,000              80,000
                    ---------                                                          ---------            ---------
                    3,192,667                                                          1,971,729            2,441,281
                    =========                                                          =========            =========
</TABLE>

         Stock option plans --

During 1994,  1995 and 1996, the Company  granted options to buy Common Stock of
the Company under five stock option plans.  Certain options qualify as incentive
stock options under the Internal  Revenue Code. The vesting and the terms of any
option granted under the plans are determined by the Board of Directors with the
requirement  that the term of an  incentive  stock  option  shall not exceed ten
years. To date, options granted range from five- to ten-year terms. The exercise
price per share of Common Stock subject to an incentive stock option will not be
less than the fair  market  value at the time of  grant.  The  Company  has also
issued  non-qualified plan options. An aggregate of 9.1 million shares have been
authorized for issuance under the Company's stock option plans.

                                      F-17

Pro forma information regarding net income and earnings per share is required by
SFAS 123,  and has been  determined  as if the  Company  had  accounted  for its
employee  stock options  under the fair value  method.  The fair value for these
options was estimated at the date of grant using a Black-Scholes  option pricing
model  with the  following  weighted-average  assumptions  for  1995  and  1996,
respectively: average risk-free interest rates of 6.6% and 6.7%; dividend yields
of 0.0%; volatility factors of the expected market price of the Company's common
stock of .63; and a weighted-average expected life of the option of 5 years.

The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded  options which have no vesting  restrictions  and are fully
transferable.  In addition,  option valuation models require the input of highly
subjective  assumptions  including the expected stock price volatility.  Because
the  Company's  employee  stock  options  have   characteristics   significantly
different from those of traded  options,  and because  changes in the subjective
input assumptions can materially affect the fair value estimate, in management's
opinion,  the  existing  models do not  necessarily  provide a  reliable  single
measure of the fair value of its employee stock options.


   
For purposes of pro forma  disclosures,  the estimated fair value of the options
is amortized to expense over the options'  vesting  period.  The  Company's  pro
forma loss is $35.6 million and $23.1  million for 1995 and 1996,  respectively,
and pro forma loss per share is $2.46 and $1.12 for 1995 and 1996, respectively.
The effect of  applying  SFAS 123 on the 1995 and 1996 pro forma net loss is not
necessarily  representative of the effects on reported net loss and net loss per
share for future years due to, among other things,  1) the vesting period of the
stock options and the 2) fair value of additional stock options in future years.
    


The  following  table  summarizes  the activity in stock  options  issued by the
Company:
                                                      Exercise
                                            Options                 Price
                                           ----------          ---------------
Balance, January 1, 1994                    3,183,250          $1.00 - $12.38
Granted                                     2,967,000           3.38 -  12.38
Exercised                                    (321,658)          1.00 -   7.63
Canceled                                     (560,792)          1.00 -  12.13
                                           ----------
Balance, December 31, 1994                  5,267,800           1.00 -  12.38
Granted                                     2,486,250           3.32 -   6.82
Exercised                                     (89,957)          2.25 -   3.75
Canceled                                   (1,163,769)          2.25 -  12.38
                                           ----------
Balance, December 31, 1995                  6,500,324           1.00 -  12.38
Granted                                     1,454,000           2.69 -   4.50
Exercised                                     (88,869)          1.00 -   3.75
Canceled                                     (851,619)          1.00 -   6.82
                                           ----------
Balance, December 31, 1996                  7,013,836          $1.00 - $ 8.75
                                           ==========


                                      F-18


At December 31, 1996,  options to purchase  3,125,102 shares had vested and were
exercisable  at a weighted  average  exercise price of $3.90 per share and had a
weighted average contractual life of 6.5 years.


NOTE 10 - REDEEMABLE PREFERRED STOCK

In December 1996,  the Company  entered into an agreement with the holder of the
Series F Preferred  Stock to redeem the shares for an  aggregate of $9.9 million
or $5.50 per share. The agreement requires the Company to make payments totaling
$6.6 million  through June 30, 1997,  and an additional  $3.6 million on January
31,  1998.  The $3.6  million  payment  due on January 31,  1998,  is subject to
certain acceleration terms that are under the control of the Company.  Under the
agreement,  the  outstanding  obligation  amount will  compound at 8% per annum,
commencing  October 1, 1996. The reduction of the Company's  Series F redemption
obligation under the terms of the agreement  resulted in a $6.0 million increase
in stockholders' equity.

NOTE 11 - INCOME TAXES

The source of the loss before income taxes was from the following jurisdictions:

                                                      Year Ended December 31,
                                                   1996                   1995
                                                          (in thousands)

U.S.                                             $(16,332)             $(23,480)
Foreign                                            (1,077)               (1,763)
                                                 --------              --------
                                                 $(17,409)             $(25,243)
                                                 ========              ========

The income tax expense (benefit) consists of the following:

   
                                                        Year Ended December 31,
                                                         1996              1995
                                                             (in thousands)
Current tax expense (benefit):

U.S. Federal                                             $  --            $  51
                                                         -----            -----
State and local                                             --               --
                                                         -----            -----
Foreign                                                     --               --
                                                         -----            -----
Deferred tax expense:
     Foreign                                               (68)            (331)
                                                         -----            -----
Total income tax                                         $ (68)           $(280)
                                                         =====            =====
    



                                      F-19


Deferred tax assets and liabilities are comprised of the following:

                                                              December 31,
                                                           1996           1995
                                                              (in thousands)
Deferred tax assets:
  Net operating losses                                   $ 24,419      $ 12,180
  Other                                                     1,659         1,997
                                                         --------      --------
    Gross deferred tax assets                            $ 26,078      $ 14,177
                                                         ========      ========
Deferred tax liabilities:
  Software development costs                               (1,372)       (1,661)
                                                         --------      --------
    Gross deferred tax liabilities                         (1,372)       (1,661)
Deferred tax asset valuation allowance                    (24,752)      (13,032)
                                                         --------      --------
                                                         $    (46)     $   (516)
                                                         ========      ========
Current deferred tax assets
 (included in prepaid and other
  current assets net of valuation allowance)                  254           257
Non-current deferred tax liabilities                         (300)         (773)
                                                         --------      --------
                                                         $    (46)     $   (516)
                                                         ========      ========

Income tax expense (benefit) differs from the amount of income tax determined by
applying  the  applicable  U.S.  statutory  federal  income tax rate to the loss
before income taxes as a result of the following differences:

                                                         Year Ended December 31,
                                                            1996       1995
                                                             (in thousands)

   
Statutory U.S. tax rate benefit                            (34.0%)    (34.0%)
State income taxes, net                                     (4.0)      (4.0)


Operating losses and tax credits with no current
     tax benefit                                            37.5       31.0
Other                                                        0.1        5.9
                                                            ----       ----
                                                            (0.4%)     (1.1%)
                                                            ====       ====
    

As of December 31,  1996,  the Company had net  operating  loss and research tax
credit carry forwards of approximately  $53 million and $913,000,  respectively,
for U.S.  income tax purposes  which expire in years through  2010.  The Company
experienced  changes in  ownership  during prior years which  triggered  certain
limitations   under  Internal  Revenue  Code  Section  382.   Accordingly,   the
utilization  of the net operating  loss and research tax credits will be limited
in future years due to the changes in ownership.

Provision  has  not  been  made  for  U.S.  or   additional   foreign  taxes  on
undistributed earnings of foreign subsidiaries.  The earnings have been and will
continue to be reinvested in those  subsidiaries.  These  earnings  could become
subject to  additional  tax if they were  remitted  as  dividends,  if they were
loaned

                                      F-20

to the Company or a U.S. affiliate, or if the Company sold its stock in the sub-
sidiaries.  It is not  practicable to estimate the amount of additional tax that
might be payable on the foreign  earnings;  however,  the Company believes that,
due to the  operation of the foreign tax credits,  any foreign tax credits would
largely eliminate any U.S. tax and offset any foreign tax.


NOTE 12 - RESTRUCTURING CHARGES AND CAPITALIZED SOFTWARE WRITE-OFFS


   
At December 31, 1996,  the Company's  1994  restructuring  plan (the "Plan") was
complete.  In accordance with the Plan, 90 employees had been terminated  and/or
resigned and the Company's  excess leased  property was sublet through the lease
termination  date.  Under the Plan, the Company incurred net charges in estimate
of  $175,000  and  $1.4  million  in  1996  and  1995,   respectively   and  net
restructuring charges of $1.7 million in 1994. In conjunction with the Plan, the
Company also expensed capitalized software of $5.3 million in 1994.
    

NOTE 13 - BUSINESS SEGMENTS

The Company sells its products and services through a single industry segment to
a wide variety of customers throughout the United States and Western Europe. The
Company  performs  ongoing  credit  evaluations  of  its  customers'   financial
condition and generally does not require collateral from its customers.

The  following table sets forth summary information for the years ended December
31, 1996, 1995 and 1994 (in thousands):

                                                    United              Western
                                                    States               Europe
1996:
     Revenue                                       $ 21,383            $ 18,094
     Net loss                                       (16,332)             (1,009)
     Total assets                                    22,718              14,060

1995:
     Revenue                                       $ 38,367            $ 30,784
     Net loss                                       (23,531)             (1,432)
     Total assets                                    30,654              19,310

1994:
     Revenue                                       $ 37,619            $ 29,409
     Net loss                                       (35,360)             (4,265)
     Total assets                                    43,963              27,908

                                      F-21


Revenue in 1996  included  sales to the U.S.  Government  and French  Government
totaling $1.1 million and $10.3 million, respectively.  Revenue in 1995 included
sales to the U.S.  Government  and French  Government  totaling $1.7 million and
$9.6  million,  respectively.  Revenue  in  1994  included  sales  to  the  U.S.
Government  and  French  Government  totaling  $3.3  million  and $7.6  million,
respectively.


NOTE 14 - COMMITMENTS

The Company leases its corporate office, sales offices,  assembly facilities and
certain equipment under non-cancelable operating leases certain of which provide
for  annual  escalations  that are  amortized  over the lease  term and pro rata
operating expense reimbursements.  Rent expense related to these leases was $1.6
million,  $2.7 million and $2.9  million for the years ended  December 31, 1996,
1995, and 1994, respectively.

Future  minimum lease  payments  under  non-cancelable  operating  leases are as
follows (in thousands):

Year Ending
December 31,

  1997                                                   $1,328
  1998                                                    1,076
  1999                                                      940
  2000                                                      363
  Thereafter                                                 --
                                                        -------
                                                         $3,707
                                                        =======

NOTE 15 - CONTINGENCIES

         Department of Justice, Securities and Exchange Commission  and  Company
            internal investigations --

During  November  1996,  the Company  received a letter from the  Securities and
Exchange   Commission   advising  the  Company  that  it  was   terminating   an
investigation that it had been conducting.  In 1994, the Company learned that it
was the  subject of  investigation  by the  Commission  and the U.S.  Attorney's
Office in the  Southern  District of New York which the Company  understood  was
focused  on  certain   accounting  issues,   including   questions  relating  to
capitalization  of software and  pooling-of-interests  accounting  treatment for
certain acquisitions, and certain matters related to activities during the years
1992 and 1993. The Company has had no  communications  with the U.S.  Attorney's
Office from the date it received the letter from the SEC.




                                      F-22


         Other --

Dorotech,  which was acquired in October 1993, had previously  co-guaranteed the
lease payment of ATG Gigadisc SA ("ATG"), a former affiliated  company,  under a
sale and  leaseback  of land and  buildings  ending  April 2007.  As part of the
December 1996 Series F Preferred Stock  redemption  agreement (See Note 10), the
holder of the Series F Preferred  Stock  agreed to use best  efforts to obtain a
release from the landlord.

The Company is also subject to other legal  proceedings  and claims which are in
the ordinary  course of business.  Management  believes that the outcome of such
matters will not have a material impact on the Company's  financial  position or
its result of operations.


NOTE 16 - RELATED PARTY TRANSACTIONS

         The Company has employment and consulting  agreements with  individuals
who are current or former  members of the Board of Directors and officers of the
Company.  The Company has five year agreements with the Chairman of the Board of
Directors and  Secretary and with the former  Chairman of the Board of Directors
and his consulting  firm. The Company also has a five year consulting  agreement
with another  former  Director and his consulting  firm. The Company  recognized
total  compensation  expense of approximately  $715,000 and $898,000 in 1996 and
1995,  respectively,  related to these  employment  and  consulting  agreements.
During  December  1996,  the Company and a  stockholder  entered  into a line of
credit  agreement.  At December 31, 1996,  there were no borrowings  against the
line of credit (see Note 8).

The  Company  holds two  notes  receivable  totaling  $525,000  from two  former
stockholders  of a subsidiary  acquired in 1994 due and payable  December  1998.
Interest accrues at 6.55% per annum.

NOTE 17 - EMPLOYEE PROFIT SHARING PLANS AND 401K PLAN

The  Company  has a  mandatory  and a voluntary  profit  sharing  plan  covering
substantially all employees in France. Contributions to the plans are based upon
earnings of the French  operations.  Plan contributions in 1996 totaled $28,000,
while there were no contributions made to the plans in 1995 and 1994.

The Company also sponsors,  in the United  States,  a 401K plan which covers all
full-time  employees.  Participants in the plan may make  contributions of up to
fifteen   percent  of  pre-tax  annual   compensation.   The  Company  may  make
discretionary  matching  contributions  at the option of the Board of Directors.
The Company made no contributions in 1996, 1995 or 1994.


                                      F-23
<PAGE>
   
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
               (In thousands, except share and per share amounts)

<TABLE>
<CAPTION>
                                                                                                                       Pro Forma at
                                                                                        December 31,   September 30,   September 30,
                                                                                           1996            1997             1997
                                                                                        -----------     -----------     -----------
                                                                                                        (Unaudited)     (Unaudited)
                           ASSETS
<S>                                                                                       <C>             <C>             <C>
Current assets:
 Cash and cash equivalents                                                                $   7,601       $   3,782       $   3,782
 Accounts and notes receivable, net                                                          13,243          14,451          14,451
 Inventories                                                                                  1,503           1,404           1,404
 Prepaid expenses and other                                                                   2,362           2,214           2,214
                                                                                          ---------       ---------       ---------
        Total current assets                                                                 24,709          21,851          21,851
Fixed assets, net                                                                             2,887           2,096           2,096
Long-term notes receivable, net                                                               1,979           1,648           1,648
Software development costs and purchased technology, net                                      3,813           3,347           3,347
Goodwill, net                                                                                 3,237           2,228           2,228
Other assets                                                                                    153             310             310
                                                                                          ---------       ---------       ---------
          Total assets                                                                    $  36,778       $  31,480       $  31,480
                                                                                          =========       =========       =========


                       LIABILITIES & STOCKHOLDERS' EQUITY

Current liabilities:
 Current debt maturities and obligations under capital leases $                               2,063       $   1,238       $   1,238
 Accounts payable                                                                             3,185           3,890           3,890
 Accrued compensation and related expenses                                                    1,891           1,983           1,983
 Deferred revenue                                                                             3,789           3,599           3,599
 Other accrued expenses                                                                       3,888           4,895           4,895
                                                                                          ---------       ---------       ---------
          Total current liabilities                                                          14,816          15,605          15,605
Long-term debt and obligations under capital leases                                              88           7,318           7,318
Deferred income taxes                                                                           300             191             191
                                                                                          ---------       ---------       ---------
          Total liabilities                                                                  15,204          23,114          23,114
Commitments
Redeemable Series F preferred stock, 1,792,186 and 792,186 shares
 issued and outstanding at December 31, 1997 and September 30, 1997
 and 792,186 shares issued and outstanding on a pro forma basis at
 September 30, 1997                                                                           9,857           6,357           6,357
Redeemable Series K preferred stock, no and 3,300 shares issued and
 outstanding at December 31, 1996 and September 30, 1997 and no
 shares issued and outstanding on a pro froma basis at September 30, 1997                      --             3,700            --
Stockholders' equity:
 Preferred stock, $.0001 par value, 20,000,000 shares authorized;
  1,605,675 and 1,605,035 shares issued and outstanding at
  December 31, 1996 and September 30, 1997 and 1,608,335 shares
  issued and outstanding on a proforma basis at September 30, 1997
 Common stock, $.0001 par value, 50,000,000 shares authorized;
  22,896,612 and 25,865,809 shares issued and outstanding at
  December 31, 1996 and September 30, 1997 and 
  25,865,809 shares issued and outstanding on a pro forma basis
  at September 30, 1997                                                                           2               3               3
 Additional paid-in-capital                                                                 124,429         121,108         124,808
 Accumulated deficit                                                                       (113,098)       (122,233)       (122,233)
 Translation adjustment                                                                         384            (569)           (569)
                                                                                          ---------       ---------       ---------
          Total stockholders' equity (deficit)                                               11,717          (1,691)          2,009
                                                                                          ---------       ---------       ---------
          Total liabilities and stockholders' equity                                      $  36,778       $  31,480       $  31,480
                                                                                          =========       =========       =========
</TABLE>

    









   The accompanying notes are an integral part of these financial statements.

                                      F-24

<PAGE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
               (In thousands, except share and per share amounts)
                                   (Unaudited)

   

                                                Three Months Ended September 30,
                                                     1997              1996
                                                  -----------       -----------

Revenue:
  Products                                        $     5,225       $     4,107
  Services                                              4,719             5,272
                                                  -----------       -----------
                                                        9,944             9,379
                                                  -----------       -----------
Costs and expenses:
  Cost of products sold                                 2,585             2,169
  Cost of services provided                             3,865             3,700
  Sales and marketing                                   3,649             3,332
  General and administrative                            1,649             1,995
  Product development                                   1,142             1,129
  Loss on sale of subsidiary                             --                 921
                                                  -----------       -----------
                                                       12,890            13,246
                                                  -----------       -----------
Loss before investment and
 interest income and income taxes                      (2,946)           (3,867)
  Investment and interest income
  (expense), net                                         (130)               41
                                                  -----------       -----------
Loss before income taxes                               (3,076)           (3,826)
  Income tax benefit                                     (142)              (77)
                                                  -----------       -----------
Net loss                                               (2,934)           (3,749)
                                                  -----------       -----------

Preferred stock preferences
  Accrued dividends                                      (930)             (865)
  Imputed dividends                                      (774)             --
                                                  -----------       -----------
Net loss applicable to
 common shares                                    $    (4,638)      $    (4,614)
                                                  ===========       ===========

Net loss per common share                         $     (0.18)      $     (0.22)
                                                  ===========       ===========

Weighted average shares outstanding                25,436,748        21,112,811
                                                  ===========       ===========
    












   The accompanying notes are an integral part of these financial statements.

                                      F-25

<PAGE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
               (In thousands, except share and per share amounts)
                                   (Unaudited)
   

                                                 Nine Months Ended September 30,
                                                     1997              1996
                                                 ------------      ------------

Revenue:
  Products                                       $     13,591      $     13,497
  Services                                             14,805            15,552
                                                 ------------      ------------
                                                       28,396            29,049
                                                 ------------      ------------
Costs and expenses:
  Cost of products sold                                 6,740             7,976
  Cost of services provided                            11,681            11,975
  Sales and marketing                                  10,901            11,652
  General and administrative                            4,949             7,522
  Product development                                   3,451             4,190
  Gain from extinguishment of debt                       (267)             --
  Loss on sale of subsidiary                             --                 921
  Exchange fee and gain on
   sale of asset, net                                    --                 619
  Restructuring costs                                    --                (175)
                                                 ------------      ------------
                                                       37,455            44,680
                                                 ------------      ------------
Loss before investment and
 interest income and income taxes                      (9,059)          (15,631)
  Investment and interest income
  (expense), net                                         (163)              188
                                                 ------------      ------------
Loss before income taxes                               (9,222)          (15,443)
  Income tax benefit                                      (87)              (89)
                                                 ------------      ------------
Net loss                                               (9,135)          (15,354)
                                                 ------------      ------------

Preferred stock preferences
  Accrued dividends                                    (2,836)           (2,749)
  Imputed dividends                                      (774)             --
                                                 ------------      ------------
Net loss applicable to
 common shares                                   $    (12,745)     $    (18,103)
                                                 ============      ============

Net loss per common share                        $      (0.51)     $      (0.90)
                                                 ============      ============

Weighted average shares outstanding                24,957,354        20,081,412
                                                 ============      ============
    












   The accompanying notes are an integral part of these financial statements.

                                      F-26

<PAGE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
            CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT
                  For the nine months ended September 30, 1997
                      (In thousands, except share amounts)
                                   (Unaudited)


   
<TABLE>
<CAPTION>
                                                                                                          Additional
                                                 Preferred Stock                 Common Stock              paid-in      Accumulated 
                                                  Shares        Amt.          Shares            Amt.       capital         Deficit 
                                              -----------------------      --------------------------     ----------     ----------
<S>                                           <C>            <C>           <C>            <C>             <C>            <C>        

Balance December 31, 1996                     1,605,675      $     --       22,896,612     $        2     $  124,429     ($ 113,098)

Issuance of common stock
 upon exercise of warrants                                                      23,331                            23

Conversion of preferred
 stock                                             (640)                     2,926,818              1

Offering costs on issuance
 of preferred stock                                                                                              (25)

Issuance of common stock                                                        19,048                            27

Issuance of warrants and
 extension                                                                                                       264

Accrued dividends on preferred
 stock                                                                                                        (2,836)

Imputed dividends on preferred
 stock                                                                                                          (774)

Translation adjustment

Net loss                                                                                                                     (9,135)
                                             ------------------------      --------------------------     ----------     ----------

Balance September 30, 1997                    1,605,035      $     --       25,865,809     $        3     $  121,108     $ (122,233)
                                             ========================      ==========================     ==========     ==========
</TABLE>

                                            Translation
                                             Adjustment               Total
                                            ------------          -------------

Balance December 31, 1996                       $    384               $ 11,717

Issuance of common stock
 upon exercise of warrants                                                   23

Conversion of preferred
 stock                                                                        1

Offering costs on issuance
 of preferred stock                                                         (25)

Issuance of common stock                                                     27

Issuance of warrants and
 extension                                                                  264

Accrued dividends on preferred
 stock                                                                   (2,836)

Imputed dividends on preferred
 stock                                                                     (774)

Translation adjustment                              (953)                  (953)

Net loss                                                                 (9,135)
                                                --------               --------

Balance September 30, 1997                      $   (569)              $ (1,691)
                                                ========               ========

    







   The accompanying notes are an integral part of these financial statements.

                                      F-27
<PAGE>
                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

   
                                                              Nine Months
                                                           Ended September 30,
                                                           1997          1996
                                                        ----------    ----------
                                                             (In thousands)

Cash flows from operating activities:
 Net loss                                                $ (9,135)     $(15,354)
 Adjustments to reconcile net loss
  to net cash used in operating
  activities:
   Depreciation and amortization                            3,752         4,465
   Gain on sale of asset                                     --            (111)
   Restructuring costs                                       --            (175)
   Loss on sale of subsidiary                                --             921
   Other non-cash items                                        15          --
   Changes in assets and
    liabilities:
     Accounts and notes receivable                         (1,837)        3,147
     Inventories                                               (6)          358
     Prepaid expenses and other                               145        (1,103)
     Accounts payable                                       1,698        (1,421)
     Accrued compensation and
      related expenses                                        242          (494)
     Accrued expenses, other                                  161        (1,656)
     Deferred revenues                                        (81)        1,707
     Deferred income taxes                                    (71)         (235)
                                                         --------      --------
Net cash used in operating activities                      (5,117)       (9,951)
                                                         --------      --------

Cash flows from investing activities:
 Sale of short-term investments                              --             111
 Capitalized software development
  and license costs                                        (1,059)       (1,513)
 Purchases of fixed assets                                   (557)         (748)
 Net cash provided in business
  divestiture                                                --            (401)
                                                         --------      --------
Net cash used in investing activities                      (1,616)       (2,551)
                                                         --------      --------

Cash flows from financing activities:
 Proceeds from issuance of common
  and preferred stocks, net                                    (2)       16,937
 Proceeds from issuance of Series
  K preferred stock, net                                    2,926          --
 Cash dividends paid on Series A
  preferred stock                                          (1,605)       (2,408)
 Cash dividends paid on Series F
  preferred stock                                            (174)         --
 Payments on Mandatory Redeemable
  Preferred Stock                                          (3,500)         --
 Proceeds from borrowings                                   5,000          --
 Proceeds from issuance of
  long-term debt                                            2,000
 Proceeds from sale and leaseback
  of fixed assets                                            --             196
 Proceeds from Notes Receivable
  related to business divestitures                             60          --
 Principal payments on capital
  lease obligations                                          (800)         (667)
 Principal payments on debt                                  (843)         (271)
                                                         --------      --------
Net cash provided by financing
 activities                                                 3,062        13,787
                                                         --------      --------

Effect of exchange rate changes on
 cash and cash equivalents                                   (148)          (77)
Net decrease in cash and cash
 equivalents                                               (3,819)        1,208
Cash and cash equivalents at
 beginning of year                                          7,601         9,359
                                                         --------      --------
Cash and cash equivalents at September 30,               $  3,782      $ 10,567
                                                         ========      ========

Supplemental Cash Flow Information:
     Interest paid                                       $    478      $    231
     Income taxes paid                                   $    261      $    170
    




   The accompanying notes are an integral part of these financial statements.

                                      F-28
<PAGE>


                  NETWORK IMAGING CORPORATION AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

   
                           September 30, 1997 and 1996
    


1.  BASIS OF PRESENTATION


   
The  unaudited  financial  statements  presented  herein  have been  prepared in
accordance with the  instructions to Form 10-Q and should be read in conjunction
with the financial  statements and notes thereto included in this Prospectus for
the year ended December 31, 1996, which include information and note disclosures
not included herein. In the opinion of management all adjustments, which include
only  those of a normal  recurring  nature,  necessary  to  fairly  present  the
Company's  financial  position,  results of operations  and cash flows have been
made to the accompanying financial statements. The results of operations for the
nine month period ended  September 30, 1997 may not be indicative of the results
that may be expected for the year ending December 31, 1997.
    

Certain   reclassifications  have  been  made  to  the  prior  period  financial
statements to conform to the current period presentation.


2.  NEW ACCOUNTING PRONOUNCEMENT

In February 1997, the Financial  Accounting Standards Board issued Statement No.
128,  Earnings per Share,  which is required to be adopted on December 31, 1997.
At that time,  the Company will be required to change the method  currently used
to compute  earnings per share and to restate all prior  periods.  Under the new
requirements for calculating  primary earnings per share, the dilutive effect of
stock options will be excluded.  The impact of Statement 128 on the  calculation
of the  primary  and fully  diluted  earnings  per share is not  expected  to be
material.

   
The Company intends to adopt Statement of Financial Accounting Standards No.131,
Disclosure  about  Segments of an Enterprise and Related  Information  (SFAS No.
131), in fiscal year 1998. SFAS No. 131 changes the way companies report segment
information  and  requires  segments to be  determined  based on how  management
measures  performance  and  makes  decisions  about  allocating  resources.  The
adoption of SFAS No. 131 is not  expected  to  materially  impact the  Company's
financial position or results of operations.
    


3.  REDEEMABLE PREFERRED STOCK


   
During the first  quarter of 1997,  the  Company  redeemed  1,000,000  shares of
Series F Preferred  Stock for $3.5  million.  The Company used proceeds from its
line of credit to finance the Series F Preferred share buy back.
    


                                      F-29



   
During  the  second  quarter  of 1997,  the  Company  was to have  redeemed  the
remaining 792,186 shares of Series F Preferred Stock for $2.8 million.  Under an
amendment to the December 1996 redemption agreement, the $2.8 million payment is
now due on January 31, 1998,  subject to certain  acceleration  terms related to
the occurrence of certain events that are under the control of the Company.
    



4.  LINE OF CREDIT


   
During the second  quarter of 1997,  the Company drew the remaining $1.5 million
from its $5.0  million  line of  credit  established  to  finance  the  Series F
Preferred  share  buy  back.  As part of the  additional  borrowing,  the use of
proceeds restriction was amended to allow its use for general corporate purposes
and the Company  entered  into an amendment  to the  security  agreement,  which
expanded the lender's  security interest to include all personal property of the
Company, including without limitation, (1) all personal property of the Company,
(2) all  leases,  licenses,  permits,  (3) all  software  products  intellectual
property now owned or hereafter developed by the Company, (4) all inventory, (5)
all accounts, contract rights, chattel papers, instruments, general intangibles,
documents,  other obligations,  monies, revenues,  credits, claims, goodwill and
causes of action,  (6) all trade or service  names,  trademarks,  service marks,
logos and all patents, patent applications, copyrights, licensing agreements and
royalty  payments,  (7)  proceeds of the  foregoing,  and (8) all of the capital
stock of Dorotech, S.A.
    


5.  NASDAQ-NMS MAINTENANCE REQUIREMENTS


   
At June 30, and September 30, 1997,  the Company had not maintained net tangible
assets  of at least $4  million,  which is one of the  quantitative  maintenance
criteria for inclusion of the Company's securities on Nasdaq National Market. To
remedy the short-fall and offset any adverse impact, the Company issued,  during
July 1997,  3,300  shares of Series K  Convertible  Preferred  Stock  ("Series K
Stock") and warrants and received net proceeds of $2.9 million.  Pursuant to the
terms of the  offering,  the  purchasers  are also  required to make  additional
purchases  of shares of Series K Stock and  warrants  for $3.0  million upon the
Company's achievement of certain performance  milestones and the satisfaction of
certain other  conditions  and an  additional  $4.7 million at their option (See
Note 7).

On August 21,  1997,  the  Company  received a letter  from the Nasdaq  National
Market  indicating that the Company may not have  sufficient  assets to continue
its listing on the Nasdaq  National  Market.  The Company has  responded to that
inquiry and after further  correspondence with Nasdaq requested a hearing before
the  Nasdaq  National  Market's  Hearing  Department  to  explain  its  plan for
achievement  and  maintenance  of the minimum net tangible  assets  requirement.
Following  a hearing  held on  Thursday,  October  30,  1997,  a Nasdaq  Listing
Qualifications  Panel  determined to grant the  Company's  request for continued
inclusion in the Nasdaq  National  Market pursuant to an exception to the Nasdaq
National Market's minimum net tangible asset requirement.
    


                                      F-30

   
The Panel found that the Company had presented a reasonable plan for compliance.
Based  upon the plan  detailed  by the  Company,  the Panel  concluded  that the
Company could achieve compliance with the continued listed  requirements for the
long-term.

In order to fully comply with the  exception  granted by the Panel,  the Company
must complete its plan of compliance in accordance with a timetable set forth by
the Panel. The Company must demonstrate full compliance with the Nasdaq National
Market  continued  listing  requirements  by December 31,  1997.  The Panel also
required that the Company have a minimum of $6.0 million in net tangible  assets
to ensure long term compliance with the net tangible assets requirement.
    


Although  the Company  believes  that it can  maintain the required net tangible
assets of at least $6 million through additional issuances of its Series K Stock
and warrants or other additional offerings of equity securities, there can be no
assurance  that the Company will complete such  offerings or that, if completed,
they will be on terms  favorable  to the Company or in an amount  sufficient  to
permit the Company to continue to maintain  net  tangible  assets of at least $6
million.


   
6.  CONVERTIBLE NOTES

During July and August 1997, the Company issued, pursuant to a private placement
exemption under the Securities Act of 1933, as amended, 8% Convertible Notes due
July 8,  2002  and  August  20,  2002  totaling  $2.0  million.  The  notes  are
convertible  into the Company's  Common Stock beginning 45 days after issue at a
conversion price of $1.875 and $1.50 per share, the prices on the issue dates.

On or after  October 30, and December  12,  1997,  the holders have the right to
redeem the convertible  notes plus accrued interest on one business days' notice
to the Company in cash or shares of Common Stock, at the Company's election.  On
or after October 30, and December 12, 1997,  the Company has the right to redeem
the convertible  notes plus accrued interest on 30 days' notice tothe holders in
cash or share of Common  Stock,  at the holders'  election.  If shares of Common
Stock  are used,  Common  Stock is  issued  at a rate of 90% of the  previous  5
trading  days   average   closing  bid  price.   The   interest  is   compounded
semi-annually.  The warrants  issued to the investors  have an exercise price of
$1.875  and  $1.50  per  share  and  expire  on July 8,  and  August  20,  2000,
respectively.


7.  CONVERTIBLE PREFERRED STOCK OFFERINGS

During  July 1997,  the  Company  agreed to issue up to 11,000  units  ("Units")
consisting  of one share of Series K Stock and  warrants to acquire 75 shares of
Common Stock at an exercise  price of $2.40 per share at the price of $1,000 per
Unit. On July 28, 1997, the Company issued 3,300 Units and received net proceeds
of $2.9 million (the  "Offering").  The Company also issued warrants to purchase
162,462 shares of Common Stock at $1.625 per share to the placement
    


                                      F-31



   
agent in the  transaction.  Under the  requirements  of a newly issued SEC staff
position, the carrying value of the Series K Stock was increased by $774,000, or
the corresponding  amount allocated to beneficial  conversion  feature described
below. The Company also recorded a related $774,000 non-cash charge to preferred
stock dividends. In accordance with the terms of the Offering, the proceeds will
be used for  working  capital and general  corporate  purposes.  Pursuant to the
terms of the Offering,  the purchasers are required to make additional purchases
of the  Units  for  $3.0  million  upon the  Company's  achievement  of  certain
performance  milestones and the  satisfaction of certain other  conditions.  The
remaining $4.7 million is to be offered to the purchasers and the purchasers, at
their election, may elect to make purchases of the Units. In connection with the
sale of the Units, the Company agreed to register the Common Stock issuable upon
the conversion of the preferred stock and the execution of the warrants.
    


The Series K Preferred Stock has a per share liquidation preference,  subject to
the  liquidation  preferences of the Series A Preferred  Stock,  the Series F-1,
F-2, F-3 and F-4 Preferred  and the Series H Preferred  Stock of an amount equal
to the sum of $1,000 plus 7% per annum  simple  interest  thereon for the period
since the date of  issuance.  Each  share is  convertible  at the  option of the
holder  into the number of shares of Common  Stock  determined  by  dividing  an
amount equal to the initial  purchase price of $1,000 by the lesser of (1) $2.00
and (2) the lowest  closing  sale price for the Common Stock for the ten trading
days  immediately   preceding  the  conversion  multiplied  by  the  "Conversion
Percentage."  The  "Conversion  Percentage"  is (a)  105%  prior to the 61st day
following  July 28,  1997 (the  "First  Closing  Date"),  (b) 96% for the period
between the 61st and the 90th day following the First Closing Date,  (c) 85% for
the period  between the 91st and the 180th day following the First Closing Date,
and (d) 81% for the period after the 180th day following the First Closing Date.
The Series K Stock has a dividend  rate of 7% per annum  which is payable at the
time of conversion  or redemption in cash or shares of Common Stock,  as elected
by the Company.



   
8.  PREFERRED STOCK DIVIDENDS

During July 1997,  the Company  announced  that it was  suspending  the dividend
payment to holders of Series A Cumulative Convertible Preferred Stock ("Series A
Stock").  Holders of Series A Stock did not  receive  dividends  payable for the
three months ended July 31, 1997 or October 31, 1997 in the amounts of $0.50 per
share or $802,512.50 in the aggregate, respectively.
    




                                      F-32



   
9.  STOCK OPTION REPRICING

In August 1997, the Board of Directors  approved a plan to reprice the Company's
outstanding stock options. The plan allowed holders of out-of-the-money options,
excluding executives,  officers, and directors,  to receive a new exercise price
of $1.50 per option  share,  the market price on the date the plan was approved.
The plan allowed  executives  and officers of  out-of-the-money  options to also
receive a new exercise price of $1.50,  but the number of shares of Common Stock
covered by these options were reduced pursuant to the  Black-Scholes  formula so
that  there  would  be  approximate  economic  equivalence  between  old and new
options.  As a result,  options  for an  aggregate  of 561,752 out of a total of
1,635,000  shares of Common Stock at exercise prices ranging from $6.82 to $1.91
per share were repriced.

10.  RESTATEMENT

In connection  with the Company's  issuance of Series K Preferred  Stock on July
28, 1997, ("the Offering"),  the Company has restated its Consolidated Financial
Statements  for the quarter ended  September 30, 1997 to reflect the Offering as
temporary equity (See Note 7). The Offering was reclassified from  shareholders'
equity to temporary  equity due to  conditions  of  redemption,  pursuant to the
terms of the  Certificate of Designation  for the Series K Stock,  that were not
solely within control of the Company.  As a result of this change, the Company's
total stockholders'  equity at September 30, 1997 decreased from $2.0 million to
negative ($1.7) million.  Subsequent to September 30, 1997, the Company received
from  the  Series K  Stockholders  an  amendment  to the  redemption  provisions
whereby,  all  conditions  of redemption  are now solely  within  control of the
Company (See Note 11).

11.  SUBSEQUENT EVENT AND PRO FORMA BALANCE SHEET

On November 30, 1997, the Company and the Series K Preferred Stockholders agreed
to amend certain redemption  provisions of the Certificate of Designation to the
Series K Stock that were not  solely  within the  control  of the  Company.  The
stockholders agreed not to exercise any right of redemption if the stockholder's
Cap  Amount  exceeds  135% of the total  number of shares of Common  Stock  then
issuable on conversion of its Series K Stock. The  stockholders  agreed to forgo
their right to  exercise  such rights so long as (i) the Company has not, at any
time,  decreased the reserved amount of shares below 12,500,000 shares of Common
Stock;  (ii) the Company shall have taken immediate action following the trigger
date to increase the  reserved  amount to 200% of the number of shares of Common
Stock then issuable upon  conversion of the  outstanding  Preferred  Stock;  and
(iii) the Company  continues  to use its good faith best efforts to increase the
reserved  amount to 200% of the number of shares of Common  Stock then  issuable
upon conversion of the outstanding  Preferred Stock. The parties agreed that the
Company  will be deemed to have used "its good faith best  efforts"  to increase
the Reserved Amount so long as it solicits shareholder approval to authorize the
issuance  of  additional  shares  of Common  Stock no less than  three (3) times
during  each  12  month  period  following  the  trigger  date.   Furhter,   the
stockholders  agreed not to exercise any right of redemption if the Common Stock
is  suspended  from  trading on any of, or is not listed on at least one of, the
New York Stock Exchange, the American Stock Exchange, the Nasdaq National Market
or the Nasdaq  Small Cap Market for an  aggregate of 10 trading days in any nine
month period,  and in such  circumstance the  stockholders  would be entitled to
receive within five (5) business days of the  occurrence of a redemption  event,
as liquidated damages an amount equal to 25% of the aggregate face amount of the
shares of Series K Stock then held by each stockholder.  The liquidated  damages
are payable,  at the Company's  option,  in cash or shares of Common Stock, such
stock based upon a price per share equal to 50% of the lowest  closing  price of
the  Common  Stock  during the 10  consecutive  trading  day period  immediately
preceding  the date of such  redemption  event.  Additionally,  the  Company has
agreed  to keep  reserved  3,000,000  shares  of  Common  Stock to  satisfy  its
obligation with respect to the liquidated  damages. In the event that the number
of shares  required  to be issued by the Company  with  respect to the amount of
liquidated  damages exceeds  3,000,000  shares of Common Stock,  and the Company
does not have a  sufficient  number of shares of  Common  Stock  authorized  and
available for issuance to satisfy its obligation  with respect to the liquidated
damages,  the Company shall issue and deliver to the  stockholders all 3,000,000
shares of Common Stock so reserved for that purpose and, upon such issuance, the
stockholders  shall  have no  right of  redemption  upon a  Redemption  Event as
specified in the  Certificate of  Designation  to the Series K Stock,  but shall
retain  all other  remedies  to which they may be  entitled  at law or in equity
which remedies shall not include the right of redemption.  The stockholders also
agreed  not to  exercise a right of  redemption  if the  registration  statement
required to be filed by the Company, pursuant to a registration rights agreement
entered into between the parties, has not been declared effective by January 31,
1998, or such registration statement, after being declared effective,  cannot be
utilized by the holders of the Series K Preferred  Stock for the resale of their
securities  for an aggregate of more than 30 days after June 30, 1998,  however,
in any such events and while any of such events continues, the Company agrees to
provide that the permanent reductions to the conversion percentages set forth in
the registration rights agreement shall accrue at the rate of two hundreds (.02)
per week  instead of two  hundreds  (.02) per month.  The  stockholders  further
agreed not to exercise a right of redemption upon an event where the Company has
50% or more of the voting power of its capital stock owned  beneficially  by one
person,  entity  or  group  (as such  term is used  under  Section  13(d) of the
Securities  Exchange Act of 1934,  as  amended),  so long as the Company has not
approved,  recommended or otherwise consented to the transaction which triggered
that event. The parties have agreed that all subsequent  holders of the Series K
Stock shall be bound by the terms of the  amendment,  and the  parties  shall be
responsible for  communicating the terms of the amendment to any such subsequent
holders.  As a result,  the Series K Preferred  Stock  classified  as  temporary
equity at September  30, 1997 will be included  within  shareholders'  equity at
December 31, 1997.  The pro forma  balance  sheet at September 30, 1997 reflects
the  Series  K  Preferred  Stock  as if it  had  been  classified  as  permanent
shareholders' equity.
    

<PAGE>





No dealer, salesperson or any other  person  has
been authorized to give any  information  or  to
make  any  representations  in  connection  with 
the  Offering  other  than  those  contained  in 
this Prospectus  and, if  given  or  made,  such
information  or   representations  must  not  be
relied upon  as  having  been  authorized by the
Company   or   any   Selling  Shareholder.  This       2,150,000 SHARES
Prospectus  does  not  constitute  an  offer  to
sell, or a solicitation of an offer to purchase,
any  securities  other  than  the  securities to
which it  relates  or an  offer  to  sell or the   Network Imaging Corporation
solicitation  of  an  offer  to  buy  the Common
Stock in any circumstances  in  which such offer
or  solicitation  is  unlawful.  Neither the de-         COMMON STOCK
livery  of  this  Prospectus  nor  any sale made
hereunder shall, under any circumstances, create
any implication that there has been no change in
the facts set forth in the Prospectus  or in the
affairs of the Company since the date hereof  or
that the information contained herein is correct
as of any time subsequent to the date hereof.
                                                      ______________________
                                  
                                                           PROSPECTUS
           -----------------------                    ______________________
                                                        
   
              TABLE OF CONTENTS
                                                 Page  
Prospectus Summary...................................  
Certain Forward Looking Statements...................
Risk Factors.........................................
Use of Proceeds......................................
Dividend and Market Price Information................
Capitalization.......................................
Selected Financial Data..............................
Management's Discussion and Analysis of
  Financial Condition and Results of Operations......
Business.............................................
Management...........................................
Ownership of Network Imaging
  Corporation Stock..................................
Certain Transactions.................................
Selling Stockholders.................................
Plan of Distribution.................................
Description of Capital Stock.........................
Shares Eligible for Future Sale......................
Independent Accountants..............................
Legal Matters........................................
Experts..............................................
Additional Information...............................
Index to Financial Statements.....................F-1
    


<PAGE>




                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 13.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

         The  following  table sets forth the  various  expenses  expected to be
incurred by the Registrant in connection  with the sale and  distribution of the
securities  being  registered  hereby.  All  amounts  are  estimated  except the
Securities and Exchange Commission registration fee.

   
SEC registration fee....................................         $  1,010.00
Listing fees............................................           17,500.00
Accounting fees and expenses............................           50,000.00
Legal fees and expenses.................................           70,000.00
Printing and engraving expenses.........................            5,000.00
Miscellaneous fees and expenses.........................            5,000.00
                                                                 -----------
    Total...............................................         $148,510.00
                                                                 ===========
    
                                                                             


ITEM 14.  INDEMNIFICATION OF DIRECTORS AND OFFICERS

         Section  145  of the  Delaware  General  Corporation  Law,  as  amended
("DGCL"),  provides that a corporation  may indemnify any person who was or is a
party  or is  threatened  to be  made a  party  to any  threatened,  pending  or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative  (other than an action by or in the right of the  corporation)  by
reason of the fact that the person is or was a  director,  officer,  employee or
agent of the corporation, or is or was serving at the request of the corporation
as a director,  officer, employee or agent of another corporation,  partnership,
joint venture, trust or other enterprise, against expenses (including attorneys'
fees),  judgments,  fines and amounts paid in settlement actually and reasonably
incurred by the person in connection  with such action,  suit or proceeding,  if
the person acted in good faith and in a manner the person reasonably believed to
be in or not opposed to the best interests of the corporation, and, with respect
to any criminal  action or  proceeding,  had no reasonable  cause to believe the
person's  conduct was unlawful.  Section 145 further provides that a corporation
similarly may indemnify any such person  serving in any such capacity who was or
is a party or is  threatened  to be made a party to any  threatened,  pending or
completed  action or suit by or in the  right of the  corporation  to  procure a
judgment in its favor,  against  expenses  actually and  reasonably  incurred in
connection  with the defense or  settlement of such action or suit if the person
acted in good faith and in a manner the person  reasonably  believed to be in or
not  opposed  to the  best  interests  of the  corporation  and  except  that no
indemnification  shall be made in respect  of any  claim,  issue or matter as to
which such  person  shall  have been  adjudged  to be liable to the  corporation
unless and only to the extent that the  Delaware  Court of Chancery or the court
in which such action or suit was brought shall determine upon application  that,
despite the  adjudication of liability but in view of all the  circumstances  of
the case,  such person is fairly and  reasonably  entitled to indemnity for such
expenses that the Court of Chancery or such other court shall deem proper.

         Section  102(b)(7) of the DGCL permits a corporation  to include in its
certificate of  incorporation  a provision  eliminating or limiting the personal
liability  of a director to the  corporation  or its  stockholders  for monetary
damages for breach of fiduciary duty as a director, provided that such provision
shall not  eliminate or limit the  liability of a director (i) for any breach of
the director's duty of loyalty to the corporation or its stockholders,  (ii) for
acts or omissions not in good faith or which involve intentional misconduct or a
knowing  violation  of law,  (iii) under  Section 174 of the DGCL  (relating  to
unlawful  payment of dividends and unlawful stock purchases and  redemptions) or
(iv) for any transaction  from which the director  derived an improper  personal
benefit. Article SEVENTH of the Registrant's Amended and Restated Certificate of
Incorporation  contains a provision that so eliminates the personal liability of
the Registrant's directors.

         Article IX of the Registrant's  Bylaws provides for  indemnification by
the  Registrant of its directors  and officers  ("Indemnifiable  Party") if such
Indemnifiable  Party acted in good faith and in a manner the Indemnifiable Party
reasonably believed to be in or not opposed to the best interests of the Company
(and with respect to any criminal action or proceeding had not reasonable  cause
to believe his or her conduct was unlawful)  and except that no  indemnification
shall be made in  respect  of any  claim,  issue  or  matter  as to  which  such
Indemnifiable  Party shall have been adjudged to be liable to the Company unless
and only to the extent  that the Court of  Chancery  of the State of Delaware or
the  court  in which  such  action  or suit was  brought  shall  determine  upon
application  that,  despite the  adjudication  of  liability  but in view of all
circumstances  of the case,  such  person is fairly and  reasonably  entitled to
indemnity  for such  expenses  which the Court of  Chancery  or such other court
shall deem proper.

ITEM 15.  Recent Sales of Unregistered Securities

   
         In July 1995,  the Company  issued 1,791 shares of Series D Convertible
Preferred  Stock  ("Series  D  Stock")  to 22  non-U.S.  investors  pursuant  to
Regulation S for an  aggregate  of  $17,910,000.  In October  1995,  the Company
rescinded  the sale of 74 shares of Series D Stock for  $766,000,  which  amount
included  $16,000 of interest at 8%. As thus adjusted,  the aggregate  number of
Series D Stock  issued  by the  Company  was  1,716.  In  connection  with  this
issuance, the Company issued to its placement agent, Swartz Investments, Inc., a
warrant to purchase  227,069 shares of Common Stock at an initial exercise price
of $7.57 per share.

         In July 1995,  the  Company  issued 250 shares of Series E  Convertible
Preferred  Stock  to 13  non-U.S.  investors  pursuant  to  Regulation  S for an
aggregate  price of $2,500,000.  In connection  with this issuance,  the Company
issued to its  placement  agent,  Oakes,  Fitzwilliams  & Co.  SA, a warrant  to
purchase 34,400 shares of Common Stock at an initial exercise price of $7.20 per
share.

         In November 1995, in connection  with  asset-based  financing  arrange-
ments,  the Company issued to Ed Feldman a warrant to purchase  25,000 shares of
Common Stock at an initial  exercise price of $3.63 per share.  This warrant was
issued pursuant to Section 4(2) of the Securities Act.

         In December  1995,  the  Company  issued to each of Jarl  McDonald  and
Christian  Stackhouse  a warrant to purchase  4,000 shares of Common Stock at an
initial  exercise price of $6.82 per share.  These warrants were issued pursuant
to Section 4(2) of the Securities Act.

         In December 1995, the Company issued 200 shares of Series G Convertible
Preferred Stock and warrants to purchase an aggregate of 40,000 shares of Common
Stock at an initial exercise price of $1.88 per share to two non-U.S.  investors
pursuant to Regulation S for an aggregate price of $2,000,000.

         In November and December 1995, the Company issued  2,467,857  shares of
Common Stock and warrants to purchase  179,400 shares of Common Stock at initial
exercise prices ranging from $3.50 per share to $4.00 per share for an aggregate
price of approximately $9 million.

         In March 1996,  the Company issued 934,634 shares of Common Stock and a
warrant to  purchase  an  additional  64,000  shares to an  accredited  investor
pursuant to Regulation D at an initial exercise price of $4.5375 per share.

         In March 1996, the Company issued 421,040 shares of Common Stock to two
non-U.S.   investors  pursuant  to  Regulation  S  for  an  aggregate  price  of
approximately $1.7 million.

         In  March  1996,  the  Company  issued  1,792,186  shares  of  Series F
Convertible Preferred Stock in exchange for 1,792 shares of Series C Convertible
Preferred Stock of the Company.

         In June 1996,  the  Company  issued 300 shares of Series H  Convertible
Preferred  Stock and  warrants to purchase  80,000  shares of Common Stock at an
initial  exercise  price of $3.75  per share  pursuant  to  Regulation  S for an
aggregate price of approximately $3 million.

         In June 1996,  the  Company  issued 300 shares of Series I  Convertible
Preferred Stock pursuant to Regulation D for an aggregate price of approximately
$3 million.

         In June 1996,  the  Company  issued 500 shares of Series J  Convertible
Preferred Stock pursuant to Regulation D for an aggregate price of approximately
$5 million.

         In  December  1996,  the Company  issued a warrant to  purchase  25,000
shares of Common Stock at an initial  exercise price of $3.06 per share to Damon
Testaverde.  This warrant was issued  pursuant to Section 4(2) of the Securities
Act.

         In December 1996,  pursuant to Regulation D under the  Securities  Act,
the  Company  issued  warrants to purchase  4,000  shares of Common  Stock at an
initial  exercise price of $3.0625 per share to Susan G. Kaufman,  in connection
with a $5 million loan from Fred Kassner to the Company.

         In December 1996,  pursuant to Section 4(2) of the Securities  Act, the
Company  issued  warrants  to  purchase  100,000  shares of  Common  Stock at an
exercise  price of $3.06 per share ("$3.06  Warrants")  to a stockholder  of the
Company  in  connection  with a $5  million  loan  from the  stockholder  to the
Company.
    

         In July 1997,  the Company  issued 3,300 shares of Series K Convertible
Preferred  Stock and warrants to purchase  247,500  shares of Common Stock at an
exercise  price of $2.40 per share to two investors  pursuant to Regulation D of
the  Securities  Act for an  aggregate  of  $3,300,000.  The Company also issued
warrants  to purchase  162,462  shares of Common  Stock at an exercise  price of
$1.625 per share,  valued at $264,000,  to a placement  agent in connection with
the above described offering in reliance on Regulation D of the Securities Act.


   
         During July and August 1997,  the Company  issued,  pursuant to Section
4(2) of the  Securities  Act, 8%  Convertible  Notes in the aggregate  principal
amount of $2.0 million and warrants to purchase an aggregate of 40,000 shares of
Common  Stock,  at an exercise  price of $1.875 per share with respect to 36,000
warrants  and at an  exercise  price of $1.50 per share  with  respect  to 4,000
warrants.  $1.8 million of the notes are convertible into shares of Common Stock
at an initial conversion price of $1.875 per share and $200,000 of the notes are
convertible into shares of Common Stock at an initial  conversion price of $1.50
per share.

         In October and November 1997,  the Company,  under the terms of certain
termination agreements (See "Management -- Compensation Committee Interlocks and
Insider  Participation"  and "Certain  Transactions"  in the Prospectus)  issued
warrants issuable for (i) 100,000 shares of Common Stock at an exercise price of
$1.50 per share,  (ii) 66,667  shares of Common  Stock an  exercise  price of at
$1.50 per share, and (iii) 50,000 shares of Common Stock at an exercise price of
$1.50 per share.  These  warrants  were issued  pursuant to Section  4(2) of the
Securities Act.

         During  1997,  the Company has issued  warrants to (i) the Poretz Group
for 3,094 shares of Common Stock at an exercise  price of $3.38 per share,  (ii)
Fred Kassner for 70,000 shares of Common Stock at an exercise price of $3.06 per
share, (iii) Damon  TestaverdeTestiverdi  for 17,500 shares at an exercise price
of $2.66 per share, (iv) the Poretz Group for 5,495 shares of Common Stock at an
exercise  price of $1.81 per share,  (iv) Fred  Kassner for 30,000  shares at an
exercise price of $2.09 per share,  (v) Damon  Testiverdi for 7,500 shares at an
exercise  price of $2.09 per share,  (vi) the Poretz  Group for 4,464  shares of
Common Stock at an exercise price of $1.38 per share, and (vii) the Poretz Group
for 5,495 shares at an exercise  price of $1.66 per share.  These  warrants were
issued pursuant to Section 4(2) of the Securities Act.

         On August 28, 1997, the Board of Directors  approved the Director Stock
Option Plan (the  "Plan"),  subject to  shareholder  approval,  to provide stock
option grants in the amount of 30,000 shares at each annual meeting of the Board
for those  directors  who are not  executive  officers of the  Company.  Persons
appointed  to the Board of  Directors  at any time after the annual  grant would
receive  pro-rata shares of the option grant.  Options vest 25% each quarter and
become  fully  vested  on the first  anniversary  of their  grant.  The Plan was
effective as of July 1, 1997. On July 1, 1997, options to purchase 30,000 shares
of Common Stock at an exercise  price of $2.03 per share were granted to each of
Robert Ripp,  C. Alan  Peyser,  Robert P.  Bernardi  and John F.  Burton.  These
options were issued pursuant to Section 4(2) of the Securities Act.

         In August 1997, the Company entered into an agreement with Alex.  Brown
& Sons,  Incorporated  whereby  Alex.  Brown would act as the sole and exclusive
financial advisor to provide the Company with general  restructuring  advice. In
connection with this  agreement,  the Company issued a warrant for 33,951 shares
of Common Stock at an exercise price of $1.56 per share. This warrant was issued
pursuant to Section 4(2) of the Securities Act.

         On  December  8, 1997,  the  Company  issued  3,250  shares of Series L
Convertible  Preferred  Stock and warrants to purchase  243,750 shares of Common
Stock at an  exercise  price of $1.65 per share to three  investors  pursuant to
Regulation  D  of  the  Securities  Act  for  an  aggregate  purchase  price  of
$3,250,000.  The Company  also issued  warrants  to purchase  160,000  shares of
Common  Stock at an exercise  price of $1.625 per share to a placement  agent in
connection with the above described  offering in reliance on Regulation D of the
Securities Act.
    


ITEM 16.  EXHIBITS.


         The  exhibits  listed  in the  Exhibit  Index  are  filed as part of or
incorporated by reference in this Registration Statement:


Exhibit No.    Description

2.1            Agreement  and Plan of  Reorganization  by and among the Company,
               Dorotech  France SA and the  stockholders  of Dorotech  France SA
               dated August 30, 1993 with the amendments thereto dated September
               29,  1993 and  October 1, 1993.  (Incorporated  by  reference  to
               Exhibit  1 to  Company's  Report  on Form  8-K  relating  to such
               Agreement and Plan of Reorganization filed October 13, 1993.)

2.2            Agreement  for the  Purchase  and Sale of Assets  of  Symmetrical
               Technologies,  Inc. as of September  30, 1996.  (Incorporated  by
               reference to Exhibit 10.a to the  Company's  Quarterly  Report on
               Form 10-Q for the period ended September 30, 1996.)

3.1            Restated  Certificate  of  Incorporation  as of November 19, 1997
               (Incorporated  by reference to Exhibit 3.1 to Amendment  No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

3.2            Restated Bylaws as of May 17, 1996  (Incorporated by reference to
               Exhibit 3.11 to Amendment  No. 1 to the  Company's  Form 10-Q for
               the quarterly period ended June 30, 1997).

3.3            Certificate of Designations  for Series A Cumulative  Convertible
               Preferred Stock filed with the Secretary of State of the State of
               Delaware on  December  7, 1993.  (Incorporated  by  reference  to
               Exhibit 3.1c to the Company's registration statement on Form SB-2
               (Registration No. 33-73164) filed December 20, 1993.)

   
3.4            Certificates  of  Designations  for Series F-1,  F-2, F-3 and F-4
               Convertible  Preferred Stock filed with the Secretary of State of
               the  State  of  Delaware  on March  29,  1996.  (Incorporated  by
               reference to Exhibit  3.(i).i to the  Company's  Annual Report on
               Form 10-K for the fiscal year ended December 31, 1995.)
    

3.5            Certificate  of  Designation  of Series K  Convertible  Preferred
               Stock  of the  Company  filed  in  Delaware  on  July  28,  1997.
               (Incorporated  by reference to Exhibit 3.12 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

4.1            Specimen Common Stock Certificate.  (Incorporated by reference to
               Exhibit  4.2 to  Amendment  No. 1 to the  Company's  registration
               statement on Form S-1 (Registration No. 33-45721) filed April 10,
               1992.)

5              Opinion of Kirkpatrick & Lockhart LLP.

   
10.1           Warrant Agreement between the Company and American Stock Transfer
               & Trust  Co.  dated as of  February  1,  1993.  (Incorporated  by
               reference  to  Exhibit  1 to  Post-Effective  Amendment  No. 1 to
               Company's  registration  statement on Form S-1  (Registration No.
               33-45721) filed April 1, 1993.)
    

10.2           Amendment  No.  1 dated  as of  April  15,  1993  to the  Warrant
               Agreement between the Company and American Stock Trust & Transfer
               Co.  (Incorporated  by reference  to Exhibit 2 to  Post-Effective
               Amendment No. 1 to Company's  registration  statement on Form S-1
               (Registration No. 33-45721) filed April 1, 1993.)

10.3           Warrant Agreement between the Company and American Stock Transfer
               &  Trust  Co.  dated  as of  April  28,  1993.  (Incorporated  by
               reference to Exhibit 4.4 to Company's  registration  statement on
               Form SB-2 (Registration No. 33-64046) filed June 8, 1993.)

   
10.4           Specimen Warrant Certificate (Public Warrants).  (Incorporated by
               reference  to Exhibit  4.3 to  Amendment  No. 1 to the  Company's
               registration  statement on Form S-1  (Registration  No. 33-45721)
               filed April 10, 1992.)
    

10.5           Specimen Warrant  Certificate  (International/Oakes  Fitzwilliams
               Series).  (Incorporated  by  reference  to  Exhibit  4.6  to  the
               Company's  Annual  Report  on  Form  10-KSB  for the  year  ended
               December 31, 1992.)

10.6           Specimen Warrant Certificate (International/Thomas James Series).
               (Incorporated   by   reference   to  Exhibit  4.7  to   Company's
               registration  statement on Form SB-2  (Registration No. 33-64046)
               filed June 8, 1993.)

10.7           Warrant to purchase 20,700 units issued to Oakes,  Fitzwilliams &
               Co.  Limited.  (Incorporated  by  reference  to  Exhibit  4.8  to
               Company's  registration  statement on Form SB-2 (Registration No.
               33-64046) filed June 8, 1993.)

10.8           Warrant to purchase 33,214 units issued to Oakes,  Fitzwilliams &
               Co.  Limited.  (Incorporated  by  reference  to  Exhibit  4.9  to
               Company's  registration  statement on Form SB-2 (Registration No.
               33-64046) filed June 8, 1993.)

10.9           Placement  Agent's  Warrant to  purchase  8,150  units  issued to
               Thomas  James  Associates,  Inc.  (Incorporated  by  reference to
               Exhibit  4.10 to  Company's  registration  statement on Form SB-2
               (Registration No. 33-64046) filed June 8, 1993.)

10.10          Representative's Warrant issued to Thomas James Associates,  Inc.
               (Incorporated   by   reference   to  Exhibit  4.11  to  Company's
               registration  statement on Form SB-2  (Registration No. 33-64046)
               filed June 8, 1993.)

10.11          Warrant  Agreement  among the Company,  American Stock Transfer &
               Trust Co. and Thomas James  Associates,  Inc.  dated as of May 8,
               1992. (Incorporated by reference to Exhibit 4.12 to the Company's
               Annual  Report on Form  10-KSB  for the year ended  December  31,
               1992.)

   
10.12          Form  of  Amendment  to  Warrant  Agreement  among  the  Company,
               American Stock Transfer & Trust Co. and Thomas James  Associates,
               Inc.  dated as of May 8,  1992.  (Incorporated  by  reference  to
               Exhibit  4.12.a to Amendment No. 1 to the Company's  registration
               statement on Form SB-2  (Registration No. 33-64046) filed January
               5, 1994.)
    

10.13          Warrant  to  purchase  50,000  shares of  Common  Stock to Oakes,
               Fitzwilliams & Co. Limited. (Incorporated by reference to Exhibit
               4.13 to Amendment No. 1 to the Company's  registration  statement
               on Form SB-2 (Registration No. 33-64046) filed January 5, 1994.)

10.14          Warrants  to  purchase an  aggregate  of 45,000  shares of Common
               Stock issued to American Wealth Management, Inc., Edsel Anderson,
               Harris  Anderson and Eric Swartz.  (Incorporated  by reference to
               Exhibit 4.14 to  Amendment  No. 1 to the  Company's  registration
               statement on Form SB-2  (Registration No. 33-64046) filed January
               5, 1994.)

   
10.15          Form of Warrant  issued in  connection  with  February  1992 debt
               financing.  (Incorporated  by reference  to Exhibit  4.6.B to the
               Company's  registration  statement on Form S-1. (Registration No.
               33-45721) filed February 13, 1992.)
    

10.16          Warrant to  purchase  227,068  shares of Common  Stock  issued to
               Swartz  Investments  Inc.  (Incorporated  by reference to Exhibit
               4.17 to the  Company's  Annual Report on Form 10-K for the fiscal
               year ended December 31, 1995.)

10.17          Warrant  to  purchase  34,400  shares of Common  Stock  issued to
               Oakes, Fitzwilliams & Co. Limited.  (Incorporated by reference to
               Exhibit 4.18 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1995.)

10.18          Form of Warrants issued in connection with December 1995 Series G
               Convertible Preferred Stock offering.  (Incorporated by reference
               to Exhibit 4.19 to the  Company's  Annual Report on Form 10-K for
               the fiscal year ended December 31, 1995.)

10.19          Form of Warrants issued in connection with November/December 1995
               Private Placement of Common Stock.  (Incorporated by reference to
               Exhibit 4.20 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1995.)

10.20          Warrant to purchase  25,000  shares of Common  Stock issued to Ed
               Feldman  dated  November 7, 1995.  (Incorporated  by reference to
               Exhibit 4.21 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1995.)

10.21          Warrant to purchase  4,000  shares of Common Stock issued to Jarl
               McDonald dated December 20, 1995.  (Incorporated  by reference to
               Exhibit 4.22 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1995.)

10.22          Warrant  to  purchase  4,000  shares  of Common  Stock  issued to
               Christian  Stackhouse  dated December 20, 1995.  (Incorporated by
               reference to Exhibit 4.23 to the Company's  Annual Report on Form
               10-K for the fiscal year ended December 31, 1995.)

10.23          Exchange  Agreement  between CDR  Enterprises  the Company  dated
               March 29, 1996. (Incorporated by reference to Exhibit 4.35 to the
               Company's  Annual  Report on Form 10-K for the fiscal  year ended
               December 31, 1995.)

10.24          Warrant to  purchase  100,000  shares of Common  Stock to Fred E.
               Kassner dated  December 31, 1996.  (Incorporated  by reference to
               Exhibit 4.36 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1996.)

10.25          Warrant to purchase up to 25,000  shares of Common Stock to Damon
               Testaverde dated January 31, 1997.  (Incorporated by reference to
               Exhibit 4.37 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1996.)

10.26          Warrant  to  purchase  4,000  shares of Common  Stock to Susan G.
               Kaufman dated  December 31, 1996.  (Incorporated  by reference to
               Exhibit 4.38 to the Company's  Annual Report on Form 10-K for the
               fiscal year ended December 31, 1996.)

10.27          Eight  Percent  (8%)  Convertible  Note between  Network  Imaging
               Corporation  and Wood  Gundy in trust  for RRSP 550  98866 19 and
               Gundyco  in trust  for RRSP 550  99119 12 as of July 9,  1997 and
               attached Schedule. (Incorporated by reference to Exhibit 10.22 to
               the Company's  Form 10-Q for the quarterly  period ended June 30,
               1997.)

10.28          Securities Purchase Agreement between Network Imaging Corporation
               and Capital Ventures International and Zanett Lombardier, Ltd. as
               of July 28, 1997.  (Incorporated by reference to Exhibit 10.23 to
               the Company's  Form 10-Q for the quarterly  period ended June 30,
               1997.)

10.29          Registration Rights Agreement between Network Imaging Corporation
               and Capital Ventures International and Zanett Lombardier, Ltd. as
               of July 28, 1997.  (Incorporated by reference to Exhibit 10.24 to
               the Company's  Form 10-Q for the quarterly  period ended June 30,
               1997.)

10.30          Warrant to purchase  20,000 shares of Common Stock issued to Wood
               Gundy  in  trust  for RRSP  550  98866  19  dated  July 9,  1997.
               (Incorporated by reference to Exhibit 10.25 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

10.31          Warrant  to  purchase  16,000  shares of Common  Stock  issued to
               Gundyco  in  trust  for RRSP 550  99119  12 dated  July 9,  1997.
               (Incorporated by reference to Exhibit 10.26 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

10.32          Warrant to  purchase  112,500  shares of Common  Stock  issued to
               Capital Ventures International dated July 28, 1997. (Incorporated
               by reference to Exhibit 10.27 to the Company's  Form 10-Q for the
               quarterly period ended June 30, 1997.)

10.33          Warrant to  purchase  135,000  shares of Common  Stock  issued to
               Zanett  Lombardier,  Ltd. dated July 28, 1997.  (Incorporated  by
               reference  to Exhibit  10.28 to the  Company's  Form 10-Q for the
               quarterly period ended June 30, 1997.)

   
10.34          Warrant to purchase  162,462 shares of Common Stock issued to the
               Zanett Securities Corporation dated July 28, 1997.  (Incorporated
               by reference to Exhibit 10.29 to the Company's  Form 10-Q for the
               quarterly period ended June 30, 1997.)
    

10.35          Placement  Agency  Agreement  dated July 2, 1997 between  Network
               Imaging  Corporation  and  The  Zanett  Securities   Corporation.
               (Incorporated by reference to Exhibit 10.30 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

10.36          Security  Agreement dated as of December 31, 1996 between Network
               Imaging Corporation and Fred Kassner.  (Incorporated by reference
               to Exhibit  10.31 to the  Company's  Form 10-Q for the  quarterly
               period ended June 30, 1997.)

10.37          Amendment  No.  1 to Loan  Agreement  dated  as of  June 8,  1997
               between   Network   Imaging   Corporation   and   Fred   Kassner.
               (Incorporated by reference to Exhibit 10.32 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

10.38          Amendment  No. 1 to Security  Agreement  dated as of June 8, 1997
               between   Network   Imaging   Corporation   and   Fred   Kassner.
               (Incorporated by reference to Exhibit 10.33 to the Company's Form
               10-Q for the quarterly period ended June 30, 1997.)

   
10.39          Consulting  Agreement by and between the Company,  BCG,  Inc. and
               Robert P. Bernardi dated May 28, 1996.  Incorporated by reference
               to Exhibit 10.a to the Company's  report on Form 8-K filed August
               2, 1996.
    

10.40          Form of Consulting Agreement by and between the Company, Sterling
               Capital  Group,  Inc.  and  Robert  M.  Sterling,  Jr.  effective
               February 1, 1994. (Incorporated by reference to Exhibit 10.4.b to
               Post-Effective  Amendment  No.  1 to the  Company's  registration
               statement on Form SB-2  (Registration No. 33-73164) filed January
               14, 1994.)

10.41          Amendment  dated  October  1, 1995 by and  between  the  Company,
               Sterling  Capital  Group,  Inc.,  and  Robert  M.  Sterling,  Jr.
               (Incorporated  by  reference to Exhibit  10.4.c to the  Company's
               Annual Report on Form 10-K for the fiscal year ended December 31,
               1995.)

10.42          Purchase Agreement by and between the Company and CDR Enterprises
               for the  repurchase  of the  Company's  Series F Preferred  Stock
               dated  December 31, 1996.  (Incorporated  by reference to Exhibit
               10.20 to the Company's  Annual Report on Form 10-K for the fiscal
               year ended December 31, 1996.)

10.43          Loan Agreement by and between the Company and Fred E. Kassner for
               a  line  of  credit  of  $5,000,000   dated  December  31,  1996.
               (Incorporated  by  reference  to Exhibit  10.21 to the  Company's
               Annual Report on Form 10-K for the fiscal year ended December 31,
               1996.)
   
10.44          Amendment   dated   January   1,  1996  among   Network   Imaging
               Corporation, Sterling Capital Group and Robert M. Sterling, Jr. *

10.45          Amendment   dated   January   1,  1996  among   Network   Imaging
               Corporation, BCG, Inc. and Robert P. Bernardi. *
    


10.46          Amendment to Purchase  Agreement  effective  May 30, 1997 between
               Network Imaging Corporation and CDR Enterprises. (Incorporated by
               reference to Exhibit  10.46 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)

   
10.47          Registration   Rights  Agreement  between  the  Company  and  CDR
               Enterprises  dated as of  December  31,  1996.  (Incorporated  by
               reference to Exhibit  10.47 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)
    

10.48          Warrant to purchase  40,000 shares of Common Stock issued to Mark
               Shoom dated as of June 25,  1996.  (Incorporated  by reference to
               Exhibit 10.48 to Amendment  No. 1 to the  Company's  registration
               statement on Form S-4 (Registration No. 333-36517) filed December
               4, 1997.)

10.49          Warrant  to  purchase  40,000  shares of Common  Stock  issued to
               Charles  Kucey  dated  as of  June  25,  1996.  (Incorporated  by
               reference to Exhibit  10.49 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)

   
10.50          Form of  Registration  Rights  Agreement  between Network Imaging
               Corporation and GFL Performance Ltd., dated as of March 15, 1996.
               (Incorporated by reference to Exhibit 10.50 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)
    

10.51          Warrant  to  purchase  5,000  shares  of Common  Stock  issued to
               Redington,  Inc. dated October 21, 1993 and Form of  Registration
               Rights   Agreement   between  Network  Imaging   Corporation  and
               Redington,  Inc.  (Incorporated  by reference to Exhibit 10.51 to
               Amendment No. 1 to Company's  registration  statement on Form S-4
               (Registration No. 333-36517) filed December 4, 1997.)

10.52          Form of  Registration  Rights  Agreement  between Network Imaging
               Corporation  and Fred  Kassner  dated as of  December  31,  1996.
               (Incorporated by reference to Exhibit 10.52 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.53          Form of Warrant Agreement between Network Imaging Corporation and
               American  Stock  Transfer  and Trust  Company to issue  shares of
               Common  Stock dated as of December  31,  1996.  (Incorporated  by
               reference to Exhibit  10.53 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)

10.54          Representative's Warrant issued to Thomas James Associates,  Inc.
               to purchase  150,000  shares of Common  Stock dated May 18, 1992.
               (Incorporated  by  reference  to  Exhibit  4.11 to the  Company's
               registration  statement on Form SB-2  (Registration No. 33-64046)
               filed June 9, 1993.)

   
10.55          (Intentionally omitted).

10.56          (Intentionally omitted).
    
10.57          Warrant to  purchase  in  aggregate  (i) up to 140,000  shares of
               Series A Preferred  Stock, or (ii) up to 253,624 shares of Common
               Stock, or (iii) any combination of such securities  issued to (a)
               RAS  Securities  Corp. and (b) R.A.  Schneider  dated December 7,
               1993.  (Incorporated  by reference to Exhibit  10.57 to Amendment
               No.  1 to  the  Company's  registration  statement  on  Form  S-4
               (Registration No. 333-36517) filed December 4, 1997.)

   
10.58          Eight Percent (8%) Convertible  Notes in the aggregate  principal
               amount of $200,000 dated August 20, 1997 and issued to Gundyco in
               trust  for RRSP 550  99119  12.  (Incorporated  by  reference  to
               Exhibit  10.34 to the  Company's  Form 10-Q for the three  months
               ended September 30, 1997.)
    

10.59          Form of Warrant dated August 21, 1997 to purchase 4,000 shares of
               Common  Stock  issued to  Gundyco in trust for RRSP 550 99119 12.
               (Incorporated by reference to Exhibit 10.35 to the Company's Form
               10-Q for the three months ended September 30, 1997.)

10.60          Termination  of  Consulting   Agreement   among  Network  Imaging
               Corporation,   Sterling  Capital  Group,   Inc.,  and  Robert  M.
               Sterling, Jr., dated October 13, 1997. (Incorporated by reference
               to Exhibit 10.60 to Amendment No. 1 to the Company's registration
               statement on Form S-4 (Registration No. 333-36517) filed December
               4, 1997.)

10.61          Termination  of  Consulting   Agreement   among  Network  Imaging
               Corporation,  Mann  Enterprises,  Inc.,  and John B.  Mann  dated
               October 17, 1997.  (Incorporated by reference to Exhibit 10.61 to
               Amendment No. 1 to the Company's  registration  statement on Form
               S-4 (Registration No. 333-36517) filed December 4, 1997.)

10.62          Termination  of  Consulting   Agreement   among  Network  Imaging
               Corporation, BCG, Inc., and Robert P. Bernardi, dated October 30,
               1997.  (Incorporated  by reference to Exhibit  10.62 to Amendment
               No.  1 to  the  Company's  registration  statement  on  Form  S-4
               (Registration No. 333-36517) filed December 4, 1997.)

10.63          Form of Warrant to purchase  (i) 100,000  shares of Common  Stock
               issued to Robert M. Sterling,  Jr.,  dated October 1, 1997,  (ii)
               66,667 shares of Common Stock issued to Mann  Enterprises,  Inc.,
               dated October 1, 1997, (iii) 50,000 shares of Common Stock issued
               to Robert P. Bernardi dated October 1, 1997, (iv) 4,464 shares of
               Common Stock issued to the Poretz Group dated August 1, 1997, (v)
               5,495  shares of Common  Stock  issued to the Poretz  Group dated
               November 1, 1997 and (vi) 33,951 shares of Common Stock issued to
               Alex   Brown  &  Sons   Incorporated   dated   August  5,   1997.
               (Incorporated by reference to Exhibit 10.63 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.64          Form of  Registration  Rights  Agreement  among  Network  Imaging
               Corporation  and the purchasers of the Series D Preferred  Stock.
               (Incorporated by reference to Exhibit 10.64 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.65          Form of  Registration  Rights  Agreement  among  Network  Imaging
               Corporation  and the purchasers of the Series E Preferred  Stock.
               (Incorporated by reference to Exhibit 10.65 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.66          Letter of Agreement between Network Imaging  Corporation and Alex
               Brown & Sons Incorporated dated August 13, 1997. (Incorporated by
               reference to Exhibit  10.66 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)

   
10.67          Form of  Warrant to  purchase  (i) 3,094  shares of Common  Stock
               issued to the Poretz  Group dated  February 1, 1997,  (ii) 70,000
               shares of Common  Stock  issued to Fred  Kassner  dated March 27,
               1997,  (iii)  17,500  shares  of  Common  Stock  issued  to Damon
               Testaverde  dated  March 27,  1997,  (iv) 5,495  shares of Common
               Stock  issued to the Poretz  Group dated May 1, 1997,  (v) 30,000
               shares of Common Stock issued to Fred Kassner dated June 9, 1997,
               and (vi) 7,500 shares of Common Stock issued to Damon  Testaverde
               dated June 9, 1997.  (Incorporated  by reference to Exhibit 10.67
               to Amendment  No. 1 to the  Company's  registration  statement on
               Form S-4 (Registration No. 333-36517) filed December 4, 1997.)
    

10.68          Form of Securities  Purchase  Agreement  between  Network Imaging
               Corporation  and  Genesee  Fund  Limited  dated  March 15,  1996.
               (Incorporated by reference to Exhibit 10.68 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.69          Form of Securities  Purchase  Agreement  between  Network Imaging
               Corporation and (i) Bank Ehinger & CIE AG, and (ii)  Privatinvest
               Bank,   respectively,   dated  in   February   and  March   1996.
               (Incorporated by reference to Exhibit 10.69 to Amendment No. 1 to
               the Company's  registration  statement on Form S-4  (Registration
               No. 333-36517) filed December 4, 1997.)

10.70          Letter  of   Employment   Agreement   between   Network   Imaging
               Corporation  and James Leto dated May 9, 1996.  (Incorporated  by
               reference to Exhibit  10.70 to Amendment  No. 1 to the  Company's
               registration  statement on Form S-4  (Registration No. 333-36517)
               filed December 4, 1997.)

10.71          Form of Convertible  Preferred Stock Purchase  Agreement  between
               Network  Imaging  Corporation  and Purchaser dated June 28, 1996.
               (Incorporated  by  reference  to  Exhibit  4.a to  the  Company's
               Quarterly  Report on Form  10-Q for the  period  ending  June 30,
               1996.)

   
10.72          Form of Convertible  Preferred Stock Purchase  Agreement  between
               Network   Imaging   Corporation   and  Southbrook   International
               Investments,  Ltd.,  dated September 30, 1996.  (Incorporated  by
               reference  to Exhibit 4.a to the  Company's  Quarterly  Report of
               Form 10-Q for the period ending September 30, 1996.)
    

10.73          Form of  Agreement  among  Network  Imaging  Corporation,  Zanett
               Lombardier Ltd., and Capital Ventures  International  dated as of
               November 30, 1997.

21             Subsudiaries.   (Incorporated  by  reference  to  Exhibit  21  to
               Amendment No. 1 to the Company's  registration  statement on Form
               S-4 (Registration No. 333-365517) filed December 4, 1997.)

23.1           Consent of Ernst & Young LLP, Independent Accountants.

23.2           Consent of Price Waterhouse LLP, Independent Accountants.

23.3           Consent of Kirkpatrick & Lockhart LLP (Contained in Exhibit 5.)

24             Power of Attorney (see page ___).

   
27.1           Financial data schedule for the year ended December 31, 1994. *

27.2           Financial data schedule for the year ended December 31, 1995. *
    

- ----------------------

   
*  Previously filed.


         The  1996  Valuation  Allowance  Schedule  was  not  included  in  this
Registration  Statement.  Such  schedule  was  omitted  from  this  Registration
Statement but the  information  required to be contained  therein is included in
the financial statements and notes included herein.
    

ITEM 17.  UNDERTAKINGS.

         (a)      The undersigned registrant hereby undertakes:

         (1) To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement:

         (i) To include any prospectus required by section 10(a)(3) of  the  Se-
urities Act of 1933;

         (ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration  statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental  change in the information set forth in the registration  statement.
Notwithstanding the foregoing,  any increase or decrease in volume of securities
offered (if the total dollar value of  securities  offered would not exceed that
which  was  registered)  and any  deviation  from  the  low or  high  end of the
estimated  maximum  offering  range may be reflected  in the form of  prospectus
filed with the  Commission  pursuant  to Rule 424(b) if, in the  aggregate,  the
changes in volume and price  represent  no more than a 20% change in the maximum
aggregate  offering price set forth in the  "Calculation  of  Registration  Fee"
table in the effective registration statement;

         (iii) To include any material  information  with respect to the plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

         Provided,  however,  that  paragraphs  (a)(1)(i) and  (a)(1)(ii) do not
apply  if the  registration  statement  is on  Form  S-3 or  Form  S-8,  and the
information  required  to be  included in a  post-effective  amendment  by those
paragraphs is contained in periodic reports filed by the registrant  pursuant to
section  13 or section  15(d) of the  Securities  Exchange  Act of 1934 that are
incorporated by reference in the registration statement.

         (2) That,  for the  purpose  of  determining  any  liability  under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

         (3) To remove from registration by means of a post-effective  amendment
any of the securities being registered which remain unsold at the termination of
the offering.

         (b)  Insofar  as  indemnification  for  liabilities  arising  under the
Securities Act of 1933 may be permitted to directors,  officers and  controlling
persons of the registrant  pursuant to the foregoing  provisions,  or otherwise,
the  registrant  has been  advised  that in the  opinion of the  Securities  and
Exchange  Commission such  indemnification is against public policy as expressed
in the Act and is,  therefore,  unenforceable.  In the  event  that a claim  for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  registrant  in the  successful  defense  of any  action,  suit or
proceeding)  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered,  the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit  to a  court  of  appropriate  jurisdiction  the  question  whether  such
indemnification  by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.

<PAGE>



                                   SIGNATURES

   
         Pursuant  to the  requirements  of the  Securities  Act  of  1933,  the
registrant  has duly caused this Amendment to its  Registration  Statement to be
signed on its behalf by the undersigned,  thereunto duly authorized, in the City
of Herndon, Commonwealth of Virginia, on this 8th day of December, 1997.

         NETWORK IMAGING CORPORATION


                                 By:      /s/ James J. Leto
                                          James J. Leto
                                          President and Chief Executive Officer



         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Amendment to its  Registration  Statement has been signed below by the following
persons in the capacities and on the dates indicated.


   Signature                     Title                           Date

/s/ James J. Leto
- --------------------
James J. Leto           President, Chief Executive Officer      December 8, 1997
                        and Chairman of the Board
    

   
/s/ Jorge R. Forgues
- --------------------
Jorge R. Forgues        Senior Vice President of Finance        December 8, 1997
                        and Administration, Chief Financial
                        Officer

/s/ Robert P. Bernardi*
- -----------------------
Robert P. Bernardi      Director and Secretary                  December 8, 1997

/s/ John F. Burton*
- -------------------
John F. Burton          Director                                December 8, 1997

/s/ C. Alan Peyser*
- -------------------
C. Alan Peyser          Director                                December 8, 1997

/s/ Robert Ripp*
- ----------------
Robert Ripp             Director                                December 8, 1997



*By:     /s/ James J. Leto
         James J. Leto,
         Attorney-in-fact
    





                -------------------------------------------------
                           KIRKPATRICK & LOCKHART LLP
                -------------------------------------------------

                         1800 MASSACHUSETTS AVENUE, N.W.
                                    2ND FLOOR
                           WASHINGTON, D.C. 20036-1800

                            TELEPHONE (202) 778-9000
                            FACSIMILE (202) 778-9100




                                                                       Exhibit 5



                                December 5, 1997



Network Imaging Corporation
500 Huntmar Park Drive
Herndon, Virginia 20170

         Re:      Network Imaging Corporation
                  Registration Statement on Form S-1
                  Registration Number 333-36385

Ladies/Gentlemen:

         We have acted as counsel to  Network  Imaging  Corporation,  a Delaware
corporation  ("Corporation"),  in connection  with the preparation and filing of
the  above-captioned  Registration  Statement on Form S-1,  Registration  Number
333-36385  ("Registration  Statement"),  under the  Securities  Act of 1933,  as
amended,  covering 2,150,000 shares of Common Stock, $0.0001 par value per share
("Common Stock"),  of the Corporation  issuable in connection with (a) the Eight
Percent (8%)  Convertible  Notes ("July  Notes") dated as of July 9, 1997 in the
aggregate  principal amount of $1,800,000 issued to Wood Gundy in trust for RRSP
550 98866 19 and Gundyco in trust for RRSP 550 9919 12 (collectively referred to
as the "Selling  Shareholders") and (b) the Eight Percent (8%) Convertible Notes
("August  Notes")  dated August 20, 1997 in the  aggregate  principal  amount of
$200,000  issued to  Gundyco  in trust for RRSP 550 99119 12,  and the resale of
such shares of Common Stock by such Selling Shareholders.

         We have examined copies of the Registration  Statement,  the Prospectus
forming a part  thereof,  the  Certificate  of  Incorporation  and Bylaws of the
Corporation,  each as amended to date,  the  minutes  of  various  meetings  and
unanimous written consents of the Board of Directors and the shareholders of the
Corporation, and original, reproduced or certified copies of such records of the
Corporation and such agreements,  certificates of public officials, certificates
of officers and  representatives  of the Corporation and others,  and such other
documents,  papers,  statutes and  authorities  as we deem necessary to form the
basis  of the  opinions  hereinafter  expressed.  In such  examination,  we have
assumed  the  genuineness  of all  signatures  and the  conformity  to  original
documents of all documents  supplied to us as copies. As to various questions of
fact material to such opinions,  we have relied upon statements and certificates
of officers and representatives of the Corporation and others.

         Based  on  the  foregoing,  we  are of the  opinion  that  each  of the
2,150,000  shares of Common Stock,  when issued in accordance  with the terms of
the July  Notes  and the  August  Notes,  as the  case may be,  will be duly and
validly issued by the Corporation, fully paid and nonassessable.

         We hereby consent to the reference to our firm under the caption "Legal
Matters" in the  Prospectus  forming part of the  Registration  Statement and to
your filing a copy of this Opinion as an exhibit to said Registration Statement.

                                                Very truly yours,



                                                /s/ Kirkpatrick & Lockhart LLP
                                                KIRKPATRICK & LOCKHART LLP







                                    AGREEMENT

         AGREEMENT  (this  "Agreement"),  dated as of November 30, 1997,  by and
among NETWORK IMAGING CORPORATION, a corporation organized under the laws of the
State  of  Delaware  (the  "Company"),   and  the  undersigned   (together  with
affiliates, the "Initial Investors").

         WHEREAS:

          A. In  connection  with that certain  Securities  Purchase  Agreement,
dated as of July 28,  1997,  by and among the Company and the Initial  Investors
(the  "Securities  Purchase  Agreement"),  the  Company  issued  and sold to the
Initial  Investors 3,300 shares of the Company's Series K Convertible  Preferred
Stock,  par  value  $.0001  per  share  (the  "Preferred  Stock").  The  rights,
preferences  and  privileges  of the  Preferred  Stock  are set  forth  in the C
Certificate of Designations Preferences and Rights of the Preferred Stock in the
form  attached  hereto  as  Exhibit  A  (the   "Certificate  of   Designation").
Capitalized  terms used and not otherwise  defined herein shall have the meaning
ascribed thereto in the Certificate of Designation.

          B. Pursuant to the Certificate of Designation,  the Initial  Investors
have the right to require  the Company to redeem the shares of  Preferred  Stock
held by such  Initial  Investors  in  certain  circumstances  set  forth  in the
Certificate of Designation (the "Redemption Rights").

          C. The Company desires to induce the Initial Investors to agree not to
exercise certain of their Redemption Rights as described herein.

         NOW,  THEREFORE,  in  consideration  of the  premises  and  the  mutual
covenants  contained  herein  and other  good and  valuable  consideration,  the
receipt and  sufficiency of which are hereby  acknowledged,  the Company and the
Initial Investors hereby agree as follows:

          1. The Initial  Investors agree not to exercise their right to require
the Company to effect a  redemption  of their  outstanding  shares of  Preferred
Stock upon a Redemption Event specified in Article VIII.A.(i) of the Certificate
of  Designation  so long as the Company  pays to each of the  Initial  Investors
within five (5) business days of the  occurrence of such  Redemption  Event,  as
liquidated damages for the decrease in the value of the Preferred stock (and the
shares of the Company's  Common Stock  issuable upon  conversion  thereof) which
will  result  from the  occurrence  of such  Redemption  Event,  an amount  (the
"Damages  Amount")  equal to  twenty-five  percent (25%) of the  aggregate  Face
Amount of the shares of Preferred Stock then held by each such Initial Investor.
The Damages Amount shall be payable,  at the Company's option, in cash or shares
of Common Stock that have been  registered by the Company  under the  Securities
Act for resale by the Initial  Investors (based upon a price per share of Common
Stock equal to fifty  percent  (50%) of the lowest  Closing  Price of the Common
Stock on any single  trading  day during the ten (10)  consecutive  trading  day
period  ending  on the  trading  day  immediately  preceding  the  date  of such
Redemption Event). The Company represents and warrants that it has reserved, and
agrees  to keep  reserved,  3,000,000  shares  of Common  Stock to  satisfy  its
obligation with respect to the Damages  Amount.  In the event that the number of
shares  required to be issued by the Company with respect to the Damages  Amount
exceeds  3,000,000  shares  of  Common  Stock  and the  Company  does not have a
sufficient  number of  shares  of Common  Stock  authorized  and  available  for
issuance to satisfy its  obligation  with  respect to the  Damages  Amount,  the
Company shall issue and deliver to the Initial Investors all 3,000,000 shares of
Common Stock so reserved for such purpose and, upon such  issuance,  the Initial
Investors shall have no right of redemption upon a Redemption Event specified in
Article VIII.A.(i) of the Certificate of Designation, but shall retain all other
remedies to which they may be entitled at law or inequity  (which remedies shall
not include the right of redemption).

          2. The  Initial  Investors  agree not to  exercise  their  right under
Article V.B. of the  Certificate of Designation to require the Company to effect
a redemption of their  outstanding  shares of Preferred Stock so long as (i) the
Company has not, at any time,  decreased  the Reserved  Amount below  12,500,000
shares of Common  Stock;  (ii) the  Company  shall have taken  immediate  action
following the applicable  Authorization  Trigger Date (including,  if necessary,
seeking  shareholder  approval to authorize the issuance of additional shares of
Common Stock) to increase the Reserved Amount to 200% of the number of shares of
Common Stock then issuable upon conversion of the outstanding  Preferred  Stock;
and (iii) the Company  continues to use its good faith best  efforts  (including
the  resolicitation  of  shareholder  approval  to  authorize  the  issuance  of
additional  shares of Common  Stock) to increase the Reserved  Amount to 200% of
the  number of shares of Common  Stock  then  issuable  upon  conversion  of the
outstanding  Preferred  Stock. The parties hereby agree that the Company will be
deemed to be using "its good faith best efforts" to increase the Reserved Amount
so long as it  solicits  shareholder  approval  to  authorize  the  issuance  of
additional  shares of Common  Stock not less than  three (3) times  during  each
twelve month period following the applicable  Authorization  Trigger Date during
which any shares of Preferred Stock remain outstanding.

          3. The parties agree that the Initial Investors shall have no right to
require  the  Company  to effect a  redemption  of their  outstanding  shares of
Preferred Stock upon a Redemption Event specified in Article  VIII.A.(ii) of the
Certificate of Designation (each, a "Registration  Redemption Event"), but that,
in lieu of such right,  Section  2(c) of the  Registration  Rights  Agreement is
hereby amended to provide that, upon the occurrence of a Registration Redemption
Event and while such  Registration  Redemption  Event  continues,  the permanent
reductions to the  Conversion  Percentages  set forth in such Section 2(c) shall
accrue at the rate of two  hundredths  (.02) per week instead of two  hundredths
(.02) per month. The parties agree that there shall be no limit on the aggregate
reductions which can be made to each of the Conversion  Percentages  pursuant to
this Section 3.

          4. The Initial  Investors agree not to exercise their right to require
the Company to effect a  redemption  of their  outstanding  shares of  Preferred
Stock  upon  a  Redemption  Event  specified  in  Article  VIII.A.(v)(c)  of the
Certificate of Designation so long as the company has not approved,  recommended
or otherwise consented to the transaction which triggered such Redemption Event.

          5. (a) Failure of any party to exercise any right or remedy under this
Agreement or otherwise,  or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.

                  (b) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Delaware  applicable to contracts made
and to be performed in the State of Delaware.  The Company irrevocably  consents
to the  jurisdiction  of the United States  federal  courts and the state courts
located  in the  City  of New  York in the  State  of New  York  in any  suit or
proceeding based on or arising under this Agreement and irrevocably  agrees that
all claims in  respect  of such suit or  proceeding  may be  determined  in such
courts.  The Company  irrevocably waives the defense of an inconvenient forum to
the  maintenance  of such suit or  proceeding.  The Company  further agrees that
service of process upon the Company,  mailed by first class mail shall be deemed
in every respect  effective service of process upon the Company in any such suit
or proceeding. Nothing herein shall affect the Initial Investors' right to serve
process in any other manner  permitted  by law. The Company  agrees that a final
non-appealable  judgment in any such suit or proceeding  shall be conclusive and
may be enforced in other  jurisdictions by suit on such judgment or in any other
lawful manner.

                  (c) Except as expressly  provided herein, all of the terms and
provisions of the  Certificate of  Designation  shall continue in full force and
effect and nothing  contained  herein shall be deemed to  constitute a waiver by
the  Initial  Investors  of  any  of  their  rights  under  the  Certificate  of
Designation,   the  Securities  Purchase  Agreement,   the  Registration  Rights
Agreement or any other agreement among the Company and the Initial Investors.

                  (d)  This  Agreement  shall  inure  to the  benefit  of and be
binding  upon the  successors  and  assigns of each of the  parties  hereto.  In
addition,  the Initial Investors (and any transferees of the Initial  Investors)
shall be  prohibited  from  transferring  any shares of Preferred  Stock unless,
prior to any such proposed  transfer,  (i) the Company is furnished with written
notice of the name and  address of such  transferee,  (ii) at or before the time
the Company  receives  the  written  notice  contemplated  by clause (i) of this
sentence,  the transferee agrees in writing for the benefit of the Company to be
bound by all of the provisions  contained herein following such transfer,  (iii)
such  transfer   shall  have  been  made  in  accordance   with  the  applicable
requirements  of  the  Securities   Purchase   Agreement,   the  Certificate  of
Designation,  the Securities Act and applicable  state securities laws, and (iv)
the further  transfer or disposition  of such Preferred  Stock by the transferee
(and any  subsequent  transferees)  is  restricted  pursuant  to the  provisions
hereof.

                  (e)  This   Agreement   may  be   executed   in  two  or  more
counterparts,  each of which shall be deemed an original  but all of which shall
constitute one and the same agreement. This Agreement, once executed by a party,
may be delivered to the other party hereto by facsimile  transmission  of a copy
of this  Agreement  bearing  the  signature  of the  party  so  delivering  this
Agreement.

                     [REMAINED OF PAGE INTENTIONALLY BLANK]



<PAGE>


         IN WITNESS  WHEREOF,  the parties have caused this Agreement to be duly
executed as of the date first above written.



NETWORK IMAGING CORPORATION

By:________________________

Name:______________________

Title:_____________________



INITIAL INVESTORS:

ZANETT LOMBARDIER, LTD.

By:_________________________

Name:_______________________

Title:______________________


CAPITAL VENTURES INTERNATIONAL

By:_________________________

Name:_______________________

Title:______________________





                         Consent of Independent Auditors


We consent to the  reference to our firm under the caption  "Experts" and to the
use of our report  dated  February 14, 1997  included in Amendment  No. 1 to the
Registration  Statement  (Form  S-1  dated on or about  December  3,  1997) and
related  Prospectus  of Network  Imaging  Corporation  for the  registration  of
2,150,000 shares of its Common Stock.



Vienna, Virginia
December 3, 1997                             /S/ Ernst & Young LLP





                       CONSENT OF INDEPENDENT ACCOUNTANTS



We  hereby  consent  to the  use in the  Prospectus  constituting  part  of this
Registration  Statement on Form S-1 of Network Imaging Corporation of our report
dated March 29, 1996  relating to the financial  statements  of Network  Imaging
Corporation, which appears in such Prospectus. We also consent to the references
to us  under  the  headings  "Experts"  and  "Independent  Accountants"  in such
Prospectus.


PRICE WATERHOUSE LLP

Falls Church, Virginia
December 2, 1997



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission